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Abstract 
 
Intrinsically disordered proteins (IDPs) are characterized by the lack of a well-
structured three-dimensional fold. This property confers them functional 
advantages, complementary to those of folded proteins, which need to be 
characterized to expand our view of how protein structural and dynamic 
features affect function beyond the static picture of a single well defined 3D 
structure.  
IDPs are often able to bind to different partners or to act as hub proteins, 
playing in this way an important role in a variety of different processes.  IDPs 
are particularly relevant for viruses which need to exploit simple amino acid 
sequences (short linear motifs, SLiMs), well exposed and ready to function, to 
interact with crucial key proteins from the host organism. However, the 
molecular basis concerning the mechanisms of these interactions are not yet 
completely understood.  
In this work we present the study of two viral proteins, the E7 from Human 
Papilloma Virus and the E1A from Human Adenovirus. E7 and E1A share 
sequence and structural similarities, shown to be crucial for interaction and 
deregulation of key proteins from the host, towards cancer development. 
Here we will show the structural and dynamic characterization of these two 
proteins by Nuclear Magnetic Resonance (NMR), supported by other 
biophysical techniques like Small-Angle X-ray Scattering (SAXS), laying the 
basis for the study of their interactions with medically relevant targets. 
Besides the importance for evolutionary biology, understanding the 
molecular basis of these interactions will open a wide range of opportunities 
to understand dozens of interactions of these viral IDPs with their partners 
through their short linear motifs. 
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1. Introduction 
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The so-called structure-function paradigm states that a three-dimensional 
structure is a prerequisite for a protein to be functional (Wright and Dyson, 
1999). Despite initial reports showing the protein-function relationship 
present in an unstructured state, reviewed in (Uversky, 2013a), the occasional 
discovery of functional disordered proteins was largely overshadowed by the 
regular appearance of specific three-dimensional protein structures obtained 
through X-ray crystallography or NMR spectroscopy methods (Rezaei Ghaleh 
et al., 2012). Only in the ‘90s the importance of local flexibility in determining 
the function of proteins has been recognized and widely scrutinized (Wagner, 
1993).  
Comparison of the results of the X-ray and NMR analyses of the same protein 
has revealed that solution and crystal structures can be quite different, with 
solution structures being, is some cases, much more flexible (Lian, 1998) than 
those obtained by crystallography. In several cases NMR spectroscopy was 
able to describe protein segments that were missing in crystallographic 
experiments and to characterize flexible regions that were escaping detection 
or had become rigid due to crystal packing (Mittermaier and Kay, 2006). 
Proteins lacking a stable well defined 3D structure characterized by extensive 
flexibility have been named in the literature in many different ways like 
"intrinsically unstructured", "natively denatured", "natively unfolded" among 
others (Dunker et al., 2013).  Intrinsically disordered proteins (IDPs) has now 
become the widely accepted term to indicate these proteins. "Intrinsically" 
rather than "natively" as many IDPs can fold upon binding to the partner, and 
"disordered" rather than "unstructured" to highlight the possible transient 
existence of local and global structures (Rezaei Ghaleh et al., 2012). In this way 
intrinsically disordered regions (IDRs) present in mainly folded proteins can 
also be defined. The Disprot database [http ://www.disprot.org, (Sickmeier et 
al., 2007)] latest release (May 2013) contains 1539 disordered regions in 694 
IDPs, numbers that are increasing over the years (Figure 1.1) even if 
IDPs/IDRs are often difficult to categorize. Recently a new database of IDPs 
was created to combine all the information obtained from different 
biophysical techniques such as NMR and SAXS, the Protein Ensemble Data 
Base (pE-DB, http://pedb.vib.be) where IDPs are described as structural 
ensembles (Varadi et al., 2013).  
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Figure 1.1. IDPRs and IDPs reported on Disprot database, since its start in 2005.  
 
If the extent of local flexibility is taken to its extreme conditions it leads to 
completely random coil behavior of a polypeptide chain (Bertini et al., 2012; 
He et al., 2009) through a wide variety of intermediate cases both in terms of 
extent of mobility or in terms of protein stretches involved, as a continuous 
spectrum of possible protein states (Uversky, 2013b).  
Despite the absence of a rigid secondary or tertiary structure, IDPs fulfill a 
number of biological functions, that range from regulation of transcription 
and translation, storage of small molecules and regulation of the self-
assembly of large multi-protein complexes (Dunker et al., 2008b; Tompa, 
2012). Indeed, many examples of IDPs appeared in the literature showing 
how their structural plasticity, adaptability, intrinsic flexibility, can actually 
be a key feature to enable them to interact with a variety of different partners, 
to adapt to different conditions and to act as hub proteins (Mittag and 
Forman-Kay, 2007; Uversky et al., 2005; Wright and Dyson, 1999). These 
peculiar properties provide functional advantages to IDPs enabling them to 
play key roles in many regulatory processes (Fuxreiter et al., 2008).  Thus, 
IDPs have been recognized as relevant players in pathologies associated with 
protein misfolding and aggregation, as observed in several human 
degenerative diseases (Uversky et al., 2008). The obsolete perception that IDRs 
simply act as domain linkers has been replaced by a model where these 
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regions may contain numerous regulatory and signaling modules (Diella et 
al., 2008; Dyson and Wright, 2005; Fuxreiter et al., 2007). Many eukaryotic hub 
proteins, such as p53, contain large segments of IDRs maximizing interaction 
interfaces in a constrained space (Haynes et al., 2006).  
Thanks to the largely extended and exposed backbones, IDPs often display 
short amino acid segments (short linear motives, SLiMs) that may interact 
with different partners (Davey et al., 2011; Tompa and Fuxreiter, 2008). This 
strategy of exploiting proteins’ SLiMs for driving interactions seems to be 
extensively used by viruses to infect healthy cells. In virtue of their small 
genomes, which are able to code only a limited number of proteins, viruses 
need effective ways to interfere with the host (Davey et al., 2011). This is the 
case of human papilloma virus (HPV) (Chemes et al., 2012) as well the human 
adenovirus (HAdV) (Pelka et al., 2008). Several proteins encoded by these two 
viral genomes play similar roles in several human pathways. Good examples 
are HPV E7 and HAdV E1A proteins, both playing a crucial interaction with 
the pRB tumor suppressor, which may lead to cancer development upon viral 
infection. Moreover, both E7 and E1A interact with key host regulators such 
as the general transcriptional co-activator CREB binding protein (CBP), a 
large human protein comprising many globular domains linked by five 
intrinsically disordered (ID) domains which have not been studied yet (Bernat 
et al., 2003; Ferreon et al., 2013). 
The HPV E7 protein has been studied for more than 30 years, and its key role 
on cervix cancer development is established (McLaughlin-Drubin et al., 2012). 
It has been reported that a multitude of different partners interact with E7 but 
the molecular basis of these interactions at atomic resolution level are not 
known. The tendency of E7 protein to form oligomers has been also reported 
that but is not clear how this phenomenon occurs. The high-resolution 
characterization of the E7 protein is crucial for further studies of protein 
interaction, oligomer formation and drug design. 
The HAdV E1A protein belongs to a different viral origin but presents a high 
homology with the E7 protein, also interacting with pRB and CBP/p300 
(Ferreon et al., 2009). The atomic resolution characterization of the full-
construct of the E1A protein has never been achieved, compromising the 
understanding of the molecular basis of interactions with possible partners 
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like the CBP. Moreover, the comparison between E7 and E1A homology 
functions has been attempted (Fera and Marmorstein, 2012) but never 
combining of low and high methods. 
Understanding the molecular basis of the functional role of IDPs requires 
their characterization at atomic resolution. The presence of dynamic 
ensembles of conformations under physiological conditions makes their 
analysis difficult to achieve but NMR has been proven a useful tool to analyze 
IDPs (Bermel et al., 2009; Davey et al., 2011; Felli and Pierattelli, 2012; Mittag 
and Forman-Kay, 2007; Wright and Dyson, 1999) in conjunction with low-
resolution techniques like circular dichroism (CD), dynamic light scattering 
(DLS) and small-angle X-ray scattering (SAXS).  Because	   IDPs	   are	   characterized	   by	   a continuous spectrum of possible 
disordered states (Uversky, 2013b), the expression and purification of these 
complex proteins may represent a serious challenge with respect to well-
folded proteins (Tompa, 2012). The NMR characterization of IDPs requires the 
production of high-purity isotopically labeled samples in sufficient amount 
for analysis. This involves the use of different techniques for the expression 
and purification of these particular proteins. Different protocols of expression 
and purification should be tested in order to optimize the expression systems.  
In the following sections the results obtained for both E7 full-length, for a 
shorter construct E7 CR3 domain as well for both E1A 12S and E1A 13S 
proteins are presented and discussed. The high-resolution characterization of 
these proteins opens the way for the understanding the molecular basis 
through which these viral IDPs hijack cell regulation. 
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2.1. Human Papilloma Virus E7 protein 
 
Human papillomaviruses (HPVs) are small double stranded DNA viruses 
that infect the squamous epithelium, the superficial layer of animal tissue. 
HPV is a family of more than 100 different viruses (Bernard et al., 2010). They 
can be clinically classified as “low-risk” (LR), causing benign warts, but 
among the genital HPVs, which are sexually transmitted, 15 are categorized 
as "high risk" (HR) and are considered the causative agents of most cervical 
cancers (Moody and Laimins, 2010a), the second most common cancer in 
women worldwide (Hausen, 2002). Infection with HPV forces quiescent cells 
to enter the cell division cycle and thus the abnormal cell proliferation 
initiates progression to the cancer (McLaughlin-Drubin and Münger, 2009; 
Schiffman et al., 2007). The entire genome of HPV includes six nonstructural 
proteins (E1, E2, E4, E5, E6, and E7) and two structural proteins (L1 and L2). 
The interactome of all these proteins have been recently reviewed (Xue et al., 
2013). The HR HPV 16 is considered the most carcinogenic (Hausen, 2002) 
and its oncogenic potential relies on the expression of two proteins, E6 and E7 
(Boulet et al., 2007; Narisawa Saito and Kiyono, 2007) which are consistently 
present in HPV-associated carcinomas and are necessary for induction and 
maintenance of the transformed phenotype (Münger et al., 2004). E6 promotes 
tumorigenesis by stimulating cellular degradation of the tumor suppressor 
p53 while E7 binds pRB, the product of the retinoblastoma tumor 
susceptibility locus, which is an important regulator of cell growth (Malloy 
and Carson, 2008) (Banks et al., 2012). The HPV 16 E6 and E7 genes together 
are necessary and sufficient for transformation of primary human 
keratinocytes, the predominant cell type in the epidermis (Münger et al., 1989).  
E7 is a small protein constituted by about one hundred amino acids. Three 
conserved regions (CR), namely CR1 and CR2 in the N-terminal half and CR3 
in the C-terminal half (Phelps et al., 1992) (Todorovic et al., 2012) can be 
identified (Figure 2.1). The first two (CR1 and CR2), which have been found 
to interact with a high variety of target proteins, (McLaughlin-Drubin and 
Münger, 2009) show a high propensity to be disordered (Uversky et al., 2006). 
The CR3 region, which contains two Cys-X-X-Cys motifs separated by 29 to 
30 amino acids, has been shown to bind zinc (Barbosa et al., 1989) and is 
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expected to be more structured (Uversky et al., 2006). The structural 
characterization of CR3 of the protein, that contains the zinc binding motifs, 
has been achieved for short constructs comprising only CR3 for the LR HPV 
1a variant through X-ray (Liu et al., 2006) and for the HR HPV 45 variant 
through nuclear magnetic resonance (NMR) spectroscopy (Ohlenschläger et al, 
2006). However the whole protein failed to give crystals and its 
characterization through NMR was never reported. Thus, atomic resolution 
information on HPV 16 E7 was lacking despite the interest in accessing high-
resolution information on the protein responsible for the high oncogenic 
potential of this variant, and on its interactions. Sedimentation equilibrium 
experiments have shown that E7 presents oligomerization properties and can 
be found as monomers, dimers, and tetramers, but under physiological 
conditions it is primarily dimeric (Clements et al., 2000).  
Among the many documented interactions of E7 with host’s proteins, 
(Chemes et al., 2012) the one with pRB plays a key role in its oncogenic 
potential and has been extensively characterized through many techniques 
(Uversky and Longhi, 2011).  The structure of a short polypeptide containing 
the LXCXE motif localized in the CR2 region (Dyson et al., 1989) bound to 
pRB is available, providing precious hints to understand how this short 
fragment binds to pRB (Lee et al., 1998). However this polypeptide has much 
lower affinity for pRB respect to the whole protein (Dyson et al., 1989) 
indicating that other parts of the protein also contribute to the binding 
(Chemes et al., 2010). The E7 mutational studies that provided the available 
functional information on all the three different CRs have been recently 
reviewed (Roman and Munger, 2013) summarizing almost 30 years of studies 
on papillomavirus E7 proteins. E7 binds to several other partners, increasing 
their activity, to enhance pRB degradation.  The cullin 2 ubiquitin ligase 
complex, is bound by the CR1 of the E7 protein (Huh et al., 2007). 
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Figure 2.1. Schematic representation of HPV16 E7 oncoprotein including the amino-acid 
sequence, its division into the three conserved regions and interaction partners (Based on 
(Chemes et al., 2012). CR1 (15 residues), CR2 (22 residues) and CR3 (61 residues) based on 
HPV45 NMR solution structure (Ohlenschläger et al, 2006).  
 
The CR3 also interacts with the subunit 4 (S4) ATPase of the S26 proteasome 
and enhances its APTase activity providing another pathway for pRB 
degradation (Berezutskaya et al., 1997). E7 interacts through the N-terminal 
half also with other pRB related tumor suppressor proteins, p107 and 130 
(Davies et al., 1993; Dyson et al., 1992b). E7 also interacts with CBP/p300 
proteins family a key host transcriptional coactivator (Bernat et al., 2003). 
These are just a few examples of the complex array of interactions established 
by viruses like HPV to hijack cell regulation and ensure survival.  
To contribute to the understanding of the sophisticated mechanisms behind 
HPV-related diseases it would be of primary importance to access high 
resolution structural and dynamic information of its small, though complex, 
oncogenic proteins.   
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2.2. Human Adenovirus E1A protein 
 
Adenoviruses (AdV) are medium-size viruses representing the largest non-
enveloped viruses. Named for their discovery in adenoid tissue, Human 
Adenoviruses (HAdV) cause a variety of respiratory, gastrointestinal tract or 
eye infections. All HAdV are 90nm diameter, with an icosahedral 
nucleocapsid and non-enveloped particles with fibers protruding from each 
vertex of the virion (Stewart et al., 1991) (Figure 2.2). 
 
Figure 2.2. The structure of adenoviruses. (a) Electron micrograph of an adenovirus. (b) 
Model of an adenovirus to show arrangements of the capsomers (Dimmock et al., 2007).  
 
Currently 57 accepted HAdV serotypes are known to transform cultured 
rodent cells promoting tumorigenesis in immune-compromised rodents 
(Gallimore, 1972) establishing HAdVs as useful model systems for studying 
the mechanisms of cancer. HAdVs have played a large role understanding the 
DNA replication, cell cycle control, transcription, apoptosis, immunological 
responses to viral infections, and mRNA processing like the importance of 
mRNA splicing. (Dimmock et al., 2007). These studies of adenovirus 
oncogenicity demonstrate how important the immune system is in preventing 
the growth of tumors. In the last few years, the activities of virus-encoded 
proteins leading to transformation and tumorigenesis have become much 
clear. The first genomes to be completely sequenced were the closely related 
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HAdV-2 and 5 and since then they have been extensively manipulated to 
create viruses that express proteins containing one or more mutations. The 
genome of HAdV contains approximately 36000 bp of linear, double-stranded 
DNA encoding five early (E1A, E1B, E2 early, E3, E4), three delayed-early (IX, 
IVa2, E2 late) which are transcribed by cellular RNA polymerase II (Halldén, 
2012). Each of these transcripts is alternatively spliced, giving rise to multiple 
mRNAs. Moreover, many alternatively spliced products of an individual 
transcriptional unit encode proteins with similar function, as the case of the 
two major E1A proteins forms – 13S and 12S. Detailed study of the E1A 
proteins has been crucial to understand how transcription can be controlled in 
eukaryotes.  
The HAdV E1A protein is the first protein produced post-HAdV infection, 
and serves two main functions. The first is to modulate host and viral 
transcription. The second is to force host cell cycle progression into S phase, to 
promote an optimal environment for viral replication. Early HAdV gene 
products are responsible for activating transcription of viral genes, inducing 
host cell cycle progression, initiating viral DNA replication, and blocking 
apoptosis and host anti-viral responses. The E1A transcriptional unit contains 
a constitutively active enhancer, and is the first viral gene expressed during 
infection and is essential for viral replication (Jones and Shenk, 1979b; Nevins 
et al., 1979). E1A gene products are the primary trans-activators of the viral 
genome, and thus the functions of other early genes intimately depend on 
E1A (Hearing and Shenk, 1983). The various E1A proteins modulate viral and 
cellular transcription, induce host cell cycle progression to S phase to create 
an optimal environment for viral replication, and inhibit host anti-viral 
responses through a variety of intricate mechanisms. Since E1A proteins have 
no enzymatic or DNA binding ability, their activities rely on manipulation of 
cellular factors to exert their effects (Ferguson et al., 1985). The E1A gene 
encodes five proteins, termed 9S through 13S based on the sedimentation 
coefficients of their respective alternatively spliced mRNAs. 13S (289 
residues) and 12S (243 residues) are the main products expressed early during 
infection, and are the best characterized (Pelka et al., 2011; Perricaudet et al., 
1979) even if no structural information is available. They differ only by a 46 
amino acid sequence found in 13S but not 12S. The 11S, 10S, and primarily 9S 
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are expressed later in infection, however their functions are not well 
understood (Stephens and Harlow, 1987). It was shown recently that 9S E1A 
could independently activate expression of viral genes, and promote HAdV 
replication, and that replication was dependent on an interaction of 9S with 
the S8 component of the proteasome (Miller et al., 2012). This is intriguing as 
only 28 amino acids are common between 9S and the larger forms of E1A.  
Amino acid sequence alignment of 13S E1A from various serotypes reveals 
the presence of four main conserved regions (CR1-CR4), which are separated 
by less conserved regions (Kimelman et al., 1985) as shown on Figure 2.3. Not 
only the CRs but also other areas of the E1A protein participate in important 
protein-protein interactions with over 50 cellular factors through SLiMs 
(Davey et al., 2011; Pelka et al., 2008). The identification of these motifs has 
been important as a molecular tool as already shown for E7 protein (Chemes 
et al., 2012).  
 
 
Figure 2.3. Diagram of E1A splice 12S and 13S E1A proteins.  B) Alignment of 13S (289R), 12S 
(243R) proteins and location of conserved regions (CR) 1-4 including the deleted CR3 region 
from splicing on 12S E1A. The sequence of each HAdV-5 E1A SLiM is indicated bellow the 
respective CR where the partners interact. The known partners are listed bellow the HAdV-5 
SLiM. Adapted from (Chinnadurai, 2011). 
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Both 13S and 12S E1A can bind pRb (Rb “pocket” domain) through CR1, and 
more importantly, through an LXCXE motif in CR2. This motif binds to the 
pRB to displace E2F, bypassing the normal cell cycle regulatory signals, and 
thereby forcing cell entry into S-phase due to constitutive activation of E2F-
responsive promoters (Bandara and La Thangue, 1991; Zamanian and La 
Thangue, 1992). Adenovirus E1A makes two distinct contacts with the 
retinoblastoma protein (Dyson et al., 1992a). E1A mutants unable to bind pRb 
still retain the ability to induce an S-phase transition in host cells, through the 
N-terminus/CR-1, and therefore other known and unknown targets of E1A 
must be influencing host cell cycling (Zerler et al., 1987).  The E1A N-terminus 
(residues 1-41) and CR-3 together are required for optimal early gene 
transactivation (Wong and Ziff, 1994). They have been shown to interact with 
repressors such as the p400 chromatin remodeling complex (Fuchs et al., 2001) 
as well with a variety of transcription-activators including histone acetylases 
p300/CBP and p300/CBP-associated factor (pCAF) (Frisch and Mymryk, 
2002; Pelka et al., 2008). The interaction of a small fragment of E1A [53-91] 
with TAZ2 domain from CBP/p300 was shown by NMR (Ferreon et al., 2009), 
opening the way to many possible studies at atomic resolution level.  
The CR3 region - the extra 46 residues unique to 13S E1A – contains four 
cysteines predicted to form a zinc-finger domain, although the structure is 
still undetermined (Culp and Webster, 1988). HAdVs with complete knockout 
of 13S E1A or mutations in CR3, experience drastically reduced rates of early 
gene transcription (Berk et al., 1979; Jones and Shenk, 1979a). This is because 
CR3 functions as a potent trans-activator by binding the DNA-binding 
domains of transcription factors at early HAdV promoters through its CR3 C-
terminal 10 amino acids, and recruiting transcriptional regulators through its 
N-terminal zinc-finger domain (Lillie and Green, 1989) (Liu and Green, 1994). 
CR3 interacts not only with transcriptional activators, such as TATA binding 
protein (TBP), and the p300/CREB-binding protein (CBP) (Pelka et al, 2009), 
but also with repressors such as BS69 (Hateboer et al., 1995) and GCN5 
(Ablack et al, 2012), indicating that CR3 modulation of early gene 
transcription is complex (Pelka et al., 2009). CR3 was also found to interact 
with CtBP causing hyper-activation of CtBP occupied promoters (Bruton et al., 
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2008). All this reported interactions of E1A CR3 have been compared across 
different HAdV subgroups (Ablack et al., 2010). 
CR4 is the region encoded by the second exon of E1A spanning residues 240 
to 288 of HAdV5 E1A (Pelka et al., 2008). While E1A can interact with over 50 
known proteins, only four binding partners have been identified for CR4. The 
first E1A CR4 binding partners, and hence the best characterized is the 
transcriptional co-repressors CtBP (the E1A C-terminus binding protein). 
Interaction of CtBP with HAdV5 E1A requires the PLDLS SLiM, and this 
sequence, or closely related variants, is present in all known E1A sequences as 
well as in those of many cellular proteins that interact with CtBP. This 
interaction removes CtBP from sequence specific transcription factors, 
relieving repression of cellular genes (Chinnadurai, 2002). Other partners are 
the Forkhead transcription factors FOXK1 and FOXK2, which interactions 
occur outside CR4 and requires residue S219, which must be phosphorylated 
for binding. The tyrosine-regulated kinase (DYRK) proteins are also reported 
to interact with CR4 as well the importin-α3 (also known as Qip1) (Cohen et 
al., 2013; Subramanian et al., 2013).  
Among the many documented interactions of E1A with a variety of different 
proteins by host cells, one of them attracted our attention, that is the one with 
the human CREB-binding protein (CBP) (UniProt Q92793). CBP is a co-
activator human protein related with long-term memory formation as well 
with acute amyloid leukemia. Together with p300 (a less extended analogous 
of CBP protein) CBP/p300 are a family of proteins playing a key role on 
interaction with G protein signaling. CBP is 2442 residues protein where five 
IDRs have never been described. A short fragment of this protein named 
CBP-ID4, constituted by a 202 residues region [1856-2058] and predicted to be 
completely unfolded (Figure 2.4), is expected to interact with E1A.  
However, the interaction was proved between a short E1A fragment [53-91], 
with the CBP-TAZ2 structured domain (91 residues) that is located before 
CBP-ID4 (Figure 2.5). 
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Figure 2.4. Schematic representation of the domain architecture of CBP/p300. The disordered 
and ordered regions were predicted by PONDR-FIT (Xue et al., 2010). The structures of each 
domain are shown and labeled. Top the CBP Bromo domain (PDB: 3DwY); the zinc-binding 
mode of the PHD domain of CBP/p300 (no high-resolution structure available); the p300 
HAT domain in complex with an inhibitor (PDB: 3BIY); the CBP ZZ domain (PDB: 1TOT). 
Bottom the CBP TAZ1 domain (PDB: 1U2N); KIX domain in complex with FOXO3a PDB: 
2LQH and 2LQI); the p300 TAZ2 domain (PDB: 3IO2) and its interaction with E1A CR1 
comprising residues [53-91] (PDB: 2KJE); the molten globule state structure of CBP NCBD 
domain (PDB: 2KKJ), and the structured complex of NCBD with p53 formed through 
binding-coupled folding (PDB: 2L14). Transactivation domains that primarily interact with 
transcriptional activators are shown below and those that interact primarily with chromatin 
are shown on top. Adapted from (Wang et al., 2013). 
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Figure 2.5. Schematic representation of CBP (blue) and E1A (red) interaction. The position of 
ID4 right after the TAZ2 domain that interacts with E1A CR1 [53-91] may lead to interaction 
with other regions of E1A due to its proximity in the architecture of CBP.   
 
The analysis of the interaction between the E1A full construct with the CBP-
ID4 may shed light on the molecular basis of the interaction mechanisms 
between these two proteins. Therefore this appears an interesting interaction 
to be investigated to contribute to the understanding of how viral protein 
such as E1A and eventually E7 do interact with transcription factors. 
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3. The Methods 
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The study of the function of biomolecules is a highly interdisciplinary field. 
IDPs require specific skills to overcome the traditional way to analyze 
structured proteins (Uversky, 2011). In this section the different methods used 
in the present work are summarized, from genome browsing to samples 
preparation and analysis. 
 
 
3.1. Bioinformatics analysis 	  
GENOME BROWSING AND BIOINFORMATICS PREDICTION 
 
The era of genome-scale biology made available an incredible amount of 
biological data with the concomitant proliferation of biological databases. 
Here we describe many tools used in this work for our research to understand 
the protein function. Proteins are the primary cellular effectors responsible for 
mediating the vast majority of functions/activities needed for the cell to 
function. Structural biology requires a large number of steps to convert DNA 
sequence information into protein including the selection of the proper 
expression constructs, the setting of the right growth conditions and efficient 
purification strategy. To reach this goal, several databases and web software 
tools are available for the scientific community. These are data banks 
containing information on DNA and protein sequences, expression profiles 
and protein ensembles and structures. A set of different tools used is 
summarized in table 3.1. The different results obtained with these tools for 
each protein studied in this work are reported in the following chapters. 
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Table 3.1. Bioinformatics tools used in this work and short description of their functionalities. 
 
QQuery 
Is a global query cross-database search engine that allows users to search many discrete 
health sciences databases at the National Center for Biotechnology Information (NCBI) 
website. [http://www.ncbi.nlm.nih.gov/gquery] 
 
ViralZone 
A web resource provides genomic and proteomic sequences as well as factsheets on all 
known virus families/genera (Hulo et al., 2011).  
 
BLAST 
Is the Basic Local Alignment Search Tool, designed to explore all the available protein and 
DNA sequence databases. It allows to find similar sequences from different genomes. 
 
Clustal Omega 
It allows multiple sequence alignment for DNA as well as for protein sequences. Multiple 
sequence alignments tools are essential in most bioinformatics analyses that involve 
comparing homologous sequences. It calculates the best match for the input sequences 
allowing the analysis of identities, similarities and differences on the output data (Sievers et 
al., 2011). From the virology viewpoint, this can be applied to compare the same protein 
belonging to different genomes in the same viral family showing the CRs, as well between 
different proteins from different viral families allowing better understanding of evolutionary 
biology. 
 
ProtParam 
Is a tool to preliminary analyzing the protein target sequence, one of the fist tools useful to 
get information about pI of proteins, as well amino acid propensity and to calculate the molar 
extinction coefficient (that helps measuring protein concentrations with UV absorbance at 280 
nm). Is located at ExPASy server (Gasteiger et al., 2005). 
 
SIGNALP 
Is a post-translational modification predictor for signal peptides, glycosylation, 
phosphorylation and cleavage sites (Emanuelsson et al., 2007). 
 
DISPHOS 
Is a predictor of phosphorylation sites (Iakoucheva et al., 2004) that uses the Phospho.ELM 
phosphorylation database (Dinkel et al., 2011). 
 
SLiMFinder 
Is a predictor to find potential shared motifs in unrelated proteins using a model of 
convergent evolution and assigning a significance value to each motif (Davey et al., 2010) 
(http://bioware.ucd.ie/slimfinder.html). 
 
TMHMM  
Is a topology predictor of transmembrane region and their orientation (Krogh et al., 2001). 
 
PSIPRED 
Is a secondary structure prediction method (Buchan et al., 2013). 
 
PROSO 
Is a predictor of protein solubility (Smialowski et al., 2007) similar to SolPro (Magnan et al., 
2009) and the Prediction of Protein Solubility in E. coli (Diaz et al., 2010). 
 
MetalDetector 
Is a predictor of disulfide bridges and metal binding sites (Passerini et al., 2011) similar to 
DIANNA (Ferrè and Clote, 2006) and EDBCP (Cheng et al., 2006). 
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PREDICTORS FOR INTRINSICALLY DISORDERED PROTEINS 
 
More than 50 disorder predictors have been developed so far, since the first 
was created in Dunker's lab in 1996 (Romero et al., 1997). The properties of 
these predictors have been summarized and reviewed in several papers 
(Dosztányi and Tompa, 2008; Ferron et al., 2006; Uversky and Dunker, 2010). 
The majority of these predictors are available through public servers, and 
links to many of them can be found in the "Disordered Protein Database" 
(Disprot, http://www.dabi.temple.edu/disprot/index.php) (Sickmeier et al., 
2007) the "Database of Disordered Protein Prediction" (D2P2, http://d2p2.pro) 
(Oates et al., 2013) and in the recently created IDPbyNMR website 
(http://www.idpbynmr.eu/home/). The intrinsic structural disorder is a 
widespread phenomenon, especially in eukaryotes, where conservative 
bioinformatics predictions suggest that 5%–15% of proteins are IDPs, and 
about 35-50% of proteins have IDRs longer than 30 residues (Ward et al., 
2004a).  It has been accepted that disorder is needed for signaling among the 
various living systems, increasing with the organism complexity (Dunker and 
Obradovic, 2001). Indeed, in mammals 75% of signaling proteins are 
predicted to contain long disordered regions (Dunker et al., 2008a).  
A comparison between the amino acid sequences of IDPs and those of 
structured globular proteins showed that there are a number of significant 
differences, including amino acid composition, sequence complexity, 
hydrophobicity, aromaticity, charge, flexibility (Dunker et al., 2001). For 
example, IDPs are significantly depleted in hydrophobic (Ile, Leu, and Val) 
and aromatic (Trp, Tyr, and Phe) amino acid residues, which form and 
stabilize the hydrophobic core of folded globular proteins. These residues are 
called order-promoting amino acids. On the other hand, IDPs/IDRs are 
substantially enriched in polar (Arg, Gln, Glu, Lys, and Ser) and structure-
breaking (Gly and Pro) disorder-promoting amino acid residues (Dunker et 
al., 2001; Radivojac et al., 2007). Among the 20 common amino acid residues, 
proline is the most disordered-promoting (Theillet et al., 2013). The predictors 
are based on different principles and can be classified into three main 
categories (Tompa and Fersht, 2009). 
(i) propensity-based predictors: based on simple relative propensity of amino 
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acid residues.  They use the difference in the probability for a given amino 
acid to be in regular secondary structure or to be in random coil. These are the 
cases of predictors "Globpot" (Linding et al., 2003b) and "Foldindex" (Prilusky 
et al., 2005).  
(ii) machine learning algorithms: these are methods based and trained on 
datasets of disorder and order and evaluate intrinsic disorder on a per-
residue basis. Those datasets are created from sequence and structural 
information existent on PDB files and their missing information from 
unfolded regions. They can use artificial neural networks (NN) like DisEMBL, 
good for short disordered regions (Linding et al., 2003a) or support vector 
networks (SVMs) like DISOPRED2 (Ward et al., 2004b) where the input data 
are generated by sequence alignment using PSI- BLAST, which is trained on a 
database of amino acids missing from PDB structures. PONDR® is a family of 
algorithms where both NN and SVMs types of machine learning algorithms 
are used (He et al., 2009).  
(iii) algorithms based on inter-residue contacts: these are based on the inter-
residue contacts essential for the maintenance of the folded protein structure. 
A level is attributed to those inter-residue contacts, thus the disorder of 
proteins is originated from the lack or low level of the inter-residue contacts, 
which cannot compensate the large decrease in conformational entropy 
during folding (Tompa and Fersht, 2009). This is the case of predictor IUPred 
(Dosztányi et al., 2005).   
Thus it is now possible to predict the tendency of a polypeptide chain to be 
disordered based on its primary sequence with an approximate accuracy of 
80% (He et al., 2009). The accuracy of predictors is regularly assessed as part 
of the critical assessment of structure prediction (CASP) experiment 
(Monastyrskyy et al., 2011). To get higher accuracies the best approach when 
analyzing a new protein sequence is to use metapredictors that combine the 
output of several individual predictors. This is the case of metaPrDOS (Ishida 
and Kinoshita, 2008), MeDor (Lieutaud et al., 2008), MD (Schlessinger et al., 
2009) and PONDR-FIT (Xue et al., 2010). In this work, all the protein 
predictions presented were done using PONDR-FIT metapredictor. 
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MODELING   
 
The development of comparative software allows to study the homology 
modeling of protein's three-dimensional structures (Eswar et al., 2006). With 
this method, the user provides a sequence alignment of the protein of interest 
and obtains a model based on known related PDB structures. For example by 
using MODELLER model containing all non-hydrogen atoms calculated by 
the comparative protein structure modeling based on satisfaction of spatial 
restrains can be obtained (Šali and Blundell, 1993). MODELLER also performs 
de novo modeling of loops in protein structures, multiple alignments of 
protein sequences and structures, optimization of various models of protein 
structure with respect to a defined objective, searching of sequence databases, 
clustering, comparison of protein structures etc.  
 
3.2. Genes and Plasmids Generation 	  
With the development of new instruments that facilitate the production of 
biological material, nowadays the synthesis of genes containing the DNA 
sequence of a target protein is feasible. Many companies like Invitrogen's 
GenArt®, OriGene, Eurofins MWG Operon, GenScrip, and DNA2.0 among 
others, provide web tools to order these genes, with several possibilities and 
strategies, including the optimization of the codons for the specific expression 
organism. For example, the strategy of over-expressing recombinant proteins 
in E. coli systems could be compromised resulting in low yields of expression 
if the open reading frame (ORF) of the protein contains infrequently codons 
used by E. coli, the so called "rare codons". In particular codons for arginine 
(AGG, AGA, CGA), isoleucine (ATA), leucine (CTA) and proline (CCC) 
should be avoided (Schenk et al., 1995). Nevertheless, the gene of interest can 
be also extracted from the organism of interest, if the corresponding cDNA is 
available. The cloning strategy should be designed carefully, as it could be the 
basis of a successful work. An incorrect/unlucky cloning strategy could 
compromise the behavior of the downstream process like protein solubility, 
yield, misfolding, etc.  
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The standard procedure to express a recombinant protein is to carry out a 
screen of different constructs to identify the most efficient for downstream 
purposes. The first step of the cloning process consists in the amplification of 
target gene from DNA template or plasmids through polymerase chain 
reaction (PCR) using specific primers. After purification, the amplified 
product is inserted into a specific expression vector. Different vectors may be 
selected in order to obtain native protein or protein fused to different tags. 
The tags are known in size and biological function and can enhance solubility 
or affinity for some specific purification systems or can allow the transport of 
protein in the periplasmic compartment (Esposito and Chatterjee, 2006). Later 
on those tags may be removed by proteolytic cleavage with specific enzyme, 
such as factor XA, enterokinase (EK) or (Tobacco Etch Virus) TEV protease 
(Arnau et al., 2006; Malhotra, 2009).  
In the present work several plasmid were constructed or mutated to obtain 
the protein of interest. In particular the plasmid pET20/E7 containing the 
HPV 16 E7 gene was generously provided by Thomas Hey, Scil Protein 
GmbH, Halle, Germany (Mirecka et al., 2006); the E7 plasmids containing the 
silent mutations to improve the expression yield as well the plasmids of 
native E7 construct and the two E7 mutants for the cysteine residues C59A 
and C68T were prepared in this work using internal facilities. The plasmid 
pDEST17/E7CR3 containing the HPV16 E7 CR3 domain gene was prepared 
in this work using internal facilities.  
The plasmid pET42/E1A13S containing the HAdV 2/5 hybrid 13S E1A gene 
was generously provided by Joe Mymryk, University of Western Ontario, 
London, Ontario, Canada (Pelka et al., 2011). The plasmid pETG-20A/E1A12S 
containing the HAdV 2 12S E1A gene was prepared in this work using 
internal facilities. 
The plasmid pET200/CBPID4 containing the CBP ID4 domain was prepared 
in this work in close collaboration with Peter Tompa, VIB, Brussels. The 
plasmids used in this work are described in the next paragraphs, including 
the initial constructs and the protein sequences after proteolysis for tag 
removal. 
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PLASMID OF THE HPV 16 E7 FULL LENGTH - PET20/E7 	  
The HPV 16 E7 construct is inserted in a pET20 (Novagen) plasmid that was 
prepared by classical restriction enzyme cloning. The HPV 16 E7 protein 
target is a native 98 residues. The final construct is not the native protein but a 
construct including a C- terminus 6xHis tag linked by 2 extra residues 
(LEHHHHHH). Thus, the final expression construct is a 106 residues protein. 
All vector polylinkers and map, as well the protein and DNA sequences are 
described on table 3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 3.2. Datasheet of expression plasmid for HPV 16 E7. Description of vector map, target 
protein sequence and final expression protein and DNA sequences. 
 
Protein sequence of interest:  HPV 16 E7,  98 residues 
MHGDTPTLHEYMLDLQPETTDLYCYEQLNDSSEEEDEIDGPAGQAEPDRAHYNIVTFCCKCD
STLRLCVQSTHVDIRTLEDLLMGTLGIVCPICSQKP 
 
Protein sequence of expression plasmid HPV 16 E7, 106 residues 
MHGDTPTLHEYMLDLQPETTDLYCYEQLNDSSEEEDEIDGPAGQAEPDRAHYNIVTFCCKCD
STLRLCVQSTHVDIRTLEDLLMGTLGIVCPICSQKPLEHHHHHH 
 
DNA sequence (optimized)	  
ATGCACGGAGATACACCAACATTGCATGAATATATGTTAGATTTGCAACCAGAGACAACTGA
TCTCTACTGTTATGAGCAATTAAATGACAGCTCAGAGGAGGAAGATGAAATAGATGGTCCAG
CTGGACAAGCAGAACCGGACAGAGCCCATTACAATATTGTAACCTTTTGTTGCAAGTGTGAC
TCTACGCTTCGGTTGTGCGTACAAAGCACACACGTAGACATTCGTACTTTGGAAGACCTGTT
AATGGGCACACTAGGAATTGTGTGCCCCATCTGTTCTCAGAAACCACTCGAGCACCACCACC
ACCACCAC 	  
Novagen pET-20 map 
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PLASMID OF THE HPV 16 E7 CR3 DOMAIN - PDEST-17/E7CR3 
 
The HPV 16 E7 CR3 domain construct is inserted in a pDEST-17 (Invitrogen) 
plasmid that was prepared by Gateway® cloning technology (Invitrogen). The 
HPV 16 E7 CR3 protein target is a native 54 residues. To this construct a N-
terminus cassette was added to enable future tag removal abilities creating a 
pENTR construct, representing a protein with 77 residues. The construct 
including N-terminus TEV cassette was further inserted in a pDEST-17 
plasmid, which confers the ability to have a 6xHis tag on the N-terminus, 
being the TEV recognition site for cleavage between the 6xHis tag and the 
target CR3 protein representing a protein of 98 residues. After the TEV 
proteolysis, the final construct will include 4 extra residues (GSFT) on N-
terminus of CR3 representing a protein with 58 residues. All vector 
polylinkers and map, as well the protein and DNA sequences are described 
on table 3.3. 
 
 
 
  
Table 3.3. Datasheet of expression plasmid for HPV 16 E7 CR3 domain. Description of vector 
map, target protein sequence and final expression protein and DNA sequences. 
 
Protein sequence goal: HPV 16 E7 CR3, 54 residues 
AEPDRAHYNIVTFCCKCDSTLRLCVQSTHVDIRTLEDLLMGTLGIVCPICSQKP 
 
Protein sequence inserted on entry vector pENTR/TEV/D-TOPO, 77 
residues 
LYKKAGSAAAVLEENLYFQGSFTAEPDRAHYNIVTFCCKCDSTLRLCVQSTHVDIRTLEDLL
MGTLGIVCPICSQKP 
 
Protein sequence of final expression vector including TEV cassette plus E7 
CR3 transferred into pDEST-17, 98 residues 
MSYYHHHHHHLESTSLYKKAGLYKKAGSAAAVLEENLYFQGSFTAEPDRAHYNIVTFCCKCD
STLRLCVQSTHVDIRTLEDLLMGTLGIVCPICSQKP 
 
Protein sequence after TEV proteolysis: HPV 16 E7 CR3, 58 residues 
GSFTAEPDRAHYNIVTFCCKCDSTLRLCVQSTHVDIRTLEDLLMGTLGIVCPICSQKP 
 
DNA sequence of final construct after proteolysis	  
GGCTCCTTCACCGCAGAACCGGACAGAGCCCATTACAATATAGTAACCTTTTGTTGCAAGTG
TGACTCTACGCTTCGGTTGTGCGTACAAAGCACACACGTAGACATTCGTACTTTGGAAGACC
TGTTAATGGGCACACTAGGAATTGTGTGCCCCATCTGTTCTCAGAAACCA 	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Invitrogen pENTR/TEV/D-TOPO map and polylinker 
 
 
 
 
 
 
 
Invitrogen pDEST-17 map and polylinker 
 
 
 
 
 
 
 
 
 
PLASMID OF THE HADV 2/5 13S E1A - PET42/E1A13S 
 
The HAdV 2/5 E1A13S construct is inserted in a pET42 (Novagen) plasmid 
that was prepared by classical restriction enzyme cloning. The HAdV 2/5 
E1A13S protein target is a native 289 residues. The final construct is not the 
native protein but a construct including a C- terminus 8xHis tag linked by 2 
extra residues (LEHHHHHHHH). Thus, the final expression E1A13S 
construct is a 299 residues protein. All vector polylinkers and map, as well the 
protein and DNA sequences are described on table 3.4. 
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Novagen pET-42 map 
  
  
Table 3.4. Datasheet of expression plasmid for HAdV 2/5 E1A. Description of vector map, 
target protein sequence and final expression protein and DNA sequences. 
 
Protein sequence of interest: HAdV 2 E1A 13S 289 residues 
MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEEAV
SQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVIDLTC
HEAGFPPSDDEDEEGEEFVLDYVEHPGHGCRSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSP
VSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVP
LCPIKPVAVRVGGRRQAVECIEDLLNESGQPLDLSCKRPRP 
 
Final construct of E1A contains 299 residues - HAdV 2/5 hybrid 
MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEEAV
SQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVIDLTC
HEAGFPPSDDEDEEGEEFVLDYVGHPGHGCRSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSP
VSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVP
LCPIKPVAVRVGGRRQAVECIEDLLNEPGQPLDLSCKRPRPLEHHHHHHHH 
 
DNA sequence	  
ATGAGACATATTATCTGCCACGGAGGTGTTATTACCGAAGAAATGGCCGCCAGTCTTTTGGA
CCAGCTGATCGAAGAGGTACTGGCTGATAATCTTCCACCTCCTAGCCATTTTGAACCACCTA
CCCTTCACGAACTGTATGATTTAGACGTGACGGCCCCCGAAGATCCCAACGAGGAGGCGGTT
TCGCAGATTTTTCCCGAGTCTGTAATGTTGGCGGTGCAGGAAGGGATTGACTTATTCACTTT
TCCGCCGGCGCCCGGTTCTCCGGAGCCGCCTCACCTTTCCCGGCAGCCCGAGCAGCCGGAGC
AGAGAGCCTTGGGTCCGGTTTCTATGCCAAACCTTGTGCCGGAGGTGATCGATCTTACCTGC
CACGAGGCTGGCTTTCCACCCAGTGACGACGAGGATGAAGAGGGTGAGGAGTTTGTGTTAGA
TTATGTGGGGCACCCCGGGCACGGTTGCAGGTCTTGTCATTATCACCGGAGGAATACGGGGG
ACCCAGATATTATGTGTTCGCTTTGCTATATGAGGACCTGTGGCATGTTTGTCTACAGTCCT
GTGTCTGAACCTGAGCCTGAGCCCGAGCCAGAACCGGAGCCTGCAAGACCTACCCGGCGTCC
TAAATTGGTGCCTGCTATCCTGAGACGCCCGACATCACCTGTGTCTAGAGAATGCAATAGTA
GTACGGATAGCTGTGACTCCGGTCCTTCTAACACACCTCCTGAGATACACCCGGTGGTCCCG
CTGTGCCCCATTAAACCAGTTGCCGTGAGAGTTGGTGGGCGTCGCCAGGCTGTGGAATGTAT
CGAGGACTTGCTTAACGAGCCTGGGCAACCTTTGGACTTGAGCTGTAAACGCCCCAGGCCAC
TCGAGCACCACCACCACCACCACCACCAC 	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PLASMID OF THE HADV 2 12S E1A - PETG20A/E1A12S 
 
The HAdV 2 E1A12S construct is inserted in a pETG-20A EMBL plasmid 
(Alzari et al., 2006) that was prepared by Gateway® cloning technology 
(Invitrogen). The HAdV 2 E1A12S protein is a native 243 residues that was 
synthesized inside a pENTR vector (ordered from GeneArt® Invitrogen) 
containing the TEV recognition sequence on N-terminus and the kanamycin 
resistance sequence for further isolation of the target destination plasmids. 
This segment was then subcloned into the pETG-20A through the Gateway 
LR reaction, yielding a plasmid expressing the HAdV 2 E1A12S protein fused 
with thioredoxin A and a His tag at the N terminus. Using this approach the 
final construct after TEV cleavage yields the native 243 residues E1A12S 
protein. The E1A12S protein and DNA sequences are described on table 3.5. 
Table 3.5. Datasheet of expression plasmid for E1A12S. Description of and DNA sequences. 
 
Protein sequence of interest after TEV cleavage: E1A12S, 243 residues 
MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEEAV
SQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVIDLTC
HEAGFPPSDDEDEEGPVSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSPVSRECNSSTDSC
DSGPSNTPPEIHPVVPLCPIKPVAVRVGGRRQAVECIEDLLNESGQPLDLSCKRPRP 
 
DNA sequence (native) 
ATGAGGCACATCATCTGCCACGGCGGCGTGATCACCGAGGAGATGGCCGCCAGCCTGCTGGA
CCAGCTGATCGAGGAGGTGCTGGCCGACAACCTGCCCCCCCCCAGCCACTTCGAGCCCCCCA
CCCTGCACGAGCTGTACGACCTGGACGTGACCGCCCCCGAGGACCCCAACGAGGAGGCCGTG
AGCCAGATCTTCCCCGAGAGCGTGATGCTGGCCGTGCAGGAGGGCATCGACCTGTTCACCTT
CCCCCCCGCCCCCGGCAGCCCCGAGCCCCCCCACCTGAGCAGGCAGCCCGAGCAGCCCGAGC
AGAGGGCCCTGGGCCCCGTGAGCATGCCCAACCTGGTGCCCGAGGTGATCGACCTGACCTGC
CACGAGGCCGGCTTCCCCCCCAGCGACGACGAGGACGAGGAGGGCCCCGTGAGCGAGCCCGA
GCCCGAGCCCGAGCCCGAGCCCGAGCCCGCCAGGCCCACCAGGAGGCCCAAGCTGGTGCCCG
CCATCCTGAGGAGGCCCACCAGCCCCGTGAGCAGGGAGTGCAACAGCAGCACCGACAGCTGC
GACAGCGGCCCCAGCAACACCCCCCCCGAGATCCACCCCGTGGTGCCCCTGTGCCCCATCAA
GCCCGTGGCCGTGAGGGTGGGCGGCAGGAGGCAGGCCGTGGAGTGCATCGAGGACCTGCTGA
ACGAGAGCGGCCAGCCCCTGGACCTGAGCTGCAAGAGGCCCAGGCCC 
 
DNA sequence (optimized for E. coli) 
ATGCGCCATATCATTTGTCATGGTGGTGTTATTACCGAAGAAATGGCAGCAAGCCTGCTGGA
TCAACTGATTGAAGAAGTTCTGGCCGATAATCTGCCTCCGCCTAGCCATTTTGAACCGCCTA
CCCTGCATGAACTGTATGATCTGGATGTTACCGCACCGGAAGATCCGAATGAAGAAGCAGTT
AGCCAGATTTTTCCGGAATCAGTTATGCTGGCAGTTCAAGAAGGTATTGACCTGTTTACCTT
TCCGCCTGCACCGGGTAGTCCGGAACCGCCTCATCTGAGCCGTCAGCCGGAACAGCCTGAAC
AGCGTGCACTGGGTCCGGTTAGCATGCCGAATCTGGTTCCGGAAGTTATTGATCTGACCTGT
CATGAAGCAGGTTTTCCGCCTAGTGATGATGAAGATGAAGAAGGTCCGGTTTCAGAACCGGA
ACCTGAGCCTGAACCAGAGCCGGAACCGGCACGTCCGACCCGTCGTCCTAAACTGGTTCCTG
CAATTCTGCGTCGTCCGACCTCACCGGTTAGCCGTGAATGTAATAGCAGCACCGATAGCTGT
GATAGCGGTCCGAGCAATACCCCTCCGGAAATTCATCCGGTTGTTCCGCTGTGTCCGATTAA
ACCGGTTGCAGTTCGTGTTGGTGGTCGTCGTCAGGCAGTTGAATGTATTGAAGATCTGCTGA
ATGAAAGCGGTCAGCCGCTGGATCTGAGCTGTAAACGTCCGCGTCCG  
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PLASMID OF THE CBP-ID4 DOMAIN - PET200/CBPID4 	  
The CBP-ID4 domain construct is inserted in a pET200 (Invitrogen) plasmid 
that was prepared by TOPO® cloning technology (Invitrogen). The CBP-ID4 
protein target is a native 206 residues. This construct was added an N-
terminus cassette that contains a 6xHis tag followed by an enterokinase (EK) 
recognition site for further tag cleavage. This construct represents expresses a 
protein with 242 residues. After tag proteolysis by EK, the final construct 
includes 5 extra residues (DHPFT) on the N-terminus of CBP-ID4 domain, 
representing a protein with 211 residues. All vector polylinkers and maps, as 
well the protein and DNA sequences are described on table 3.6. 
 
  
Table 3.6. Datasheet of expression plasmid for CBP-ID4. Description of vector map, target 
protein sequence and final expression protein and DNA sequences. 
 
Protein sequence of interest: CBP-ID4, 206 residues 
QQQIQHRLQQAQLMRRRMATMNTRNVPQQSLPSPTSAPPGTPTQQPSTPQTPQPPAQPQPSP
VSMSPAGFPSVARTQPPTTVSTGKPTSQVPAPPPPAQPPPAAVEAARQIEREAQQQQHLYRV
NINNSMPPGRTGMGTPGSQMAPVSLNVPRPNQVSGPVMPSMPPGQWQQAPLPQQQPMPGLPR
PVISMQAQAAVAGPRMPSVQ 
 
Protein sequence on final expression vector construct, 242 residues 
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDLDHPFTQQQIQHRLQQAQLMRRRMATMNTRNV
PQQSLPSPTSAPPGTPTQQPSTPQTPQPPAQPQPSPVSMSPAGFPSVARTQPPTTVSTGKPT
SQVPAPPPPAQPPPAAVEAARQIEREAQQQQHLYRVNINNSMPPGRTGMGTPGSQMAPVSLN
VPRPNQVSGPVMPSMPPGQWQQAPLPQQQPMPGLPRPVISMQAQAAVAGPRMPSVQ  
 
Protein sequence after proteolysis with EK protease, 211 residues 
DHPFTQQQIQHRLQQAQLMRRRMATMNTRNVPQQSLPSPTSAPPGTPTQQPSTPQTPQPPAQ
PQPSPVSMSPAGFPSVARTQPPTTVSTGKPTSQVPAPPPPAQPPPAAVEAARQIEREAQQQQ
HLYRVNINNSMPPGRTGMGTPGSQMAPVSLNVPRPNQVSGPVMPSMPPGQWQQAPLPQQQPM
PGLPRPVISMQAQAAVAGPRMPSVQ 
 
DNA sequence	  
GATCATCCCTTCACCCAGCAGCAGATCCAGCACCGCCTGCAGCAGGCCCAGCTCATGCGCCG
GCGGATGGCCACCATGAACACCCGCAACGTGCCTCAGCAGAGTCTGCCTTCTCCTACCTCAG
CACCGCCCGGGACCCCCACACAGCAGCCCAGCACACCCCAGACGCCGCAGCCCCCTGCCCAG
CCCCAACCCTCACCCGTGAGCATGTCACCAGCTGGCTTCCCCAGCGTGGCCCGGACTCAGCC
CCCCACCACGGTGTCCACAGGGAAGCCTACCAGCCAGGTGCCGGCCCCCCCACCCCCGGCCC
AGCCCCCTCCTGCAGCGGTGGAAGCGGCTCGGCAGATCGAGCGTGAGGCCCAGCAGCAGCAG
CACCTGTACCGGGTGAACATCAACAACAGCATGCCCCCAGGACGCACGGGCATGGGGACCCC
GGGGAGCCAGATGGCCCCCGTGAGCCTGAATGTGCCCCGACCCAACCAGGTGAGCGGGCCCG
TCATGCCCAGCATGCCTCCCGGGCAGTGGCAGCAGGCGCCCCTTCCCCAGCAGCAGCCCATG
CCAGGCTTGCCCAGGCCTGTGATATCCATGCAGGCCCAGGCGGCCGTGGCTGGGCCCCGGAT
GCCCAGCGTGCAG 
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Invitrogen pET-200 map and polylinker 
 
 
 
 
 
 
 
CLONING STRATEGIES 
 
The classic method to insert an amplified PCR product into a vector is to use 
restriction enzymes that cleave DNA at specific recognition sites. Both DNA 
and cloning vector have to be treated with two restriction enzymes that create 
compatible ends. Later on those ends are connected by a ligation reaction 
performed by the bacteriophage T4 DNA ligase. Finally an aliquot of the 
product of the reaction is transformed in DH5α E. coli competent cells and 
positive clones are screened both by PCR in DNA sequencing. However the 
classic cloning strategy sometimes is not feasible to prepare different 
constructs in parallel because not all host vectors and target genes can be 
cleaved by the same restriction enzymes. Thus, other cloning strategies are 
available exploiting ligation-independent cloning, such as Gateway® 
(Invitrogen) and the most recent ElectraTM (DNA2.0) (Katzen, 2007). 
Gateway® cloning technology has been one of the most used strategies 
allowing simultaneous preparation of plasmids for different expressions 
systems strategies. Basically is consists in the generation of an entry clone that 
can be recombined in several compatible vectors without the use of any 
restriction enzyme. There are many ways to create an entry clone but the most 
straightforward method is by adding four bases to the forward primer 
(CACC) to create blunt-end PCR products for directional TOPO® cloning. The 
ligation reaction of the PCR product to the pENTR vector is performed by the 
topoisomerase I. After isolation of the entry clone, the second step is to 
generate an expression vector. This is done by an exchange between the gene 
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on the entry clone with the final expression vector, performed by LR 
Clonase®. Because each vector contains different antibiotics resistance, the 
isolation of the final expression vector can be easily obtained by 
transformation of E. coli competent cells and selection on specific resistance 
plates (Figure 3.1).  A large selection of Gateway expression vectors is 
available, with the possibility to express the native target protein as well as 
conferring the possibility to include tags on its N-terminus or C-terminus. 
Those tags can be only histidine tails for helping the purification strategies, or 
even well known fusion proteins that confer solubility and can help on 
increasing expression yield.  
 
 ➜ LR® Clonase® ➜  
Figure 3.1. Gateway cloning system. The exchange of genes between entry and destination 
vectors is performed by the LR® Clonase®. Each vector contains different resistance genes to 
allow selective isolation of the final expression vector.  
 
In the present thesis, the cloning system used to create the entry clone for 
HPV 16 E7 CR3 domain was the Gateway Cloning System pENTR/TEV/D-
TOPO. This version of Gateway Cloning System includes the existence of a 
cassette of TEV recognition site on the N-terminus of the protein. Thus, any 
destination expression vector containing tags on the N-terminus may be 
removed by proteolysis using TEV protease. The following expression vectors 
have been used for the creation of simultaneous expression vectors: pDEST-17 
(conferring 6x histidine N-terminus), pETG-30A (conferring GST plus 6x 
histidine N-terminus), and pDEST-His-MBP (conferring MBP plus 6x 
histidine N-terminus). It is important to highlight that using this method, the 
final purified protein will include extra residues on the N-terminus. For 
example using the expression vector pDEST-17 that contains the 6xHis tag, 
the expressed and purified target protein will have extra 44 amino acids. After 
tag removal using TEV protease, the final construct will contain 4 extra 
residues on the N-terminus, GSFT. 
For the creation of the expression vector for CBP-ID4 protein, a similar 
strategy was used. This work was done on Peter Tompa's lab where the entire 
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gene of the big 2442 amino acid CBP protein is available. To easily access the 
different domains present in CBP (Figure 2.4), a library of primers to read the 
specific region one wants to clone is available. Those primers were created 
thinking on the TOPO Cloning System strategy and therefore every forward 
primer contains the CACC sequence at the 5' end of the primer, to enable 
directional cloning. Due to experience with similar domains of CBP protein, 
the blunt end DNA constructs created by PCR are directly ligated into a final 
expression vector pET200/D-TOPO avoiding the generation of entry clones 
that need afterwards to be exchanged into destination expression vectors. 
This methodology as vantages and disadvantages because from one side it is 
a really fast method to get an expression plasmid, but on the other hand there 
are no ways to try other vectors containing different tags. The pET200/D-
TOPO confers 6xHis tag on the N-terminus that may be cleaved due to the 
presence of enterokinase (EK) recognition site. It is important to notice that 
using this methodology the final construct before cleavage will contain 36 
extra amino acids an the N-terminus. After removing the tag by using EK 
protease, the final construct will keep 5 extra residues on the N-terminus, 
DHPFT. 
 
 
MUTAGENESIS 
 
Site-directed mutagenesis is a standard technique to improve the final 
expression vector, or to study different point mutations as a strategy to 
understand downstream protein structural and functional modifications. This 
method is used to make point mutations, replace amino acids, and delete or 
insert single or multiple adjacent amino acids. The point mutations that 
exchange a single nucleotide, but the new codon specifies the same amino 
acid are called silent mutations. Basically it codes the same amino acid, being 
an easy way to avoid "rare codons" that may decrease the expression yield. In 
the present work all mutagenesis were performed using the QuikChange II 
Site-directed Mutagenesis kit, Agilent Technologies. This method uses 
basically the double-stranded DNA vector template containing the target 
gene and two complementary synthetic oligonucleotide primers, both 
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containing the desired mutation. The primers are mixed with the DNA vector 
template and extended during PCR cycles performed by a high fidelity DNA 
polymerase (PfuUltra, Stratagene).  The PCR product is then treated with 
DpnI (Figure 3.2), an endonuclease that will digest the DNA template due to 
its high specificity to Dam methylated and hemimethylated DNA isolated 
from E. coli strains. The new copies of DNA PCR product were never 
methylated and thus are not digested. The digested solution is then 
transformed into XL1-Blue super-competent cells and subsequently subjected 
to sequencing analysis. 
 
 
Figure 3.2. Overview of the QuikChange II Site-directed Mutagenesis Method adapted from 
Agilent Technologies. 
 
 
The expression vector pET20-E7 containing the HPV 16 E7 gene was 
generously provided by Thomas Hey, Scil Protein GmbH, Halle, Germany 
(Mirecka et al., 2006). The sequencing analysis of this vector showed the 
sequence corresponding to the native DNA of E7 protein. Using the Biomax 
ProteoExpert tool, it was found that the native codon for His-2 might allow 
the possibility of alternative translation initiation and premature termination 
of translation. Moreover the native codon for Pro-6 might induce low 
expression yields in E. coli.(Mirecka et al., 2006). Two silent mutations in a 
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single site-directed mutagenesis reaction were preformed to avoid those two 
situations. The His-2 was mutated from CAT to CAC and the Pro-6 was 
mutated from CCT to CCA. To generate the optimized plasmid containing the 
E7 gene PCR was performed using the forward primer 5’-
GGAGATATACATATGCACGGAGATACACCAACATTGCATGAATATAT
G-3’ and the reverse primer 5’-CATATATTCATGCAATGTTGGTGTAT 
CTCCGTGCATATGTATATCTCC-3’ designed to generate both silent 
mutations for His-2 and Pro-6 in a single PCR reaction. The optimized 
plasmid was transformed into E. coli XL1-Blue (Stratagene) competent cells 
and the resulting clones were screened by DNA sequence analysis. The 
optimized plasmid was replicated and used for all the HPV 16 E7 full-length 
protein samples preparations presented in this work. 
Site directed mutagenesis was used as well to create 3 different constructs of 
the full-length HPV 16 E7 protein: the mutants C59A and C68T, and the 
native HPV 16 E7 protein without any tags. The E7 mutant C59A was 
generated using the forward primer 5'- 
CAATATTGTAACCTTTTGTGCCAAGTGTG ACTCTACGCTTC-3' and the 
reverse primer 5'- GAAGCGTAGAGTCACA 
CTTGGCACAAAAGGTTACAATATTG-3'. The E7 mutant C68T was done 
using the forward primer 5'- GACTCTACGCTTCGGTTGACGGTAC 
AAAGCACACACG-3' and the reverse primer 5'- CGTGTGTGCTTTGTA 
CCGTCAACCGAAGCGTAGAGTC-3'. The native HPV 16 E7 protein was 
generated by the introduction of a stop codon TAG right after the codon for 
the E7 protein C-terminus residue, Pro98, thus removing the C-terminus 
6xHis tag LEHHHHHH. For this purpose the forward primer 5'-
GTTCTCAGAAACCATAGCTCGAGCACCACCACC-3' and the reverse 
primer 5'-GGTGGTGGTGCTCGAGCTATGGTTTCTGAGAAC-3' were used 
(regions of codon mutation/insertion are highlighted). 
 
3.3. Sample Preparation 
 
This section describes all laboratory practices done since the use of generated 
plasmids till the preparation of protein samples necessary for further 
characterization. 
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RECOMBINANT PROTEIN EXPRESSION IN E. COLI. 
 
Currently the number of recombinant proteins used for research applications 
has increased dramatically. Several host systems are available for protein 
production, including fungi, plants, bacteria, insects, yeast and mammalian 
cells (Shatzman, 1995). The selection of an expression system for high-level 
production of recombinant proteins depends on many factors, including 
biological activity of the target protein, post-translational modifications, cells 
growth features, intracellular and extracellular characteristics and expression 
levels. Production of these proteins has a remarkable demand on structural 
biology research and is crucial to the present work. Escherichia coli (E. coli) 
offers a means for the rapid and economical production of recombinant 
proteins (Tong et al., 2008). A wealth of biochemical and genetic knowledge of 
E. coli, have driven the development of a variety of strategies for achieving 
high-level expression of protein. The major challenges for obtaining the high 
yield of protein at low cost involves several aspects such as expression vectors 
design, gene dosage, transcriptional regulation (promoter), mRNA stability, 
translational regulation (initiation and termination), host design 
considerations, codon usage, and fermentation factors available for 
manipulating the expression conditions (Jana and Deb, 2005).  Different E. coli 
strains, each one with specific features for different expression systems, were 
used in the present work. 
Once selected the expression system, the strategy to understand the optimal 
expression conditions needs to be tested and is subjected to several variations.  
Thus, the best approach is to use parallel test expression strategies (Lesley, 
2009). A preliminary expression test can be performed using small volume 
scale to find the best conditions to be reproduced in large volumes in order to 
get soluble recombinant protein (Hunt, 2005). The purification trials should be 
well designed taking in consideration all the typical variant conditions like, 
culture medium, temperature, optical density, isopropyl β-D-1-
thiogalactopyranoside (IPTG) inducer concentrations, end expression times. 
A library of different E. coli strain is available each one with specific 
advantages to overcome typical difficulties. The E. coli strains used in the 
present work were: BL21(DE3); BL21(DE3)pLysS, a protease deficient strain, 
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Rosetta(DE3) for genes containing rare codons; Origami(DE3) for proteins 
containing disulfide bridges and Gold(DE3) for increasing expression yields. 
Typically one can try one E. coli strain and try two different optical densities 
(0.6 and 1.0), two IPTG concentrations (0.1 and 1.0 mM), three different 
expression temperatures (17, 30 and 37 ºC), three expression times (4h, 8h and 
overnight). Cells should be harvested and disrupted in equal conditions and 
solubility of the target protein should be checked by SDS polyacrylamide gel 
(SDS-PAGE). In case of non-satisfactory results, one can try different strains of 
E. coli cells. If all the trials to get soluble protein fail, the insoluble fraction can 
be recovered performing refolding trials. The composition of the culture 
medium is one of the most important conditions to take in consideration and 
should be planned carefully. The additives to be added can influence the 
yield and solubility of the protein expression. For example, proteins 
coordinating metal ions like zinc-fingers need extra-addition of zinc (II) into 
the culture medium. The amount of carbon and nitrogen source can also 
influence the yield. Also changing the carbon and nitrogen sources to isotopic 
labeled ones may change the protein expression yield. Moreover, culture 
medium containing deuterated water may need cells adaptation due to its 
potential toxicity.  
 
PROTEIN PURIFICATION 	  
The protein purification strategy depends always on the proteins' biophysical 
and biochemical properties. Several characteristics must be considered 
whether the protein is soluble and, if not, which agents might help to 
solubilize it. Is the protein sensitive to high or low salt concentrations, high or 
low pH, high or low temperatures, or oxidation, particularly by oxygen? Is 
the protein labile at high or low concentrations? A set of preliminary 
experimental trials should be done to learn which reagents might be present 
during the purification, which must be avoided, and under which conditions 
the protein has to be stored. Designing the protein purification strategy for a 
new protein starting from scratch requires preliminary bioinformatics study 
to predict some biochemical and biophysical characteristics and also to 
compare with homologous proteins purification strategies published in the 
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literature, helping to draft a purification plan (Hunt, 2005). For example, if the 
protein contains several free cysteine residues, anaerobic purification 
methods and the use of reducing agent may be required to avoid the 
formation of non-physiological multimers and oligomers. Besides each 
protein has particular characteristics, the first protein purification step will 
depend mainly upon the localization of the produced protein within the host, 
considering if it was produced within the cytoplasm either as soluble or 
insoluble protein, the so called inclusion bodies (IBs), transported into the 
periplasmic space, enclosed into the cell membranes or even excreted into the 
growth medium (Linn, 2009). For each case the isolation is performed in 
different ways. Assuming the protein was not excreted into the growth 
medium, the cell lysis is the first step for protein purification. The disruption 
of the cells can be performed though several techniques, spanning from 
physical to detergent-based methods. For instance the French-press is an 
efficient method, though heating the final lysate, while freeze-thaw or 
enzymatic and detergent lysis are considered mild methods but less efficient. 
In the present work, the cell disruption was performed by sonication, which 
comprises pulsed, high frequency sound waves to mechanically agitate and 
lyse the cells. The isolation of protein using sonication should be done 
carefully because the mechanical waves energy will heat the sample. To avoid 
sample warming, the sonication should be carried using an ice-bath and 
performed with short pulses with intervals to allow for temperature 
decreasing. Sonication methods can be also performed inside an anaerobic 
chamber (glove-box) for anaerobic purification strategies. 
Once the impure protein fraction is isolated, the following purification step 
can be performed in a multitude of chromatography runs. The methodology 
should be always optimized to reach an efficient protocol in terms of yield, 
speed and costs. Among all the different chromatography techniques, in this 
work will be described the three most used technique: immobilized metal ion 
affinity chromatography (IMAC), ion exchange chromatography (IEX) and 
size exclusion chromatography (SEC).  
The immobilized metal ion affinity chromatography (IMAC) is currently the 
most used affinity technique exploiting the interaction between chelated 
transition metal ions (like Zn2+ or Ni2+) and the side chains of specific amino 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   CHAPTER	  3	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   MATERIAL	  AND	  METHODS	  
	  
	   38	  
acid (like histidines) on the protein. Basically using IMAC the target protein is 
tightly bound to the resin matrix and the impurities washed out with 
increasing concentrations of imidazole, which acts like a competitive agent. 
At higher imidazole concentrations the target protein is also eluted, almost 
pure (Block et al., 2009). The tags may be cleaved afterwards depending on the 
present of protease specific recognition sites cloned in the expression vector 
designed. Enzymatic digestions can be performed by proteases like TEV, 
Enterokinase, Thrombin etc., according to the strategy chosen. Thus, a second 
IMAC reverse chromatography is performed in order to separate the cleaved 
target protein from the tags. 
Ion exchange chromatography (IEX) separates proteins on the basis of a 
reversible interaction between the polypeptide chain and a specific charge 
ligand attached to a chromatographic matrix. The isoelectric point (pI) of the 
target protein must be known. The sample is loaded in conditions favoring 
specific binding like carefully calibrated pH and low ionic strength salt 
concentration, in order to enhance the interaction between target protein and 
column matrix. The unbound impurities are washed out and the bound 
protein is eluted changing the pH or the ionic strength of the elution buffer. If 
the overall net charge of the protein is positive, an cationic IEX resin must be 
used; thus if its negative, an anionic IEX resin must be used. The buffer pH 
should be at least ± 1 unit different from the protein pI. 
Size exclusion chromatography (SEC) is a separation technique based on 
hydrodynamic radius of the proteins. The column matrix is composed by 
precision sized beads containing pores of given sizes. Larger proteins	  whose 
hydrodynamic dimensions are big to fit inside any pore will have access only 
to the mobile phase between the beads, being excluded as they just follow the 
solvent flow and reach the end of the column before molecules with smaller 
size. Proteins whose hydrodynamic dimensions are smaller will be drawn 
into the pores by diffusion, having access to the mobile phase inside and 
between the beads. Thus, smaller molecules had long ways to cross with 
several small retention times between the diffusion movements through the 
beads pores. Due to largest retention smaller hydrodynamic molecules will 
elute last during the size exclusion separation. SEC can be used to separate 
protein by size and shape, to exchange the buffer and also to isolate protein 
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mixtures, to separate monomers, multimers or oligomers. In case of folded 
proteins, it can be also used to determine the molecular mass performing a 
molecular weight distribution analysis using available standards.  
Therefore SEC profiles are dependent on the hydrodynamic volume of a 
protein being one of the most important and fundamental structural 
parameters of a protein molecule. Hydrodynamic volume is a prerequisite for 
an accurate classification of a protein conformation. It changes dramatically 
depending if the protein hydrodynamic dimension is compact like a folded 
protein or extended or partially extended like an IDP.  
Comparing two proteins with the same molecular weight, a well folded 
protein will have a smaller hydrodynamic radius while an IDP will have 
bigger hydrodynamic radius behaving like a big folded protein on SEC. Thus, 
the SEC retention times for a folded protein and an IDP of same molecular 
mass will be different and the IDP will elute first. SEC has been used early for 
separation of unfolded and folded proteins (Gupta, 1983). However due to the 
particular characteristics of IDPs, SEC can be used for analytical study the 
conformational IDP properties in solution where size and shape of molecules 
are the prime separation parameters (Uversky, 2013a).  In the present work, 
SEC was performed as the last step purification for the preparation HPV 16 
E7 and HAdV 2/5 13S E1A proteins. A HiLoad 16/60 Superdex 75 column 
with a sample loop of 5.0 ml was used connected to a water thermostatic 
cooling system at 4 ºC. The details of the SEC protein purification are reported 
in the results chapter of the present work. 	  	  
REFOLDING 
 
Purification and refolding a protein from the insoluble fraction could be a 
challenging task and should be planed carefully. The strategy can be based on 
a previous bioinformatics analysis of the target protein combined with the 
state of art similar protein systems. Although each protein is unique requiring 
specific treatments, the literature is full of successful protocols summarized in 
many reviews and book chapters (Burgess et al., 2009; Cowieson et al., 2006; 
Qoronfleh et al., 2007; Singh et al., 2005; Vincentelli et al., 2004). 
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The first step on refolding is to solubilize the IBs. The solubilizing 
agent/denaturant could be a chaotropic agent like GuHCl and urea, or a 
detergent like SDS and it should be prepared in controlled pH buffer. As for 
the other technique strategies already described in this work, the key concept 
for refolding is the systematic, parallel screening of multiple refolding 
conditions. Many additives may prove useful in refolding, but to prevent 
aggregation and precipitation upon refolding is crucial to refold at low 
protein concentration. However, many variables in refolding should be 
controlled such as pH, temperature, salt concentration, redox environment, 
and the presence of divalent metal ions.  
Redox agents, various redox pairs can be used including reduced and 
oxidized cysteine or glutathione as well as reducing agent like β-
mercaptoethanol (BME), dithiothreitol (DTT) or tris (2-carboxyethyl) 
phosphine hydrochloride (TCEP) to control the oxidation state of the protein. 
Since the cytoplasm of E. coli is very reducing, most internal proteins are in 
the reduced state. If the protein as native disulfide bonds, the molar ratio of 
reduced to oxidized form is sometimes varied to achieve optimal native 
disulfide bond formation keeping native free cysteine residues. However if 
the protein doesn't have native disulfides bonds, and higher NMR samples 
concentration are required, the high concentration allow better intermolecular 
interaction and the presence of free cysteine residues may induce incorrect 
disulfide bridges prone to aggregation states. In this cases higher amount of 
DTT and TCEP are required. 
Salt concentration, on range from 50-100mM is used to increase solubility of 
the native protein. Often 50–100 mM salt is used, when removing the IBs 
solubilizing agent. 
Chaotropic agents, to avoid aggregation during refolding, 1 M urea and 0.5 
M GuHCl have been used in refolding solution to dissociate possible 
aggregates due to interactions among partially folded intermediates.  
pH, in general the buffer pH should be at least one pH unit away from the pI 
to avoid a zero net charge of the protein becoming prone to precipitation. 
Some protocols relies only on single pH refolding procedure (Coutard et al., 
2012).  
Temperature, most refolding procedures are carried at room temperature, 
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which is low enough to prevent thermal damage to the protein and high 
enough to increase the thermal motion of the molecules important to reach its 
native state.  
Proline and Arginine, proline is considered a osmoprotectant and has been 
found to be effective increasing solubility both in vitro and in vivo (Ignatova 
and Gierasch, 2006). Arginine can decrease aggregation by slowing the rate of 
protein–protein interactions by supramolecular assemblies formations in 
solution. However the effective concentrations are reported in a range of 0.5–
1.0 M (Das et al., 2007).  
Glycerol, has been found to be an excellent refolding additive in many cases, 
usually used in the 5–30% range. 
Detergents, can prevent aggregation during refolding. At low concentrations 
they bind weakly to exposed hydrophobic regions preventing aggregation. 
As their concentration decreases they dissociate and allow reformation of 
native structure. At high concentration detergents are denaturants, but at low 
concentration they can act as an artificial chaperone promoting refolding 
without aggregation. An important aspect about detergents is the Critical 
Micelle Concentration (CMC), the concentration at which micelles begin to 
form. The CMC value depends on the buffer used, on pH and on ionic 
strength. For each buffer system the CMC must be determined or obtained 
from tabulated values (Brito and Vaz, 1986; Jumpertz et al., 2011).  
Once the protein of interest is solubilized and all the refolding buffer 
conditions have been defined, the refolding can be attempted. The refolding 
procedure is the removal of the denaturant agent allowing the protein to 
reach its native state. Thus, refolding can be performed by dilution, multi-step 
dialysis, single dialysis, or with on-column refolding. Dialysis is one of the 
most used methods, while the on-column refolding can exploit the presence 
of a tag on the protein for affinity, binding to the column, allowing the 
removal of denaturant agent by washing steps. If it doesn't precipitate inside 
the column, the refolded protein can be further eluted.  On the other hand, the 
dilution refolding can be performed by: Reverse dilution, addition of 
refolding buffer to denatured protein with mixing between each addition; 
Flash dilution, addition of denatured protein to refolding buffer quickly) and 
Drip dilution, addition of denatured protein to refolding buffer very slowly, 
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drop-by-drop, allowing refolding at low concentration.  
Several commercial products have been developed to help identifying 
suitable refolding conditions like EMD/Novagen's iFOLD kits, Pierce 
Biotechnology’s ProMatrixTM and AthenaES's QuickFoldTM. 
The HPV 16 E7 CR3 domain was tested in many different plasmids constructs 
including only 6xHis tag as well other fusion protein tags like GST and MBP 
ton increase E7 CR3 solubility. All the expression tests using those different 
constructs showed E7 CR3 domain to be expressed in insoluble phase as IBs. 
The construct containing only the N-terminus 6xHis tag was chosen for a 
scale-up protein expression and purification. The refolding trials were carried 
using all the trials described for here refolding. The results and description of 
the successful protocol for the refolding of HPV 16 E7 CR3 domain are 
described in the results chapter of the present work.  
 
SAMPLE HANDLING 	  
The preparation of samples for many different biophysical and biochemical 
characterization should be prepared according to technical limits of each 
technique.  
Test expression, is a preliminary assay to learn the best conditions for a scale-
up downstream process. To avoid different expression results, the medium 
where those tests are done should be identical to the scaled-up final medium. 
For instance, a test using LB rich medium may present different results from a 
test using M9 minimal medium, special due to the controlled additives one 
can choose for the M9 medium preparation (like the addition of a specific 
metal essential for protein correct folding as in the case of zinc-proteins). 
When isotopically labeling a protein, the sources of carbon and nitrogen are 
different from the ones used for test expression and in some cases may lead to 
different expression yields.  
Zinc additive, zinc is essential for many cellular processes, including DNA 
synthesis, transcription, and translation, but excess can be toxic (Babich and 
Stotzky, 1978; Kindermann et al., 2005). To find the optimal amount of zinc 
additive, different trials should be performed using controlled minimal 
medium instead of rich LB (Outten and O'Halloran, 2001). The amount of zinc 
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was tested comparing cultures depleted of zinc to a concentration range of 10 
- 400 µM of ZnCl2 and ZnSO4 additions.  
Reducing agents, can be exogenous sulfhydryl containing reducing agents 
like DTT, or non-sulfhydryl reducing agents like TCEP. The optimal reducing 
activity of DTT is on 6.5 - 9.0 pH range, white TCEP as a wide optimal 
reducing activity pH range spanning from 1.5 - 9.0. In some cases was 
reported TCEP to be more useful than DTT for protein sample preparations 
(Getz et al., 1999; Krezel et al., 2003). In the present work the control of the 
redox state of the proteins was crucial. Three different reducing agents and 
their concentration were compared and analyzed.  
Anaerobic purification, protein containing cysteine residues must be handled 
inside an anaerobic chamber under nitrogen atmosphere to prevent oxidation 
of cysteine residues. With exception for CBP-ID4 protein, all buffers used in 
this work were extensively degassed with nitrogen and argon and used for all 
purification steps and sample preparation. Reducing agents were added to 
keep the cysteine residues reduced.  
 
Samples of different proteins 
HPV 16 E7 protein was prepared as unlabeled, 15N labeled and 13C,15N 
labeled, to accomplish its NMR characterization. 
E7 cysteine mutants, were done using E7 6xHis tag sequence as template. The 
C59A and C68T mutants were expressed and purified in identical way as for 
E7 6His tag protein without any mutations. The proteins where compared by 
NMR and no significant changes were observed when comparing with the 
non-mutated samples. 
E7 native protein was generated by the insertion of a stop codon right before 
the 6xHis tag. The protein was purified three runs of size exclusion 
chromatography purification. The buffers used were prepared in identical 
conditions as those used for 6xHis tag E7 sample. The comparison of pure 
protein samples was performed by NMR spectroscopy, and no significant 
changes were observed when compared with the E7 including the 6xHis tag. 
Metal removal, was performed for HPV 16 E7 sample, by removing zinc to 
prepare E7 apoprotein using 10mM EDTA as chelating agent on degassed 
10mM HEPES buffer pH 8.0, 50mM KCl, and 10 mM DTT reducing agents.  
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E7 CR3 protein was prepared to help in the assignment of the folded region 
due to the difficulties to observe this domain on the full-length E7 protein. It 
was not possible to overcome the concentration of 40µM of E7 CR3. 
HAdV 2/5 E1A protein was prepared as unlabeled, 15N labeled and 13C,15N 
labeled, to accomplish its NMR characterization.  
CBP-ID4 has been expressed and purified and the first HSQC acquired. 
Different trials are still under investigation in order to increase the 
concentration yield and avoid observed sample degradation. 
 
Samples for different techniques 
MS samples, the mass spectrometry E7 and E1A proteins samples were 
prepared using of unlabeled carbon and nitrogen sources as for CD DLS and 
SAXS. Samples were purified using the same protocol to ensure the use of 
degassed buffers and the fresh addition of 10mM DTT to keep the cysteine 
residues reduced. For MS technique some specific buffers should be avoided 
so the final MS samples was dialyzed against degassed 10mM ammonium 
sulfate at pH 6.6 using sealed containers.  It has been reported that cysteine 
residues can be oxidized to Cys-SOH which can be observed by MS (Conte 
and Carroll, 2013; Ratnayake et al., 2013; Rehder and Borges, 2010; Shetty et 
al., 2007). 
CD samples, of HPV 16 E7 and HAdV 2/5 E1A proteins where prepare in 
anaerobic conditions. For CD technique some specific buffers should be 
avoided so the final CD samples were dialyzed against 5mM potassium 
chloride at pH 7.5 using sealed containers with addition of fresh 10 mM DTT.  
DLS samples, of HPV 16 E7 protein were prepared in the same conditions as 
for the other biophysical techniques like SAXS and NMR. The final buffer was 
10mM Hepes pH 7.5, 150mM KCl, 10mM DTT, 10µM ZnCl2. 
SAXS samples, of HPV 16 E7 protein were prepared and carried to the SAXS 
facility at EMBL X33 beam line storage ring DORIS III on DESY, Hamburg in 
close collaboration with Dmitri Svergun and colleagues. Sample were 
prepared in the same buffer used for NMR measurements, 10mM Hepes pH 
7.5, 150mM KCl, 10µM ZnCl2, 10mM DTT. Samples were prepared in a 
concentration range from 1.3 - 2.7 mg ml-1 (108 - 223 µM) was used. 
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Concentrated samples where prepared right before the measurements using a 
refrigerated centrifuge. 
 
Samples for NMR 
15N labeled samples were prepared to screen different conditions by NMR 
such as pH, temperature and sample concentration. pH titrations 
experiments were done by dilution with desired pH buffer followed by 
concentration steps using Millipore centrifugal concentrator device at 4ºC. 
Additions of fresh DTT and Roche protease inhibitors were done right before 
their use for all concentration steps. The final sample pH was checked on the 
concentrator flow-through buffer. Temperature experiments were carried in a 
range from 4ºC to 40ºC. For concentration dependence the NMR samples 
were analyzed in a stepwise concentration screening, to avoid aggregates and 
oligomer formation and screen the optimal concentration value. 13C,15N 
samples were prepared to NMR experiments using carbon detection to help 
the sequence assignment of the different protein in study. 2H,13C,15N samples 
were prepared to understand the oligomer formation as the case of E7 
protein. The deuterated NMR samples were prepared starting with the 
adaptation of E. coli cells transformed with pET20/E7 in deuterated medium 
done stepwise from 20 - 90% deuterium. The final expression medium was 
Silantes® OD2 CON triple-labeled medium. The purification was performed 
in identical way as done for unlabeled, 15N and 13C,15N samples for further 
NMR experiments comparison. SedNMR samples, were prepared using a 
double labeled HPV 16 E7 sample concentrated till 15 mM and loaded on a 3 
mm rotor. 
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3.4. Biophysical and Biochemical Characterization 	  	  
UV-VISIBLE SPECTROSCOPY 
 
The ultraviolet (UV)–visible spectroscopy applied for protein research field 
can be used for many application including detection of eluting components 
in high performance liquid chromatography (HPLC), determination of the 
oxidation state of a metalloprotein center of a cofactor as well the 
determination of the maximum absorbance of proteins and DNA for 
measurement of their concentrations. The DNA quantification is based on the 
purine and pyrimidine absorption that has maximum around 260 nm. 
Proteins contain aromatic amino acid residues, which absorb light in the UV-
range with absorption maxima around 280 nm. These amino acids are 
tryptophan (Trp), tyrosine (Tyr), and phenylalanine (Phe). The Trp, Tyr, and 
Phe absorption spectra of IDPs can be compromised as typically IDPs are 
depleted of these residues (Dunker et al., 2001).  
The concentrations can be calculated using the Beer-Lambert law, ε = !!.! , 
where A is the absorbance value at the chosen wavelength, c the sample 
concentration (M) and l length of the light path through the sample (cm). The 
absorption spectrum of a protein is usually normalized to a concentration unit 
and cell width, thus depending on protein specific molar absorption 
coefficient ε and the measured wavelength 𝜆 absorption values. The protein 
molar extinction coefficient can be calculated, for example using the ExPASy 
Protparam tool (Gasteiger et al., 2005) [http://web.expasy.org/ protparam/]. 
The theoretical molar extinction coefficients of the proteins studied in this 
work are reported on table 3.7, considering all cysteine residues are reduced 
when they exist on the respective protein sequence. Moreover is important to 
notice that imidazole used for IMAC protein elution absorbs at 280 nm 
influencing the protein concentration measurements.  
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MASS SPECTROMETRY 
 
The potential of mass spectrometry (MS) to analyze proteins is due to the 
advances gained through the development of soft ionization techniques such 
as electrospray ionization (ESI) and matrix-assisted laser desorption 
ionization (MALDI) that can transform biomolecules into ions. ESI can 
efficiently be interfaced with separation techniques expanding the range of 
applications in life sciences (Di Marco and Bombi, 2006). MALDI, has the 
advantage of producing singly charged ions of peptides and proteins, 
minimizing spectral complexity. Regardless of the ionization source, the 
sensitivity of a mass spectrometer is related to the mass analyzer where ion 
separation occurs. Both quadrupole and time of flight (ToF) mass analyzers 
are commonly used and they can be configured together as QToF tandem 
mass (known as MS/MS) spectrometric instruments (El-Aneed et al., 2009). 
Recently non-denaturing ESI-MS has been used to study IDPs (Testa et al., 
2013).  
Unlabeled proteins were used for mass spectrometry as well as for other 
biophysical techniques like SAXS, CD and DLS. A 50 µM HPV16 E7 stock 
sample was prepared in 10mM Hepes pH 7.5, 150mM KCl, 10µM ZnCl2, 
10mM DTT was dialyzed against degassed 10mM ammonium acetate pH 6.6 
Table 3.7. Summary of the protein properties studied in this work. For E7 CR3 and CBP-ID4 
domains, also the values of protein including tags are reported in parenthesis, since they can 
help during the purification steps. The column on the right includes a fast calculation of the 
molar protein concentration (µM) considering a solution containing 1.0 mg-­‐1ml-­‐1 of pure 
protein (after removal of tags when applicable). 
Protein	   Nº	  of	  residues	   MW	  (Da)	   pI	   ε (M-1cm-1)	   µM	  	  (1 mg/ml)	  
HPV16	  E7	   106	   12087	   4.7	   5960	   83	  
HPV16	  CR3	   58	  	  (98)	   6401	  (11044)	   6.0	  	  (7.1)	   1490	  (8940)	   156	  	  
HAdV	  2/5	  13S	  E1A	   299	   33176	   4.9	   7450	   30	  
HAdV	  2	  12S	  E1A	   243	   26500	   4.4	   1490	   38	  
CBP-­‐ID4	   211	  (242)	   22539	  (26051)	   12.1	  (11.4)	   6990	  (8480)	   46	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buffer, using sealed containers.  Mass spectra were recorded in positive 
reflectron mode of a MALDI-TOF mass spectrometer (Bruker Daltonics 
Ultraflex TOF/TOF). The protein mass data files were analyzed afterwards  
using the PERL script algorithm. For ESI-MS an E7 aliquot from the 50µM 
stock solution in 10mM ammonium acetate pH 6.6 buffer was used. The 
addition of 0.1% formic acid was needed to enhance protonation and increase 
sensitivity of ESI experiment. ESI-MS spectra were recorded for 5 min in the 
m/z region from 500 to 30000 Da. For example, the E7 apoprotein theoretical 
mass is 12087 Da, which in turn containing 1 Zn atom is 12152. Mass 
spectrometry measured by ESI analysis showed 12149 Da representing the 
presence of 1 Zn atom. After treatment with 0.1% formic acid for 2.5 hours ESI 
mass was 12085 Da representing the apoprotein with released zinc 
(summarized on Figure 3.3). 
 
  
 
 
 
 
 
 
 
 
Figure 3.3. The HPV 16 E7 protein ESI mass spectrum, after the treatment with 0.1% formic 
acid for 2.5h. The highest intensity peak with a molecular weight of 12085 Da represents the 
E7 apoprotein. The other species with less intensity represents the different free cysteine 
residues of E7 being oxidized by 1 molecule of oxygen forming Cys-SOH. Also the E7 mass 
values before treatment with formic acid are described. The values in parenthesis are 
difference compared to the measured E7 apoprotein. The standard atomic weight of zinc is 
65.38 ± 0.002 Da. Values in Dalton (Da).  
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The HAdV 2/5 13S E1A was also prepared using unlabeled nitrogen and 
carbon sources. The final E1A protein stock was 10µM prepared in 10mM 
Hepes buffer at pH 7.5 with 150mM KCl, 10mM DTT and 10µM ZnCl2 and 
was dialyzed against degassed 10mM ammonium acetate pH 6.6 buffer, using 
sealed containers. MALDI and ESI experiments were recorded always in the 
presence of DTT. The theoretical molecular weight of E1A apoprotein is 33176 
Da while containing 1 atom of zinc is 33241 Da. 
	  
	  
CIRCULAR	  DICHROISM	  
 
Circular Dichroism (CD) is based on the differential absorption of left- and 
right-handed circular polarized light. CD is a fast technique, which allows for 
the assessment of the secondary structural properties of a protein or protein 
regions. IDPs present particular CD characteristic different from those of 
folded proteins and also different from random coil polypeptides, presenting 
specific conformational preferences, thus revealing partially populated 
secondary content. These dynamic secondary structure elements can be 
stabilized or perturbed by temperature; by different chemical agents like 
solvent, pH, ionic strength, and reducing agents; by post-translational 
modifications, like phosphorylation and by the presence of metal ligands. 
Thus the secondary structural properties of IDPs can be studied by CD 
measurements changing the chemical conditions to analyze the nature of the 
intrinsically disordered protein samples. 
Proteins present CD bands in the far-UV or amide region (175–250 nm) giving 
information about the secondary structure content, mostly based on the 
asymmetric conformation attained by the main polypeptide backbone. CD 
bands in the far-UV region are characteristic for different types of secondary 
structure. Alpha helix structure displays the most invariable band pattern: a 
characteristic spectrum with a positive band at 190 nm and two negative 
bands at 208 and 222 nm. Beta sheet elements, however, are more variable 
with a positive band at around 198 nm and a single negative band ranging 
from 214 to 218 nm, depending on the type of structure. The random coil 
conformation is characterized by a negative band below 200 nm (Figure 3.4) 
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(Kelly et al., 2005).  
 
 
Figure 3.4. CD spectra examples of different pure secondary structures. 
 
The CD measurements were performed in a Jasco J-715 spectropolarimeter 
using a 0.1 cm path length cell with cooling jacket connected to a water 
thermostatic device at 25 ºC. Spectra were recorded from 190-250 nm at a scan 
speed of 20 nm/min combined from an average of 3 scans. The final spectra 
were baseline-corrected by subtracting the corresponding buffer obtained 
under identical conditions. Results were shown as the mean residue ellipticity 
[𝜽] at a given wavelength. The data were fitted using the secondary structure 
estimation program K2D3 (Louis-Jeune et al., 2012) 
[http://www.ogic.ca/projects/k2d3/]. As an example the HPV 16 E7 protein 
CD were recorded to validate the expected secondary structure prediction of 
the model. Concentrations from 15µM to 30µM were used and a typical 
spectrum is reported in Figure 3.5. Its analysis accomplished with the use of 
the K2D3 webserver confirmed that E7 contains about 50% α-helix and about 
10% β-sheet were the remaining 40% is random coil. This data are consistent 
with bioinformatics predictions indicating that the N-terminus is largely 
disordered while the CR3 is ordered. 
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Figure 3.5. CD spectrum of 15µM HPV 16 E7 protein CD spectrum in 5mM KPi buffer at pH 
7.5 measured at 25 ºC. The obtained CD spectrum of HPV 16 E7 protein is the typical profile 
of a protein both containing ordered and disordered regions, was it has been already 
reported in the literature (Garcia-Alai et al., 2007). 	  	  
DYNAMIC	  LIGHT	  SCATTERING	  
 
Molecular parameters such as size, molar mass, and intermolecular 
interactions, which are important to identify and characterize IDPs, can be 
obtained from light scattering measurements.  
All techniques based on scattering like dynamic light scattering (DLS), small 
angle X-ray scattering (SAXS) and small angle neutron scattering (SANS), 
require very homogeneous samples. The presence of even small fraction of 
the aggregated material is known to dramatically affect the scattering profile, 
making interpretation of data difficult.  
DLS analyzes the temporal fluctuations of the light scattering intensity caused 
by hydrodynamic motions in solution. Thus, DLS is an appropriate technique 
to determine the hydrodynamic radius (RH) of a protein also known as the 
Stokes radius. Measuring the RH it reflects the apparent size adopted by the 
solvated tumbling molecule and thus is possible to monitor expansion or 
compaction of protein molecules. This is especially important for IDPs, which 
can be recognized and characterized by comparing the measured RH radii 
with those calculated for particular reference states, such as the compactly 
folded or the fully unfolded states.  
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In the present thesis DLS was performed using a SEC column attached to DLS 
instrument to avoid the presence of aggregates and to separate multispecies 
in solutions like monomer and multimers. Samples in a concentration range 
of 0.1-1.0 mM were injected on a Superdex75 HR-10/30 size exclusion column 
on a AKTA FPLC system (Amersham Pharmacia Biosciences) connected with 
a multiangle light scattering (DAWN-EOS, Wyatt Technologies, Santa 
Barbara, CA) coupled with a quasielastic light scattering detectors. Data 
analysis and MW were automatically calculated using Wyatt's Astra software. 
For example, the HPV 16 E7 protein DLS measurements were performed 
using the same buffer used for SAXS and NMR experiments, 10mM Hepes 
pH 7.5, 150mM KCl, 10µM ZnCl2 in presence of 10mM DTT. The E7 sample 
was centrifuged for 5min at 13000 rpm at 4ºC and 100 µl from the supernatant 
with a concentration of 150µM was injected a Superdex75 HR-10/30 size-
exclusion column at a flow-rate of 0.6 ml/min and analyzed as described 
above. Using these conditions, the DLS as well the refractive index 
measurements versus elution volume are represented on Figure 3.6. 
 
 Figure 3.6. DLS profile of HPV 16 E7 protein eluted from the size-exclusion column. Dash line 
is the scattering light and line is the refractive index. The first peak showed an RH of 250 Å 
and the second peak showed an RH of 15 Å. The chromatogram also shows the molecular 
mass estimation, but it was not considered in this work because in DLS this calculation is 
based in the partial volume considering a spherical protein, which is not the case. 
 
The RH measured was 15 Å meaning an elongated extent of the 106 residues of 
the analyzed E7 protein in solution. Is important to notice that DLS molecular 
weight estimation is calculated on the basis of the empirical equation Mr	   =	  4/3NA(RH	   f/f0)3/Vk, where NA is Avogrado's number, f/f0 is the ratio of 
frictional coefficients (set to 1.2 for spherical proteins), and	  Vk	   is the partial 
volume set to 0.73 for a spherical protein.  
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SMALL ANGLE X-RAY SCATTERING 
 
It is becoming evident that IDPs are not fully disordered, but they have all 
sort of transient, short, and long-range structural organization that are 
function-related. The major techniques toward describing the resultant 
structural ensemble made use of structural calculations supported by NMR 
and small-angle X-ray scattering (SAXS) data. SAXS, mostly contributes 
information on the hydrodynamic behavior and topology of the polypeptide 
chain. In a SAXS experiment, samples containing soluble protein are exposed 
to an X-ray beam. The different scattered beam intensities are further 
recorded by a detector as function of the scattering angles of the soluble 
protein (fig. 3.6), giving rise to an isotropic scattering intensity (I). The solvent 
scattering is subtracted and the background corrected intensity is presented 
as a radially averaged one-dimensional curve I(s). 
 Figure 3.6. Schematic representation of a solution SAXS experiment, adapted from 
(Petoukhov and Svergun, 2013). 
 
For monodisperse solutions of non-interacting identical and randomly 
oriented proteins, the SAXS curve is proportional to the scattering of a single 
particle averaged over all orientations. Thus, the scattering profile carries 
information about the major geometrical parameters of the particle. 
Particularly, molecular mass (M) of the solute and its radius of gyration (Rg) 
are derived from the slope of the Guinier plot. Moreover, the values of the 
hydrated particle volume (V) and its specific surface (S) can be obtained using 
the so-called Porod invariant (Petoukhov and Svergun, 2013). 
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SAXS has been actively used to characterize flexible protein, using advanced 
approaches that take the insights of conformational flexibility of IDPs 
(Bernadó and Svergun, 2012a; Bernadó et al., 2007a). A set of different 
conditions to be studied should be designed in advance in order to estimate 
the number of condition/samples to measure. Conditions such as buffer 
composition, ionic strength, pH, temperature among others, can be used to 
analyze the conformational properties of the IDP under investigation. The 
data analysis of the SAXS measurements can be performed using the available 
software package like ATSAS, which is in use at DESY (Konarev et al., 2006; 
Petoukhov et al., 2012). The following is the workflow implemented at the 
beam line workstation for the analysis of the data. The standard procedure 
starts with the subtraction of the buffer for each measurement. Then the SAXS 
curve is loaded on the program PRIMUS to generate a Kratky plot where the 
folding state of the protein can be assessed (Figure 3.7) and thus qualitatively 
identify the IDP conformational disorder (Mertens and Svergun, 2010).  
 
Figure 3.7. Kratky plot representation of typical SAXS curves measured for different protein 
folding domains. (blue) globular domain; (red) partly disordered domain; (purple) fully 
disordered domain. Figure adapted from (Bernadó and Svergun, 2012a). 
 
Then the Guinier tool is used to calculate the Rg and I(0) by a simple linear fit 
in logarithmic scale, derived from the very small angles initial part of the 
scattering profile. Rg of a protein is defined as the root mean square distance 
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of all the protein atoms from the center of gravity of the molecule. The I(0) 
provides the estimate of the molecular mass (MM) of the protein and hence 
suggests its oligomeric state. Then the program GNOM is used to calculate 
the distance distribution function, P(r) defined as the distribution of distances 
between volume elements inside the protein particle. Using the P(r) function 
it is possible to define the maximum particle distance, Dmax (Svergun, 1992).  
The SAXS analysis of flexible systems takes in consideration an infinite 
amount of conformations that are in fast equilibrium exchange. The tool 
Ensemble Optimization Method (EOM) has been developed as a strategy for 
the structural characterization of IDPs using SAXS (Bernadó et al., 2007a) and 
is also included in the ATSAS package. The use of EOM approach consists in 
three consecutive steps: 1) generation of a pool of conformations; 2) selection 
of a sub-ensemble of conformations describing the SAXS data; 3) quantitative 
description of the structural properties of the selected ensemble, as discussed 
in details in (Bernadó and Svergun, 2012b). 
The sample preparation for SAXS experiments should follow standard 
guidelines (Jacques et al., 2012) and requires highly pure, monodisperse 
proteins in a concentration range from 1mg -10mg/ml to fulfill the condition 
of a “dilute” solution. The concentrations must be determined with accuracy 
as is required to appropriately normalize the scattering data and thus to 
estimate the effective molecular mass of the solute. If the sample is 
aggregated, the scattering data will be difficult or even impossible to 
interpret. Depending on the SAXS station used, a typical sample volume of 
50µl is required for each single measurement. Each SAXS experiments of 
different condition such as buffer, ionic strength, pH, temperature etc., 
requires 1-2 mg of purified sample in order to prepare at least 3 different 
concentrations. The concentration range can be prepared by dilution of a 
concentrated stock, if is known the protein is not affected by aggregation. In 
case the protein tends to aggregate it is better to prepare a stock of diluted 
protein sample and perform the concentrated samples, right before the SAXS 
experiments. Is important to highlight that for each experiment at a given 
condition, the scattering of the buffer is also measured by SAXS for further 
subtraction, thus the background can be corrected and the intensity is 
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presented as a radially averaged one-dimensional curve I(s). The buffer 
composition must precisely match the composition of the sample. A small 
mismatch in the chemical composition of the solvent between the buffer and 
the sample may lead to difficulties during background subtraction. Thus, the 
best approach is to use the dialysis buffer where the protein was prepared.  
In the present work we used SAXS for the characterization of HPV 16 E7. This 
protein was prepared in 10mM Hepes pH 7.5, 150mM KCl, 10mM DTT, 10µM 
ZnCl2 as a diluted stock solution of 50µM (0.6 mg ml-­‐1). The samples where 
concentrated right before the SAXS measurements to prepare a concentration 
range from 1.3 - 2.7 mg ml-1 (108 - 223 µM). The results are reported in chapter 
4.2. 
 
 
Nuclear Magnetic Resonance Spectroscopy 
 
Due to the high flexibility and heterogeneous nature of IDPs/IDRs, NMR is 
the only spectroscopic technique that can provide atomic resolution 
structural and dynamic information on these macromolecules. Together with 
SAXS, NMR has been the key tool to provide experimental information on 
the importance of disorder and flexibility for protein function. The atomic 
resolution experimental results are going to contribute to the understanding 
not only of the individual characteristics of IDPs, but also of their behavior 
when interacting either with other protein partners or with possible drugs to 
accomplish their function. The highly flexible nature of IDPs induces 
extensive conformational averaging, reducing the nuclear chemical shift 
dispersion (Bertini et al., 2012).  Taking flexibility to its extreme, chemical 
shifts progressively collapse to those of random coil polypeptides, causing 
extensive resonance overlap. The intrinsic chemical shift dispersion increases 
from protons to heteronuclei (13C, 15N). Therefore exclusively heteronuclear 
NMR experiments based on 13C direct detection has crucial relevance for 
IDPs studies (Bermel et al., 2006a; 2006b; Braun et al., 1994; Zhang et al., 1997) 
of course in combination with 1H detectable experiments as when studing 
complex systems, all the information available is welcome. In addition the 
determination of 15N relaxation rates provides accurate information on the 
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motional properties of the backbone for each amino acid, as well it provides a 
general estimation of the expected transverse relaxation rates, which of 
course have a large impact on the overall sensitivity of multidimensional 
NMR experiments. 
 
Sequence specific assignment 
The sequence specific assignment of the protein backbone resonances is the 
initial step of NMR experiments to allow getting further structural and 
dynamic information on IDPs. The most suitable nuclear spins to be 
exploited for sequence specific assignment are backbone ones, which are 
more influenced by the contributions of neighboring amino acids 
(Schwarzinger et al., 2001), and carbonyl carbon nuclei and nitrogen nuclei 
linked in the peptide bond (Braun et al., 1994; Dyson and Wright, 2001; 
Zhang et al., 1997). Thus, C´-N correlations display the most favorable 
chemical shift dispersion allowing the detection of proline residues, often 
very abundant in IDPs. The chemical shifts can be calculated for any protein 
by simply taking the primary sequence and using random coil values typical 
of each amino acid, properly corrected using the contributions from 
neighboring amino acids.  The suite of NMR experiments generally used for 
protein sequence-specific assignment includes experiments that provide 
additional correlations involving backbone C´ and N atoms. These 
experiments exploit the small 3JC´C´ (Grzesiek and Bax, 1993; Liu et al., 2000) as 
well as multiple magnetization transfer steps mediated by heteronuclear 
scalar couplings (1JC´N, 1JCαN, 2JCαN) (Bermel et al., 2006b; 2009) to detect 
correlations with the previous and following carbonyls and nitrogens (Figure 
3.8). Another approach to increase the resolution is to move to experiments 
with higher dimensionality than 3D. Including additional indirect 
dimensions is now feasible due to improvements in instrumental sensitivity 
and techniques to reduce the number of sampled points, being very 
appropriate to increase the resolution study of IDPs (Bermel et al., 2012).  
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Figure 3.8. Diagram representing an example of sequence specific assignment based on 
HSQC and CON experiments. The dots in the graphs represent the expected correlations 
involving backbone nitrogens with the directly bound amide proton (NHi-HNi) or carbonyl 
carbon (NHi-C´i-­‐1), calculated using random coil chemical shifts appropriately corrected for 
the contributions from the primary sequence, taking human securin as an example. For a 
fair comparison, the same spectral widths (in units of Hz) are shown in the two graphs (2 
ppm for 1H correspond to 8 ppm for 13C). The HN HSQC and CON experiments acquired 
on intrinsically disordered human securin are reported in the original publication. 
Adapted from (Bertini et al., 2012). 
 
Information from NMR chemical shifts 
The chemical shifts can be analyzed to understand the secondary structural 
propensity of the protein. If the sequence-specific assignment of the protein 
has been achieved it will be possible to attribute the secondary structural 
propensity to specific regions of the polypeptide chain of an IDP. Because 
IDPs are characterized by a continuous spectrum of possible disordered 
states, deviations from random coil chemical shifts can be used to estimate 
the secondary structural propensities. Compact conformations typical of α-
helices and the elongated ones typical of β-strands do cause chemical shift 
variations in opposite directions for the various nuclei (Spera and Bax, 1991). 
Therefore, when chemical shifts are identified for several consecutive 
residues, they can provide information on the secondary structural 
propensities of different regions of the polypeptide (Marsh et al., 2006). 
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Information from 15N relaxation rates 
15N relaxation rates (15N R1, 15N R2, 1H-15N NOEs) provide very useful 
information to characterize the different local mobility of different parts of 
the polypeptide chain (Kay et al., 1989; Peng and Wagner, 1994). The 
heteronuclear NOEs in particular, are the most sensitive reporter of fast local 
motions on IDPs. Depending on the local effective correlation time, span a 
large range from -4 to +1 and for this reason provide very effective 
information on the regions of the protein characterized by different mobility. 
While a lot of information is directly available from chemical shifts and 15N 
relaxation rates, additional observables such as exchange effects with the 
solvent, scalar couplings, residual dipolar couplings, 1H-1H NOEs and PREs 
can be determined to describe the structural and dynamic properties of the 
IDP conformational ensemble. 
 
Performing NMR experiments 
The most suitable NMR experiments to evaluate the feasibility of a complete 
NMR characterization of the protein are the 2D experiments correlating the 
amide nitrogen with the directly bound amide proton (HSQC) or carbonyl 
(CON). The low chemical shift dispersion of CON provides the first 
indication that the protein is not characterized by a stable 3D structure. The 
heteronuclear correlations involving backbone nitrogen nuclei, both for HN 
and C’N, can be detected with several different variants of the experiments 
that may help to increase the sensitivity, increase the resolution, decrease 
experimental time, increase the number of detected cross peaks and so on.  
The spectral quality can often also be improved through minor changes in 
the experimental conditions (temperature, pH, buffer, salt, etc.). The suite of 
experiments generally used for the sequence-specific assignment of folded 
proteins can also be applied to IDPs, taking care to optimize the experimental 
set-up for resolution using high number of acquired data points. The long 
magnetization transfer pathways and the small scalar couplings, which 
generally drastically reduce the sensitivity of these experiments when 
applied to study folded proteins, have less impact when used to IDPs since 
the high protein flexibility causes an increase in coherences lifetime. Thus, 
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experiments with long coherence transfer delays as well as with multiple 
coherence transfer steps can be planned. The list of the most suitable 3D 
NMR experiments, either based on 1H detection or on 13C detection, as well as 
the correlations expected in each experiment, is reported in Table 3.8. The 
necessary number of experiments of course depends on the complexity of the 
protein. A larger set of 3D spectra reduces the time necessary for the 
assignment and may help to solve ambiguities (Bertini et al., 2012). 
Table 3.8. Suite of 2D and 3D experiments either based on 1H or on 13C direct detection to 
achieve protein sequence-specific assignment (only correlations involving backbone nuclei 
and Cβ are indicated). Adapted from (Bertini et al., 2012). 
Experiment	   Correlations	  observed	   J	  couplings	  HN	  HSQC/HMQC	   N(i)-­‐HN(i)	   1JNH	  CBCA(CO)NH	   Cβ(i-­‐1)-­‐N(i)-­‐HN(i),	  Cα(i-­‐1)-­‐N(i)-­‐HN(i)	   1JNH,	  1JNCα,	  2JNCα,	  1JNC´,	  1JCβCα,	  1JC´Cα,	  1JCH	  
CBCANH	   Cβ(i-­‐1)-­‐N(i)-­‐HN(i),	  Cα(i-­‐1)-­‐N(i)-­‐HN(i),	  Cβ(i)-­‐N(i)-­‐HN(i),	  Cα(i)-­‐N(i)-­‐HN(i)	   1JNH,	  1JNCα,	  2JNCα,	  1JCβCα,	  1JCH	  HNCA	   Cα(i-­‐1)-­‐N(i)-­‐HN(i),	  Cα(i)-­‐N(i)-­‐HN(i)	   1JNH,	  1JNCα,	  2JNCα	  HNCO	   C´(i-­‐1)-­‐N(i)-­‐HN(i)	   1JNH,	  1JNC´	  HN(CA)CO	   C´(i-­‐1)-­‐N(i)-­‐HN(i),	  C´(i)-­‐N(i)-­‐HN(i)	   1JNH,	  1JNCα,	  2JNCα,	  1JNC´1JC´Cα,	  HN(CO)CA	   Cα(i-­‐1)-­‐N(i)-­‐HN(i)	   1JNH,	  1JNCα,	  2JNCα,	  1JNC´1JC´Cα,	  HN(CA)NNH	   N(i)-­‐	  N(i)-­‐HN(i),	  N(i+1)-­‐	  N(i)-­‐HN(i),	  N(i-­‐1)-­‐	  N(i)-­‐HN(i)	   1JNH,	  1JNCα,	  2JNCα	  (H)CACO	   Cα(i)-­‐C´(i)	   1JCH,	  1JC´Cα	  (H)CBCACO	   Cβ(i)-­‐C´(i),	  Cα(i)-­‐C´(i)	   1JCH,	  1JCβCα,	  1JC´Cα	  CON	   C´(i-­‐1)-­‐N(i)	   1JNC´	  (H)CBCACON	   Cβ(i-­‐1)-­‐C´(i-­‐1)-­‐N(i),	  Cα(i-­‐1)-­‐C´(i-­‐1)-­‐N(i)	   1JCH,	  1JCβCα,	  1JC´Cα,	  1JNC´	  (H)CBCANCO	   Cβ(i)-­‐C´(i-­‐1)-­‐N(i),	  Cα(i)-­‐C´(i-­‐1)-­‐N(i),	  Cβ(i)-­‐C´(i)-­‐N(i+1),	  Cα(i)-­‐C´(i)-­‐N(i+1)	   1JCH,	  1JCβCα,	  1JC´Cα,	  1JNC´,	  1JNCα,	  2JNCα	  COCON	   C´(i)-­‐C´(i)-­‐N(i+1),	  C´(i-­‐1)-­‐C´(i)-­‐N(i+1),	  C´(i+1)-­‐C´(i)-­‐N(i+1)	   1JNC´,	  3JC´C´	  (H)NCANCO	   N(i)-­‐N(i)-­‐C´(i-­‐1),	  N(i+1)-­‐N(i)-­‐C´(i-­‐1),	  N(i-­‐1)-­‐N(i)-­‐C´(i-­‐1)	   1JCH,	  1JNH,	  1JC´Cα,	  1JNC´,	  1JNCα,	  2JNCα	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An example of these NMR methodologies is shown on figures 3.9 and 3.10, 
where both E1A 13S and 12S can be compared. The E1A 13S has been 
assigned and a scientific manuscript is being submitted. The E1A 12S data is 
under analysis and is going to be compared with the E1A 13S data.  
	  
Figure	  3.9.	  1H-­‐15N	  HSQC	   and	   13C-­‐15N	   CON-­‐IPAP	   spectra	   recorded	   for	  HAdV	   2/5	  E1A13S.	  Experiments	  were	  recorded	  at	  16.4	  T	  and	  278	  K	  for	  a	  0.2	  mM	  E1A13S	  sample	  in	  10	  mM	  HEPES	  buffer	  at	  pH	  7.5,	  50	  mM	  KCl,	  10	  µM	  ZnCl2,	  and	  10	  mM	  DTT.	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Figure	   3.10.	   1H-­‐15N	   HSQC	   and	   13C-­‐15N	   CON-­‐IPAP	   spectra	   recorded	   for	   HAdV	   2	  E1A12S.	  Experiments	  were	  recorded	  at	  16.4	  T	  and	  278	  K	  for	  a	  0.8	  mM	  E1A12S	  sample	  in	  10	  mM	  HEPES	  buffer	  at	  pH	  7.5,	  50	  mM	  KCl,	  10	  µM	  ZnCl2,	  and	  10	  mM	  DTT.	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4. Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: The author of the present work performed the molecular 
biology, biochemical and biophysical analysis and 
characterization of all studied protein constructs presented. 
He carried out the protein characterization using light 
scattering, circular dichroism, small-angle X-ray scattering 
and simple NMR experiments. During the PhD course he 
was seconded for a period at VIB, Brussels, under the 
supervision of Prof. Peter Tompa, to learn different 
techniques of protein expression and purification of IDPs. 
He also spent a period at DESY, Hamburg, under 
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4.1. The heterogeneous structural behavior of E7 from HPV16 
revealed by NMR spectroscopy 
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4.2. On the super-tertiary structure of HPV 16 E7 	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INTRODUCTION	  Many	  intrinsically	  disordered	  proteins	  (IDPs)	  consist	  of	  combinations	  of	  globular	  domains,	  linear	  motifs	  and	  disordered	  regions.	  These	  IDPs	  are	  characterized	  by	  a	  dynamic	   ensemble	   of	   conformations	   that	   cannot	   be	   easily	   described	   by	  traditional	   structural	   biology	   and	   have	   often	   a	   heterogeneous	   structural	  behavior	  that	  render	  their	  investigation	  troublesome.	  This	   is	   the	   case	   of	   the	   protein	   E7	   from	   Human	   Papilloma	   Virus	   (HPV).	   This	  protein	   has	   been	   investigated	   since	   long	   time	   as	   it	   is	   the	   main	   transforming	  product	  from	  HPV	  (Phelps	  et	  al.,	  1988)	  and	  has	  been	  reported	  to	  interact	  with	  a	  large	   number	   of	   cellular	   targets.	   This	   feature	   enables	   E7	   to	   interfere	   with	  multiple	  cell	  regulatory	  pathways,	  eventually	  leading	  to	  cell	  transformation	  and	  cancer	  in	  the	  case	  of	  the	  most	  aggressive	  HPV	  phenotypes	  (Moody	  and	  Laimins,	  2010b).	  E7	  is	  constituted	  by	  about	  one	  hundred	  amino-­‐acids	  that	  can	  be	  grouped	  in	  three	  conserved	  regions	  (CR),	  namely	  CR1	  and	  CR2	   in	   the	  N-­‐terminal	  half	   (E7N)	  and	  CR3	   in	   the	  C-­‐terminal	   half	   (E7C)	   (Phelps	  et	  al.,	   1992).	  The	   first	   two	   conserved	  regions	  (CR1	  and	  CR2)	  show	  a	  high	  propensity	  to	  be	  disordered.	  The	  CR3	  region,	  which	   contains	   two	  CXXC	  motifs	   separated	   by	   29	   or	   30	   amino	   acids,	   has	   been	  shown	  to	  bind	  zinc	  and	  is	  more	  structured	  (Uversky	  et	  al.,	  2006).	  The	  structural	  characterization	   of	   the	   C-­‐terminal	   part	   of	   the	   protein,	  which	   contains	   the	   CR3	  and	  the	  zinc	  binding	  motifs,	  has	  been	  achieved	  for	  short	  constructs	  of	  the	  HPV	  1	  variant	   through	   X-­‐ray	   (Liu	   et	   al.,	   2006)	   and	   of	   the	   HPV	   45	   variant	   through	  nuclear	   magnetic	   resonance	   (NMR)	   spectroscopy	   (Ohlenschläger	   et	   al.,	   2006).	  The	  E7	  CR3	  of	   these	  variants	   assembles	  as	   a	  dimer.	  Each	   subunit	  of	   the	  dimer	  contains	  a	  two-­‐stranded	  antiparallel	  sheet	  formed	  by	  residues	  44–52	  and	  58–65	  followed	  by	  a	  sharp	  U-­‐turn	  leading	  to	  12	  amino-­‐acids	  long	  helix,	  a	  bend	  and	  an	  extended	  strand,	  leading	  to	  a	  final	  short	  helix.	  (Liu	  et	  al.,	  2006).	  If	  the	  CR3	  region	  is	   structurally	  well	   characterized,	   the	  whole	   protein	   failed	   to	   give	   crystals	   and	  was	  not	  characterized	  through	  NMR	  until	  very	  recently	  (Calçada	  et	  al.,	  2013).	  	  In	  the	  previous	  work	  (Calçada	  et	  al.,	  2013)	  we	  have	  studied	  with	  high-­‐resolution	  techniques	  for	  the	  first	  time	  the	  full	   length	  of	  E7	  from	  HPV	  16,	  one	  of	  the	  most	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relevant	  variant	  of	  the	  virus,	  which	  proved	  to	  be	  responsible	  for	  the	  occurrence	  of	  cervix	  cancer	  (Hausen,	  2002).	  This	  protein	  shares	  most	  of	  the	  characteristics	  of	  E7	   isolated	   from	  other	  variants,	  but	   resulted	   to	  be	  even	  more	  difficult	   to	  be	  investigated	   due	   to	   the	   high	   tendency	   to	   form	   macromolecular	   assemblies	  (Clements	   et	  al.,	   2000)	   .	  We	   have	   shown	   that	   the	   combined	   use	   of	   1H	   and	   13C	  direct	   detected	   NMR	   experiments	   on	   the	   entire	   construct	   of	   HPV	   16	   E7	   can	  provide	   the	  complete	  assignment	  of	   the	   first	  half	  of	   the	  protein,	  which	  showed	  the	  high	  mobility	  and	   the	   favorable	   relaxation	  properties	  of	  an	   IDP	  (Calçada	  et	  
al.,	  2013)	  	  while	  the	  second	  part	  failed	  to	  give	  useful	  triple	  resonance	  spectra	  due	  to	   large	   signal	   broadening	   and	   poor	   sensitivity.	   The	   latter	   effect	   is	   likely	   the	  result	   of	   both	   the	   tendency	   of	   this	   protein	   to	   form	   large	  molecular	   assemblies	  and	   the	   chemical	   exchange	   between	   monomeric/dimeric/tetrameric	   forms	   of	  the	   protein	   (and	   higher	   order	  multimers)	   (Chinami	   et	  al.,	   1994;	  Munger	   et	  al.,	  2007).	  The	  formation	  of	  these	  multimers	  is	  mediated	  by	  the	  CR3	  region	  of	  HPV	  E7	  but	  mutations	  that	  prevent	  E7	  oligomerization	  lead	  to	  protein	  instability	  and	  disrupt	   the	   cell	   transforming	   properties	   of	   E7	   (Fera	   and	   Marmorstein,	   2012)	  render	  the	  investigation	  of	  these	  mutated	  forms	  of	  the	  protein	  far	  less	  significant	  than	  studies	  of	  the	  wild-­‐type	  protein.	  	  High-­‐resolution	   information	   obtained	   by	   NMR	   spectroscopy	   can	   be	   profitably	  complemented	  with	  data	  from	  low-­‐resolution	  techniques,	   like	  small-­‐angle	  x-­‐ray	  scattering	   (SAXS),	   which	   are	   able	   to	   provide	   information	   of	   the	   molecular	  assembly	  of	  a	  molecule	  in	  solution	  (Bernadó	  and	  Svergun,	  2012b;	  Bernadó	  et	  al.,	  2007a).	  In	  a	  SAXS	  experiment	  on	  a	  dilute	  macromolecular	  solution,	  the	  measured	  intensity	   is	   the	   result	   of	   the	   scattering	   of	   all	   the	   particles	   in	   the	   illuminated	  sample	   volume.	   For	   monodisperse	   samples	   systems	   containing	   randomly	  oriented	   molecules	   with	   identical	   structures,	   the	   isotropic	   SAXS	   intensity	   is	  proportional	  to	  the	  single	  particle	  scattering,	  averaged	  over	  all	  orientations.	  	  Over	   the	   last	   decade	   major	   advances	   in	   instrumentation	   have	   led	   to	   the	  possibility	   to	   investigate	   an	   extremely	   broad	   range	   of	   macromolecules,	   from	  small	   proteins	   to	  macromolecular	   complexes	   up	   to	   several	   hundred	  daltons.	   A	  concomitant	   improvement	   in	   the	   computational	   analysis	   of	   the	   data	   allow	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nowadays	  to	  investigate	  also	  highly	  flexible	  systems	  such	  as	  IDPs.	  Exploiting	  the	  possibility	  to	  represent	  the	  data	  by	  an	  average	  of	  conformers,	  a	  pool	  containing	  a	  large	   number	   of	   possible	   conformations	   is	   randomly	   generated	   to	   cover	   the	  configurational	   space	   and	   appropriate	   subsets	   of	   models	   is	   selected	   using	   the	  “Ensemble	   Optimization	   Method	   (EOM).	   Even	   if	   the	   interpretation	   of	   data	  obtained	   for	   heterogeneous	   systems,	   particularly	   in	   the	   presence	   of	  polydispersed	  particles	   in	   solution,	   is	   challenging	   this	   approach,	   the	  SAXS	  data	  complemented	   by	   NMR	   information	   are	   able	   to	   provide	   a	   description	   of	   the	  supertertiary	  structure	  of	  HPV	  16	  E7	  and	  of	  the	  species	  present	  in	  equilibrium	  in	  solution.	  	  
MATERIALS	  AND	  METHODS	  
Bioinformatics	  analysis	  and	  modeling	  Primary	  sequences	  of	  HPV	  16,	  1	  and	  45	  were	  aligned	  by	  using	  the	  Clustal	  Omega	  software	   tool	   (Sievers	  et	  al.,	   2011).	   Protein	   disorder	   prediction	   from	   sequence	  analysis	   of	   these	   E7	   proteins	  was	   performed	   using	   PONDR-­‐FIT,	   which	   detects	  both	  the	  contribution	  of	  each	  residue	  to	  the	  disorder	  and	  the	  disorder	  content	  of	  the	  protein	  (Xue	  et	  al.,	  2010).	  	  
Homology	  modeling	  The	   E7	   sequence	   from	   HPV	   16	   was	   modeled	   partially	   by	   homology	   using	   the	  NMR	   solution	   structure	   from	   the	   Protein	   Data	   Bank	   (PDB)	   of	   the	   C-­‐terminal	  domain	   (monomer)	   of	   the	   HPV	   45	   E7	   (PDB	   ID:	   2EWL)(Ohlenschläger	   et	   al.,	  2006)	   which	   has	   65	   %	   similarity	   with	   E7	   from	   HPV	   16,	   as	   a	   template.	   The	  homology	   modeling	   was	   performed	   using	   MODELLER	   9.12	   (Šali	   and	   Blundell,	  1993).	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Protein	  preparation	  and	  purification	  The	   recombinant	   plasmid	   pET20-­‐E7	   containing	   the	   E7	   gene	   from	  HPV16,	  was	  generously	   provided	   by	   Scil	   Proteins	   GmbH.	   As	   previously	   described	  (Ohlenschläger	  et	  al.	  2006)	  the	  gene	  was	  modified	  to	  generate	  silent	  mutations	  in	  codons	  for	  His-­‐2,	  to	  eliminate	  the	  possibility	  of	  alternative	  translation	  initiation	  and	   premature	   termination	   of	   translation,	   and	   Pro-­‐6,	   to	   increase	   the	   protein	  expression	  yield.	  The	  optimized	  and	  correctly	  sequenced	  plasmid	  construct	  was	  transformed	   into	   E.	   coli	   BL21/pLysS	   competent	   cells	   for	   protein	   expression.	  HPV16	   E7	   were	   prepared	   growing	   cultures	   at	   37ºC,	   induction	   at	   0.6	   optical	  density	  (OD)	  with	  1mM	  IPTG	  at	  30ºC	  during	  4h.	  Different	  test	  expressions	  were	  done	  and	  best	  conditions	  were	  found	  obtaining	  an	  yield	  of	  36mg/L.	  	  All	  steps	  of	  purification	  since	  cell	  disruption	  until	  	  sample	  preparation	  were	  done	  in	   glove-­‐box	   using	   degassed	   buffers	   containing	   also	   10	   mM	   DTT.	   Cells	   were	  disrupted	   by	   sonication	   and	   soluble	   fraction	  was	   loaded	   on	   a	   5ml	  Ni2+	  HiTrap	  column	  (Amersham	  biosciences	  Europe)	  under	  anaerobic	  conditions.	  The	  HPV16	  E7	   protein	   was	   washed	   and	   eluted	   with	   imidazole	   and	   finally	   the	   buffer	   was	  exchanged	  by	  using	  size-­‐exclusion	  chromatography	   into	  10	  mM	  HEPES,	  50	  mM	  KCl,	  pH	  7.5.	  Samples	  were	  concentrated	  till	  3.0	  ml	  in	  the	  presence	  of	  10	  mM	  DTT	  and	  stored	  at	  4ºC	  for	  biophysical	  analysis.	  	  	  
Dynamic	  Light	  Scattering	  DLS	   measurements	   on	   E7	   protein	   were	   done	   preliminary	   to	   SAXS	  measurements.	   Protein	   concentrations	   were	   determined	   with	   UV	   and	   the	  samples	  were	  prepared	  in	  10mM	  HEPES	  pH	  7.5,	  150mM	  KCl,	  10µM	  ZnCl2,	  10mM	  DTT.	  Tests	  without	  the	  addition	  of	  DTT	  were	  also	  done,	  establishing	  the	  need	  of	  the	  reducing	  agent	  in	  the	  protein	  solution.	  	  The	  E7	  sample	   in	  a	  concentration	  of	  150µM	  was	   injected	  on	  a	  pre-­‐equilibrated	  Superdex75	  HR-­‐10/30	  size-­‐exclusion	  column	  at	  a	  flow-­‐rate	  of	  0.6	  ml/min	  and	  at	  298	  K,	  controlled	  by	  an	  AKTA	  FPLC	  system	  (Amersham	  Pharmacia	  Biosciences).	  The	   column	  was	   connected	   to	  a	  multiangle	   light	   scattering	   (DAWN-­‐EOS,	  Wyatt	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Technologies,	   Santa	   Barbara,	   CA)	   coupled	   with	   quasielastic	   light	   scattering	  detectors,	  where	   the	  DLS	  data	  were	   recorded.	  To	   calculate	   the	  RH	  and	  MM	   the	  DLS	  data	  analysis	  was	  performed	  using	  Wyatt's	  Astra	  software,	  supplied	  with	  the	  instrument.	  	  Two	   elution	   peaks	   were	   always	   observed.	   The	   first	   peak	   elutes	   at	   6.3	   ml,	  corresponding	   to	   an	  oligomeric	   form	  of	   the	  protein,	  with	   an	  Rh	   of	   250	  Å.	   	   The	  second	   peak	   elutes	   at	   9.3	   ml	   with	   an	   Rh	   of	   15	   Å.	   Both	   the	   analysis	   of	   the	   e	  refractometer	   peaks	   and	   a	   native-­‐PAGE	   showed	   that	   the	   oligomer	   present	   in	  solution	   was	   5	   times	   less	   concentrated	   than	   the	   dimer,	   but	   still	   sizable.	   The	  shapes	  of	  the	  peaks	  were	  very	  large	  due	  to	  the	  presence	  of	  highly	  flexible	  regions	  of	  E7	  protein	  that	  enlarge	  the	  apparent	  hydrodynamic	  radius.	  	  
Small-­‐angle	  X-­‐ray	  scattering	  (SAXS)	  SAXS	  data	  of	   the	  HPV	  16	  E7	  protein	  were	  collected	  at	   the	  EMBL	  X33	  beamline	  (DESY,	  Hamburg)	  (Roessle	  et	  al.,	  2007)	  using	  a	  robotic	  sample	  changer	  (Round	  et	  
al.,	  2008).	  	  Samples	  were	  prepared	  in	  10mM	  HEPES	  pH	  7.5,	  150mM	  KCl,	  10µM	  ZnCl2,	  10	  mM	  DTT.	   A	   concentration	   range	   from	   1.3	   -­‐	   2.7	  mg	  ml-­‐1	   (108	   -­‐	   223	   µM)	  was	   used.	  Concentrated	   samples	  where	   prepared	   right	   before	   the	  measurements	   using	   a	  refrigerated	  centrifuge	  with	  the	  addition	  of	  10	  mM	  DTT	  both	  to	  keep	  the	  protein	  protected	   from	   radiation	  damage	   and	   reduced.	  Radiation	  damage	  during	  X-­‐ray	  exposure	  was	  monitored	  by	  several	  successive	  measurements	  of	  a	  single	  protein	  solution.	  No	  significant	  changes	  were	  observed	  (data	  not	  shown).	  SAXS	   data	   were	   recorded	   on	   a	   PILATUS	   1M	   pixel	   detector	   (DECTRIS,	   Baden,	  Switzerland)	  at	  a	  sample–detector	  distance	  of	  2.7	  m	  and	  a	  wavelength	  of	  1.5	  Å.	  This	  set	  up	  covers	  a	  range	  of	  momentum	  transfer	  of	  0.012	  b	  s	  b	  0.6	  Å−1	  (s	  =	  4π	  sin(θ)	  /	  λ,	  where	  2θ	  is	  the	  scattering	  angle).	  The	  measured	  data	  were	  processed	  by	  PRIMUS	  (Konarev	  et	  al.,	  2003).	  The	  forward	  scattering	  I(0)	  and	  the	  radius	  of	  gyration	   (Rg)	  were	   calculated	   using	   the	  Guinier	   approximation	   (Guinier,	   1939)	  and	  assuming	  that	  at	  very	  small	  angles	  (s	  b	  1.3	  /	  Rg)	  the	  intensity	  is	  represented	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as	   I(s)	   =	   I(0)	   ∗	   exp(−(sRg)2	   /	   3).	   The	   pair-­‐distance	   distribution	   function	   p(r),	  from	  which	  the	  maximum	  particle	  dimension	  (Dmax)	  is	  estimated,	  was	  computed	  using	   GNOM	   (Svergun,	   1992).	   Finally,	   the	   excluded	   volume	   of	   the	   hydrated	  particle	  was	   computed	   using	   the	   Porod	   invariant	   and	   the	  molecular	  mass	  was	  estimated	  as	  0.6	   times	   the	  Porod	  volume.	  Low	  resolution	  shape	  analysis	  of	   the	  solute	  was	  performed	  using	  the	  ab-­‐initio	  program	  DAMMIF	  (Franke	  and	  Svergun,	  2009).	  This	  algorithm	  represents	  the	  macromolecule	  by	  an	  assembly	  of	  densely	  packed	   beads	   and	   employs	   simulated	   annealing	   to	   build	   a	   compact	  interconnected	   configuration	   of	   beads	   inside	   a	   sphere	   with	   a	   diameter	   (Dmax)	  that	   fits	   the	   experimental	   data	   Iexp(s)	   and	   minimizes	   the	   discrepancy	   χ2.	   The	  protein	   ensembles	   based	   SAXS	   data	   where	   created	   using	   the	   program	   EOM	  (Bernadó	  et	  al.,	  2007b).	  	  All	  programs	  used	  for	  analysis	  of	  the	  SAXS	  data	  belong	  to	  the	  ATSAS	  package	  (Petoukhov	  et	  al.,	  2012).	  	  
RESULTS	  AND	  DISCUSSION	  
Modeling	  of	  the	  structure	  The	   high-­‐risk	  HPV16	   E7	   oncoprotein	   is	   38%	   analogous	   to	   the	   low-­‐risk	  HPV1a	  and	   45%	   analogous	   to	   the	   high-­‐risk	   HPV45.	   Sequence	   alignment	   for	   all	   the	  constructs	  confined	  to	  the	  CR3	  shows	  that	  HPV	  45	  E7	  has	  the	  highest	  similarity	  with	  the	  HPV	  16	  E7,	  arriving	  at	  65%.	  From	  the	  comparison	  among	  E7	  primary	  sequences	  by	  using	  different	  structural	  predictors	  it	  results	  that	  E7	  expected	  to	  be	  highly	  disordered	  in	  the	  N-­‐terminal	  of	  the	  polypeptide	  for	  all	  the	  strains	  here	  compared,	  as	  shown	  in	  Figure	  1.	  HPV16	  E7	  is	  the	  one	  showing	  the	  largest	  tendency	  of	  disorder,	  while	  HPV1a	  E7	  the	  least.	  The	  CR3	  region,	  instead,	  is	  predicted	  largely	  structured	  for	  all	  the	  variants.	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Figure	  1.	  PONDR-­‐FIT	  prediction	  tool	  applied	  to	  E7	  sequences	  from	  HPV1a,	  HPV16	  and	  HPV45.	  Values	  close	  to	  1	  indicate	  high	  disordered	  propensity.	  	  The	   current	   version	  of	  MODELLER	  9.12	  was	  used	   to	   create	   a	  model	   of	   the	   full	  length	   HPV	   16	   E7	   protein	   based	   on	   the	   HPV	   45	   E7	   CR3	   monomer	   (PDB	   ID:	  2EWL)	  as	  template.	  The	  generated	  model	  and	  the	  template	  have	  a	  RMSD	  =	  0.496	  Å,	   which	   is	   not	   surprising,	   seeing	   the	   high	   homology	   between	   the	   primary	  sequences.	   In	   Figure	   2	   the	   two	   structures	   are	   superimposed	   to	   show	   the	   high	  quality	  of	  the	  fit.	  The	  first	  half	  of	  the	  polypeptide	  is,	  of	  course,	  randomly	  placed	  in	  the	  modeled	  HPV	  16	  E7	  and	  represents	  just	  a	  screen-­‐shot	  for	  the	  description	  of	  its	  disordered	  nature.	  
	  
Figure	  2.	  Model	  of	  HPV16	  E7	  (blue)	  based	  on	  ‘monomer	  a’	  from	  2EWL	  NMR	  structure	  of	  HPV45	  E7	  protein	  (brown).	  Both	  proteins	  were	  created	  matched	  and	  pictures	  created	  using	  the	  Chimera	  software.	  The	  CR3	  region	  is	  zoomed	  to	  highlight	  the	  zinc-­‐binding	  motif	  of	  E7.	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SAXS	  In	  Figure	  3	  the	  experimental	  profiles	  of	  the	  SAXS	  data	  are	  reported.	  The	  overall	  parameters	   derived	   from	   the	   extrapolated	   curve	   displayed	   in	   Figure	   3	   are	  presented	  in	  Table	  1.	  The	  programs	  DAMMIF	  and	  GASBOR	  were	  used	  to	  compute	  the	  ab-­‐initio	  and	  reconstruction	  shapes	  respectively	  presented	  in	  Figure	  4.	  	  	  Based	  on	   the	  Porod	  volume,	   the	  molecular	  mass	  of	   the	  protein	   in	  solution	  was	  determined	   to	   be	   about	   48	   ±	   5	   kDa,	   which	   corresponds	   well	   to	   the	   expected	  value	  for	  a	  tetrameric	  arrangement	  of	  the	  protein,	  being	  the	  monomer	  about	  12	  kDa.	  The	  p(r)	  function	  had	  a	  shape	  typical	  for	  an	  elongated	  particle	  and	  revealed	  a	   Dmax	   =	   125	   Å.	   Twelve	   independent	   runs	   of	   DAMMIF	   computed	   without	  symmetry	   restrictions	   were	   averaged	   by	   DAMAVER,	   providing	   the	   molecular	  mass	  estimate	  of	  about	  42	  kDa,	  which	  is	  still	  compatible	  with	  a	  tetramer.	  	  
	  
Figure	   3.	   	  Experimental	   SAXS	  data	  of	   the	  E7	  oncoprotein	  and	   theoretical	   scattering	   (red).	  The	  logarithm	  of	   the	   scattering	   intensity	   is	   plotted	   against	   the	  momentum	   transfer,	   using	   PRIMUS.	  The	   figure	   also	   shows	   the	   derived	   pair-­‐distance	   distribution	   function	   p(r)	   and	   the	   derived	  Kractky	  plot.	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Figure	   4.	   ab-­‐initio	   shape	   generated	   with	   DAMMIF	   program	   (left)	   and	   reconstruction	   shape	  generated	  with	  GASBOR	  (right)	  data	  analysis.	  	  Due	   to	   the	   largely	  unfolded	  nature	  of	   the	  HPV	  16	  E7	  oncoprotein,	   the	  program	  EOM	  was	  used	   to	  build	  a	   structural	  model	   taking	   into	  account	   the	   flexibility	  of	  the	  system.	  Since	  high-­‐resolution	  information	  for	  the	  structured	  part	  of	  HPV	  16	  E7	   oncoprotein	   are	   not	   available,	   the	   model	   obtained	   in-­‐silico	   was	   used	   as	   a	  starting	   point,	   taking	   into	   consideration	   the	   available	   information	   on	   the	  molecular	   assembly	   derived	   from	  both	   the	  NMR	   (pdb	   ID:	   2F8B)	   and	   the	  X-­‐ray	  (pdb	  ID:	  2B9D)	  structure	  resolved	  for	  the	  E7	  CR3	  of	  HPV	  45	  and	  1,	  respectively,	  to	  define	  the	  multimerization	  interfaces.	  In	  this	  way	  we	  assumed	  the	  presence	  of	  a	   folded	   domain	   and	   an	   extended	   portion	   of	   protein,	   flexible	   and	   possibly	  elongated.	  The	  EOM	  program	  generated	  a	  pool	  with	  15000	  models	  where	  multiple	  runs	  of	  the	   genetic	   algorithm	   were	   performed	   and	   the	   Rg	   distribution	   of	   the	   selected	  ensembles	  compared	  to	  the	  Rg	  distribution	  of	  the	  entire	  pool.	  In	  this	  way	  flexible	  features	  of	  the	  particle	  can	  be	  speculated.	  Multiple	  runs	  of	  EOM	  were	  performed	  and	   the	   results	   were	   averaged	   to	   provide	   quantitative	   information	   about	   the	  flexibility	  of	  the	  protein	  in	  solution	  (in	  particular,	  about	  the	  Rg	  distribution	  in	  the	  selected	   ensembles).	   The	   Figure	   5	   shows	   the	   models	   with	   the	   highest	   score.	  These	   results	   suggest	   the	  presence	  of	   tetrameric	  E7	   in	   solution	   formed	  by	   two	  dimers,	  with	  a	  P222-­‐like	  symmetry.	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Figure	   5.	   A)	   Tetrameric	   E7	   generated	   starting	   from	   the	   modeled	   monomeric	   unit	   assembled	  taking	   into	  account	   the	  HPV	  45	  E7	  CR3	  and	  the	  HPV	  1	  E7	  CR3	  structures	  (pdb	   ID:	  2F8B,	  2B9D	  respectively);	  B)	  EOM	  tetramer	  model	  of	  HPV	  16	  E7	  protein	  based	  on	  the	  tetrameric	  unit.	  	  The	  dimerization	  involves	  the	  first	  α-­‐helices	  of	  each	  monomer	  and	  the	  formation	  of	   an	   intermolecular	   two-­‐stranded	   antiparallel	   β-­‐sheet	   between	   the	   first	   β-­‐strand	  of	  one	  monomer	  and	  the	  second	  β-­‐	  strand	  of	  the	  other,	  forming	  an	  highly	  hydrophobic	   core.	   The	   dimers	   assemble	   tanks	   to	   the	   interaction	   established	  between	  one	  α-­‐helices	  of	  one	  dimer	  and	  the	  opposed	  strand	  of	  the	  other	  dimer.	  The	  disordered	  regions,	  as	  they	  appear	  from	  the	  EOM	  models,	  tend	  to	  assume	  an	  extended	  conformation,	  typical	  of	  intrinsically	  disordered	  proteins.	  	  However,	  a	  careful	  analysis	  of	  the	  data,	  very	  noisy,	  and	  of	  the	  results	  of	  the	  fitting	  opens	  up	  also	  the	  possibility	  of	  the	  presence	  in	  solution	  of	  a	  simple	  dimeric	  form	  of	   the	   protein.	   Indeed,	   a	   highly	   extended	   dimer	   could	   result	   as	   large	   as	   a	  tetramer	   according	   to	   the	   Rg.	   In	   Figure	   6	   the	   possible	   EOM	   model	   obtained	  assuming	  only	  the	  presence	  of	  dimeric	  E7	  cover	  an	  ample	  conformational	  space.	  	  	  
	  
Figure	  6.	  EOM	  dimeric	  model	  of	  HPV	  16	  E7	  protein.	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The	   presence	   in	   solution	   of	   different	   forms	   of	   E7	   (monomer/dimer/tetramer)	  has	  been	  already	  proposed	  based	  on	  sedimentation	  experiments	  (Clements	  et	  al.,	  2000).	   Also	   the	   NMR	   evidences	   pointed	   out	   the	   presence	   of	   a	   heterogeneous	  system,	   suggesting	   a	   high	   aggregation	   tendency	   for	   the	   C-­‐terminal	   part	   of	   the	  protein,	  still	  in	  the	  presence	  of	  an	  highly	  mobile	  and	  flexible	  N-­‐terminal	  part.	  The	  presence	  of	  polydispersity	   in	  solution	  renders	  difficult	   the	  analysis	  of	   the	  SAXS	  data.	   Indeed,	   the	   presence	   of	   oligomers	   in	   solution,	   even	   in	   small	   amount,	  produces	   the	   scattering	   of	   the	  majority	   of	   the	   X-­‐ray	   beam	   and	   the	   results	   are	  subject	  of	  large	  error.	  Further	  studies	  are	  in	  progress	  to	  optimize	  the	  collection	  of	  the	  SAXS	  data.	  	  
To	   complete	   the	   present	   study	   there	   is	   the	   need	   to	   implement	   size-­‐exclusion	  
chromatography	  directly	   on	   the	   SAXS	   instrument	   to	   be	   able	   to	   separate,	   at	   least	  
partially,	  oligomeric	  forms	  of	  the	  protein	  from	  monomeric,	  dimeric	  and	  tetrameric	  
E7.	  This	  part	  of	  the	  work	  is	  currently	  in	  progress	  in	  DESY,	  Hamburg.	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Table	   1,	   SAXS	   data	   collection	   and	   scattering	   parameters	   for	  HPV	  16	  E7	   protein.	   Abbreviations:	  
Dmax:	  maximal	  particle	  dimension;	  MM:	  molecular	  mass;	  Rg:	  radius	  of	  gyration;	  Vp:	  Porod	  volume;	  
Vex:	   particle	   excluded	   volume.	   The	   dry	   volume	   was	   calculated	   using	   the	   web	   tool,	  http://www.basic.northwestern.edu/biotools/proteincalc.html,	  (Harpaz	  et	  al.,	  1994).	  Instrument	   EMBL	  X33	  beam	  line	  storage	  ring	  DORIS	  III	  (DESY,	  Hamburg)	  Beam	  geometry	   2	  x	  0.6	  mm2	  Wavelength	  (Å)	   1.5	  q-­‐Range	  (Å−1)	   0.006	  -­‐	  0.600	  Exposure	  time	  (min)	   2	  (8	  x	  15sec)	  Concentration	  range	  (mg	  ml−1)	   1.3	  -­‐	  2.7	  Temperature	  (K)	   298	  	  
Structural	  parameters	   	  
I(0)	  (relative)	  (from	  P(r))	   11040	  
Rg	  (Å)	  (from	  P(r))	   36	  ±	  3	  
I(0)	  (cm−1)	  (from	  Guinier)	   11066	  
Rg	  (Å)	  (from	  Guinier)	   36	  ±	  2	  
Dmax	  (Å)	   125	  ±	  10	  Porod	  volume	  estimate	  (Å3)	   69221	  Excluded	  volume	  estimate	  (Å3)	   95400	  Dry	  volume	  calculated	  from	  sequence	  (Å3)	   14734	  	  
Molecular	  mass	  determination	   	  Molecular	  mass	  MM	  (Da)	  from	  	  Porod	  volume	  (Vp	  ∗	  0.6)	   41500	  ±	  5000	  Molecular	  mass	  MM	  (Da)	  from	  excluded	  volume	  (Vex	  /	  2)	   48000	  ±	  5000	  Calculated	  monomeric	  MM	  from	  sequence	   12087	  	  
Software	  employed	   	  Data	  processing	   PRIMUS	  
Ab	  initio	  analysis	   DAMMIF	  Validation	  and	  averaging	   DAMAVER	  Computation	  of	  ensembles	   EOM	  3D	  graphic	  representations	   CHIMERA	  and	  MACPYMOL	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4.3. The highly flexible and heterogeneous nature of HAdV E1A 
characterized at atomic resolution through NMR 
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Abstract	  
	  The	   small	  DNA	   tumor	   viruses	   encode	   some	   of	   the	  most	   versatile	   hub	  proteins	  like	   the	   E1A	   protein	   from	   human	   Adenovirus	   (HAdV).	   The	   E1A	   protein	   is	  essential	  for	  productive	  viral	  infection	  in	  human	  cells and	  a	  vast	  amount	  of	  data	  are	  available	  on	  its	  interactions	  with	  host	  proteins.	  Up	  to	  now	  no	  high-­‐resolution	  information	   on	   the	   full	   length	   E1A	   protein	   is	   available	   despite	   its	   important	  biological	  role.	  Here	  we	  present	   the	  NMR	   characterization	   of	   the	   entire	   289	   residue	   long	  E1A	  protein	  from	  HAdV.	  The	  protein	  is	  very	  heterogeneous	  in	  terms	  of	  structural	  and	  dynamic	   properties	  with	   highly	   flexible	  modules.	   This	   study	   opens	   the	  way	   to	  characterize	  the	  manyinteractions	  in	  which	  this	  protein	  is	  involved.	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Introduction	  It	   is	  well	   known	   that	   the	   structural	   and	  dynamic	  properties	  of	   proteins	   are	   an	  essential	   aspect	   determining	   their	   function.[1-­‐3]	   What	   is	   less	   known	   is	   all	   the	  modes	  through	  which	  highly	  disordered	  and	  flexible	  proteins	  or	  protein	  modules	  have	  an	   impact	  on	  protein	   function	  as,	  until	   recently,	   it	  was	  believed	   that	  only	  proteins	   characterized	   by	   well	   folded	   structures	   could	   be	   functional.[4;5]	  However,	   recent	  evidence	  accumulating	  at	  a	  very	   fast	  speed	  shows	   that	  also	   in	  the	   absence	   of	   a	   3D	   structure	   proteins	   are	   functional	   and	   that	   actually	   a	   high	  extent	  of	  disorder	  and	  flexibility	  can	  provide	  functional	  advantages	   in	  a	  variety	  of	  different	  situations.	  	  In	   particular	   the	   possibility	   to	   adopt	   different	   conformations	   may	   enable	   a	  protein	   to	   interact	   with	   many	   different	   partners.[6-­‐8]	   This	   contributes	   to	  expanding	   our	   view	   on	   how	   proteins	   interact	  with	   each	   other	   based	   on	  many	  examples	   well	   documented	   in	   the	   PDB,	   such	   as	   with	   the	   presence	   of	   large	  complementary	  surfaces	  mediating	  protein-­‐protein	  interactions.	  Of	  course	  more	  open,	   largely	   flexible	   conformations	   with	   large	   portions	   of	   exposed	   backbone	  may	  also	  be	   involved	   in	   interactions	  although	   in	  very	  different	  ways.	   Indeed,	   it	  has	  been	  suggested	   that	   short	   linear	  motifs,	   in	  other	  words	  short	   sequences	  of	  aminoacids	  with	  specific	  patterns,	  may	  be	  sufficient	   to	  mediate	  protein-­‐protein	  interactions	  both	  in	  folded	  or	  in	  intrinsically	  disordered	  modules.[9]	  Of	  course,	  if	  short	   linear	  motives	  are	  sufficient	  to	  mediate	  protein-­‐protein	  interactions,	  then	  the	  more	  exposed	  the	  backbone	  is	  the	  more	  short	  linear	  motives	  result	  exposed	  and	   available	   for	   mutual	   cross-­‐talk	   between	   different	   proteins.	   Therefore	   the	  investigation	   of	   hub	   proteins	   and	   of	   how	   their	   function	   is	  modulated	   by	   their	  overall	  structural	  and	  dynamic	  properties	  and	  by	  short	  linear	  motives	  mediating	  interactions,	   is	   a	   theme	  under	   the	   spotlight	   of	  modern	   structural	   biology,	  with	  impressive	  examples	  appearing	  in	  the	  literature.	  [10;11]	  In	   this	   frame,	  we	  would	   like	  here	   to	   focus	  on	  a	  viral	  protein,	  E1A	   from	  human	  adenovirus	  (HAdV).	  Viruses,	  with	  their	  small	  genomes,	  do	  need	  economic	  ways,	  in	   terms	  of	  genome	  usage,	   to	   interfere	  with	  host	  proteins.	  Therefore	  exploiting	  short	  linear	  motifs	  in	  intrinsically	  disordered	  protein	  modules	  does	  appear	  as	  an	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appealing	  strategy	  towards	  this	  goal.	  HAdV	  is	  well	  characterized,	  routinely	  used	  in	  molecular	  biology	  techniques	  and	  a	   lot	  of	   information	   is	  available	  on	   it.[12-­‐15]	  Among	   the	   few	  proteins	  encoded	  by	  HAdV	  we	  decided	   to	   focus	  on	  E1A,	  one	  of	  the	   first	  proteins	  produced	  and	  key	  for	  viral	   infection[16-­‐18],	  because,	  despite	  all	  the	   information	   available	   on	   this	   virus	   and	   all	   the	   documented	   interactions	   of	  this	  protein	  with	  key	  players	  in	  host	  cells,	  there	  is	  no	  high-­‐resolution	  structural	  and	  dynamic	  information	  available	  on	  the	  whole	  protein,[19]	  as	  the	  3D	  structure	  of	  the	  protein	  could	  not	  be	  resolved	  by	  X-­‐ray	  crystallography.	  	  An	  interesting	  NMR	  investigation,	  instead,	  showed	  how	  a	  module	  of	  the	  protein	  is	   important	   in	   the	   interaction	  with	   a	   partner,	   CREB	   binding	   protein	   (CBP)[20],	  providing	   an	   interesting	   example	   of	   folding	   upon	   binding	   for	   a	   disordered	  protein.	  Therefore	  we	  decided	  to	  undertake	  the	  NMR	  investigation	  to	  the	  whole	  E1A	   in	   an	   attempt	   of	   understanding	   the	   molecular	   basis	   of	   how	   such	   a	   hub	  protein	  function.	  	  
Materials	  and	  methods	  
Cloning,	  expression	  and	  purification	  The	   recombinant	   vector	   pET42-­‐E1A	   containing	   the	   E1A	   gene	   from	  HAdV,	  was	  generously	   provided	   by	   Peter	   Pelka	   and	   Joe	   Mymryk,	   University	   of	   Western	  Ontario,	   London,	  Ontario,	   Canada.[21]	   The	  plasmid	   construct	  was	   amplified	   and	  the	  DNA	  screened	  showing	  the	  sequence	  of	  the	  E1A	  13S	  from	  HAdV	  2/5	  hybrid.	  The	  final	  construct	  is	  basically	  the	  HAdV-­‐2	  13S	  E1A	  protein	  sequence	  where	  SER	  276	  is	  changed	  to	  PRO	  as	  in	  the	  HAdV-­‐5	  13S	  E1A	  protein	  sequence	  and	  GLU	  148	  is	  mutated	  to	  GLY.	  	  The	   recombinant	   vector	   pET42-­‐E1A	   was	   transformed	   into	   E.	   coli	  BL21(DE3)pLyS	  (Stratagene)	  for	  protein	  expression.	  One	  colony	  was	  selected	  to	  inoculate	   50	  ml	   LB	  medium	   containing	   ampicillin	   and	   chloramphenicol	   grown	  overnight	  at	  37º	  C,	  180	  rpm.	  For	  15N	  and	  13C,15N	   labelling	   	  10	  ml	  pre-­‐inoculum	  were	   used	   to	   inoculate	   1	   l	   minimal	   medium	   (48.5	   mM	   Na2HPO4,	   22.0	   mM	  KH2PO4,	  8.5	  mM	  NaCl,	  0.2	  mM	  CaCl2,	  2.0	  mM	  MgSO4,	  10.0	  µM	  ZnCl2,	  1	  mg/l	  each	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of	  biotin	  and	  thiamin,	  7.5	  mM	  (15NH4)2SO4	  and	  11.1	  mM	  glucose/13C6-­‐glucose,)	  at	  37ºC	  with	  constant	  agitation	  at	  160	  rpm.	  When	  optical	  density	  at	  600nm	  reached	  0.6,	  cells	  were	  induced	  with	  0.5	  mM	  final	  concentration	  of	  IPTG	  and	  allowed	  to	  grow	   for	   additional	  16h	  at	  25ºC.	  The	   cells	  were	  harvested	  by	   centrifugation	  at	  8000g	  for	  20	  min	  and	  the	  cell	  pellet	  stored	  at	  -­‐20ºC.	  Frozen	   cells	   were	   thawed	   and	   suspended	   in	   40	   ml	   of	   equilibration	   buffer	   A	  (50mM	  Hepes,	  300	  mM	  NaCl,	  5	  mM	  imidazole,	  pH	  8.0).	  Cells	  were	  disrupted	  by	  sonication	  on	   ice	   (at	  40%	  sonication	  power)	  with	  cycles	  of	  1	  s	  with	  10	  s	  delay	  pulses	  for	  30	  min.	  Lysate	  cells	  were	  centrifuged	  at	  30000	  rpm	  for	  30min	  at	  4ºC	  and	   the	   supernatant	   was	   loaded	   on	   a	   5ml	   Ni2+	   HiTrap	   column	   (Amersham	  biosciences	  Europe)	  pre-­‐equilibrated	  with	  buffer	  A	  under	  anaerobic	  conditions.	  Column	   was	   washed	   using	   10x	   column	   volumes	   of	   buffer	   A	   with	   50	   mM	  imidazole	  and	  the	  E7	  protein	  was	  eluted	  using	  buffer	  A	  with	  250	  mM	  imidazole.	  The	  eluted	  sample	  was	  then	  purified	  by	  size-­‐exclusion	  chromatography	  using	  a	  HiLoad	  16/60	  Superdex	  75	  (Amersham	  biosciences	  Europe)	  column	  previously	  equilibrated	  with	  10	  mM	  HEPES	  buffer,	  150	  mM	  KCl,	  10	  μM	  ZnCl2,	  10	  mM	  DTT.	  The	  column	  was	  refrigerated	  at	  4	  0C	  and	  sample	  was	  purified	  using	  a	  flow-­‐rate	  of	  1.5	  ml	  mn-­‐1.	  The	  collected	  purified	  samples	  were	  checked	  both	  by	  SDS-­‐PAGE	  and	  mass-­‐spectrometry	  (MALDI	  and	  ESI)	   to	  confirm	  the	  molecular	  mass	  and	  purity	  E1A	   protein.	   All	   samples	   for	   NMR	   experiments	   were	   prepared	   in	   buffer	  containing	   10	   mM	   HEPES,	   150	   mM	   KCl,	   10	   μM	   ZnCl2,	   10	   mM	   DTT.	   The	   E1A	  sample	   concentrations	   for	   NMR	   were	   250µM,	   estimated	   using	   the	   molar	  extinction	   coefficient	   (7450	   M-­‐1cm-­‐1)	   calculated	   from	   ExPASy	   ProtParam	   tool	  [http://web.expasy.org/	  protparam/].[22]	  The	  sample	  pH	  was	  7.5.	  10%	  D2O	  was	  added	  for	  the	  lock	  signal.	  	  
NMR	  Experiments	  The	   1H	   detected	   NMR	   experiments	   for	   sequence	   specific	   assignment	   were	  acquired	   at	   278	   K	   on	   the	   21.1	   T	   Bruker	   AVANCE	   900	   NMR	   spectrometer,	  operating	  at	  902.60	  MHz	  for	  1H,	  equipped	  with	  cryogenically	  cooled	  TCI	  probe.	  A	  dataset	  of	  1H	  detected	  NMR	  experiments	  (1H-­‐15N	  BEST-­‐TROSY[23;24],	  BEST-­‐TROSY	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HNCO[25;26],	   BEST-­‐TROSY	   HNCACO[25;26],	   BEST-­‐TROSY	   HNCOCACB[25;26],	   BEST-­‐TROSY	   HNCACB[25;26],	   BEST-­‐TROSY	   HN(CA)NNH[25;27;28]	   and	   TROSY	  HN(COCA)NNH[29;30])	  was	  necessary	   for	   sequence	   specific	   assignment	   of	  HN,	  N,	  C',	  Cα,	  Cß	  resonances.	  To	   characterize	   the	   structural	   and	   dynamic	   features	   of	   HAdV	   2/5	   E1A	   the	  following	  1H	  detected	  NMR	  experiments	  were	  acquired	  (at	  278	  K):	  15N	  relaxation	  experiments	   (R1,	   R2	   and	   1H-­‐15N	   NOEs)	   on	   a	   16.44	   T	   Bruker	   AVANCE	   700	  spectrometer	  equipped	  with	  a	  cryogenically	  cooled	  probe.	  The	   13C	   detected	   CON-­‐IPAP	   experiment	   was	   acquired	   on	   the	   16.44	   T	   Bruker	  AVANCE	   700	   spectrometer	   equipped	   with	   a	   cryogenically	   cooled	   probe	  optimized	  for	  13C	  direct	  detection.	  All	  experimental	  parameters	  used	  to	  acquire	  NMR	  experiments	  described	  above	  are	  reported	  in	  more	  detail	  in	  the	  Supplementary	  Material	  (Table	  S1).	  Data	   were	   processed	   with	   TopSpin	   2.0	   and	   were	   analyzed	   with	   program	  ccpNMR[31].	   The	   secondary	   structure	   propensity	   from	   chemical	   shifts	   was	  determined	  using	  the	  SSP	  program.[32]	  The	  15N	  relaxation	  rates	  (R1	  and	  R2)	  were	  determined	  by	  fitting	  the	  cross-­‐peak	  volumes	  measured	  as	  a	  function	  of	  variable	  delay,	   to	   single-­‐exponential	  decay.	   1H-­‐15N	  NOE	  values	  were	  obtained	  as	   a	   ratio	  between	  peak	  volumes	  in	  spectra	  recorded	  with	  and	  without	  1H	  saturation.	  	  	  
Results	  The	   primary	   sequence	   of	   E1A	   can	   be	   used	   to	   predict,	   through	   the	   available	  bioinformatics	  tools,	  the	  tendency	  of	  the	  different	  parts	  of	  the	  polypeptide	  chain	  to	  adopt	  more	  ordered	  or	  disordered	  conformations.	  As	  an	  example,	  predictions	  performed	  with	  the	  IUPred[33],	  Anchor[34]	  and	  PONDR-­‐FIT[35]	  are	  reported	  in	  the	  Supplementary	   Material	   (Figure	   S1).	   These	   clearly	   indicate	   that	   E1A	   is	  characterized	   by	   significant	   structural	   heterogeneity,	   with	   largely	   disordered	  parts	  as	  well	  as	  largely	  ordered	  ones.	  Aminoacid	   sequence	   alignment	   of	   E1A	   from	   different	   serotypes	   reveals	   four	  main	  conserved	  regions	  (CR1-­‐CR4),	  as	  schematically	  indicated	  in	  Figure	  1,	  which	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are	  separated	  by	  less	  conserved	  regions.[36]	  Not	  only	  the	  CRs	  but	  also	  other	  parts	  of	   the	  E1A	  protein	   are	   involved	   in	   important	  protein-­‐protein	   interactions	  with	  over	  50	  cellular	  factors	  through	  short	  linear	  motifs	  (SLiMs).[10;19]	  As	  an	  example,	  the	  SLiMs	  identified	  in	  the	  conserved	  regions	  are	  indicated	  in	  black	  in	  Figure	  1.	  The	  high	  resolution	  structural	  and	  dynamic	  characterization	  of	  E1A	  represents	  thus	  an	  important	  step	  forward	  in	  the	  understanding	  of	  the	  molecular	  basis	  of	  its	  functional	   properties	   by	   providing	   experimental	   data	   to	   be	   compared	   with	  predictions	   and	  with	   a	  wealth	   of	   complementary	   information	   available	   on	   the	  protein	  through	  different	  molecular	  biology	  and	  biophysical	  techniques.	  The	  2D	  1H-­‐15N	  correlation	  experiment	  acquired	  on	  E1A	  is	  shown	  in	  Figure	  2.	  The	  low	   chemical	   shift	   dispersion	   of	   the	   cross	   peaks	   observed	   confirms	   that	   the	  protein	   is	   characterized	  by	  a	  high	  extent	  of	  disorder	  and	   flexibility,	   as	   inferred	  from	  bioinformatic	  predictions	  (Figure	  S1).	  	  The	   sequence	   specific	   assignment	   of	   the	   resonances	   represents	   thus	   a	  challenging	  task,	  both	  due	  to	  the	  extensive	  overlap	  observed	  as	  well	  as	  from	  the	  predictions	   that	   indicate	  a	  structurally	  heterogeneous	  system,	  characterized	  by	  highly	   disordered	  parts	   as	  well	   as	   by	  more	   structured	  modules.	  Moreover,	   the	  tendency	  of	   the	  protein	   to	   aggregate	  upon	   increasing	   concentration	   also	  poses	  limits	  in	  terms	  of	  protein	  concentrations	  that	  can	  be	  used	  for	  NMR	  experiments,	  restricting	   the	   choice	   among	   the	   available	   strategies	   (the	   2D	   HN	   and	   2D	   CON	  spectra	  are	  reported	  in	  Figure	  S2).	  With	  this	  in	  mind	  a	  series	  of	  3D	  experiments	  based	   on	   amide	   proton	   detection	   were	   selected	   for	   the	   sequence	   specific	  assignment	   which	   included,	   in	   addition	   to	   the	   widely	   used	   ones	  (HNCO/HNCACO,	  CBCANH,	  CBCACONH)	  also	  two	  additional	  experiments	  which	  provide	   sequential	   correlations	   exploiting	   backbone	   nitrogen	   atoms	   and	  carbonyl	   carbons	   (HNCANNH,	   HNCOCANNH)	   which	   are	   known	   to	   provide	  valuable	   information	   to	   resolve	   ambiguities	   in	   particular	   when	   investigating	  highly	   disordered	   protein	   segments.	   The	   BEST-­‐TROSY	   versions	   of	   the	  experiments	  were	  used.	  While	  the	  extensive	  overlap	  observed	  in	  the	  2D	  HN	  correlation	  experiments	  does	  not	   allow	  us	   to	   have	   an	   estimate	   on	   the	   number	   of	   identified	   correlations,	   the	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analysis	   of	   the	   HNCO,	   thanks	   to	   the	   increased	   resolution	   provided	   by	   the	  carbonyl	  dimension,	  enables	  us	  to	  count	  the	  number	  of	  cross	  peaks	  that	  can	  be	  detected.	  In	  the	  present	  case	  200	  isolated	  cross	  peaks	  could	  be	  identified	  in	  the	  HNCO,	  which	  is	  significantly	  less	  than	  what	  expected	  on	  the	  basis	  of	  the	  primary	  sequence	  but	  still	  represents	  more	  than	  80%	  of	  the	  number	  of	  residues	  that	  can	  be	  studies,	  significantly	  extending	  the	  atomic	  resolution	  characterization	  of	  E1A	  toward	  the	  entire	  polypeptide	  chain.	  	  The	  careful	  analysis	  of	  the	  3D	  spectra	  allowed	  us	  to	  achieve	  essentially	  complete	  sequence	  specific	  assignment	  of	  the	  polypeptide	  chain	  comprising	  CR1	  and	  CR2	  as	  well	  as	   the	   final	  module	  comprising	  CR4.	   Instead,	  our	  experiments	  are	  blind	  toward	   the	   CR3	   region.	   The	   assigned	   residues	   include	   most	   of	   the	   residues	  involved	  in	  interactions	  with	  protein	  partners,	  as	  identified	  by	  ANCHOR,	  and	  the	  vast	   majority	   of	   the	   residues	   which	   are	   part	   of	   the	   SLiMs,	   indicating	   that	   the	  sequence	   specific	   assignment	   is	   going	   to	   open	   new	   avenues	   for	   the	   high	  resolution	  characterization	  of	  the	  many	  interactions	  in	  which	  E1A	  is	  involved.	  	  The	  sequence	  specific	  assignment	  provides	  the	  first	  information	  to	  characterize	  the	   structural	   and	   dynamic	   properties	   of	   the	   protein	   through	   the	   analysis	   of	  backbone	   heteronuclear	   chemical	   shifts	   and	   of	   those	   of	   Cβ	   carbons.	   Indeed	   by	  comparing	   experimental	   chemical	   shifts	   with	   those	   predicted	   assuming	   a	  completely	   random	   coil	   conformation	   it	   is	   possible	   to	   identify	   if	   secondary	  structural	  elements	  are	  partially	  populated.	  The	  resulting	  CSI	  values	  for	  Cα,	  Cβ,	  C´	  and	  N	  as	  well	  as	  the	  SSP	  score	  are	  reported	  in	  Figure	  3.	  	  Further	  observables	  providing	  useful	   information	  to	  characterize	  the	  structural	  and	  dynamic	  properties	  of	  the	  protein	  are	  15N	  relaxation	  data,	   in	  particular	  15N	  R1,	   15N	  R2	  and	  1H-­‐15N	  NOE,	  reported	   in	  Figure	  4.	  These	  show	  average	  values	  of	  1.79	  Hz	  for	  R1	  and	  of	  4.89	  Hz	  for	  R2	  (excluding	  in	  this	  case	  peak	  values	  in	  regions	  15-­‐23,	   42-­‐48,	   70-­‐75,	   125-­‐137,	   265-­‐270),	   which	   indicate	   that	   the	   protein	   is	  largely	  disordered.	  In	  addition	  the	  1H-­‐15N	  NOE	  values,	  all	  significantly	  lower	  than	  1,	  also	  confirm	  that	  the	  protein	  is	  largely	  disordered.	  However,	  inspection	  of	  all	  the	  data	  does	  indicate	  that	  the	  protein	  is	  characterized	  by	  a	  significant	  structural	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and	  dynamic	  heterogeneity,	  with	  several	  regions	  characterized	  by	  a	  propensity	  to	  populate	  more	  structured	  and/or	  less	  flexible	  conformations.	  	  The	   first	   striking	   evidence	   of	   a	   region	   characterized	   by	   a	   more	   structured	  conformation	  comes	  from	  the	  analysis	  of	  chemical	  shifts.	  Indeed	  both	  CSI	  as	  well	  as	  SSP	  do	   indicate	   that	   in	   the	   initial,	  N-­‐terminal	  part	  of	   the	  protein	  aminoacids	  13-­‐23	   have	   a	   significant	   a-­‐helical	   secondary	   structural	   propensity.	   This	   is	  confirmed	   by	   reduced	   local	   mobility	   in	   this	   region	   as	   identified	   through	   15N	  relaxation	  measurements,	  with	  R2	  values	  higher	  than	  the	  average	  (15-­‐17,	  19-­‐20,	  22-­‐23)	   as	  well	   as	  with	   larger	   1H-­‐15N	  NOEs	   (14,	   16-­‐20,	   22,	   24).	   The	   rest	   of	   the	  polypeptide	  chain	  instead	  shows	  smaller	  CSI	  and	  SSP	  values.	  However	  inspection	  of	   the	   15N	   relaxation	   data	   does	   show	   several	   regions	   characterized	   by	   R2	   and	  NOE	  values	   larger	   than	   average	  which	   in	   general	   are	   indicative	   of	   less	   flexible	  parts	   of	   the	   polypeptide	   chain	   (40-­‐44,	   68-­‐75,	   123-­‐137,	   253-­‐258,	   261-­‐270).	  Interestingly	   these	   regions	  are	  mainly	   found	   in	   the	  conserved	  regions.	   Starting	  from	   CR1,	   two	   SLiMs	   can	   be	   identified	   in	   this	   region	   (Figure	   1)	   and	   are	  characterized	   by	   the	   presence	   of	   several	   hydrophobic	   residues	   which	   result	  characterized	  by	  lower	  local	  flexibility.	  	  The	  interaction	  of	  this	  initial	  part	  of	  the	  polypeptide	  chain	  with	  the	  TAZ2	  module	  of	   the	   CBP	   has	   been	   investigated	   by	   analyzing	   several	   short	   constructs	   and	  revealed	   that	   different	   regions	   are	   involved	   in	   binding	   to	   the	   partner	   with	  different	   properties.[20]	   These	   regions	   include	   the	   first	   part	   of	   the	   polypeptide	  where	  a	  high	  helical	  propensity	  has	  been	  identified	  (13-­‐23)	  as	  well	  as	  two	  other	  regions	   comprising	   residues	   59-­‐65	   and	   72-­‐75	   that	   adopt	   an	   alpha	   helical	  conformation	  upon	  binding	  to	  the	  partner.	  Our	  data	  show	  that	  in	  the	  isolated	  full	  length	  E1A	  these	  fragments	  are	  largely	  disordered	  with	  a	  very	  weak	  tendency	  to	  adopt	  a	  a-­‐helical	  conformation	  identified	  for	  aminoacids	  68-­‐70,	  right	  in	  between.	  The	  other	  region	  characterized	  by	  15N	  relaxation	  parameters	  indicative	  of	  a	  less	  flexible	  and	  thus	  more	  structured	  part	  of	  the	  polypeptide	  chain	  are	  identified	  in	  CR2	   (residues	   123-­‐137)	   and	   in	   CR4	   (residues	   253-­‐258,	   261-­‐270).	   The	   LXCXE	  short	   linear	   motif	   (122-­‐126),	   located	   in	   CR2,	   is	   is	   known	   to	   interact	   with	   the	  retinoblastoma	  binding	  protein	  (pRb),	  deregulating	  it.[10]	  Indeed,	  the	  interaction	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of	   a	   short	   peptide	   mimicking	   this	   part	   of	   the	   polypeptide	   chain	   from	   the	  homologous	   protein	   E7	   from	   the	   human	   papilloma	   virus	   with	   pRb	   has	   been	  characterized	   and	   showed	   that	   the	   LXCXE	   motif	   adopts	   an	   elongated	  conformation	   upon	   binding	   to	   pRb.[37]	   Interestingly	   the	   investigation	   of	   full	  length	  E7	   showed	   a	  mild	   propensity	   of	   this	   part	   of	   the	   backbone	   as	  well	   as	   of	  neighboring	  ones,	  to	  assume	  an	  elongated	  conformation.	  In	  the	  present	  case,	  the	  aminoacid	  composition	  is	  slightly	  different,	  with	  a	  THR	  and	  a	  HIS	  and	  probably	  justifies	  why	  a	  local	  propensity,	  if	  any,	  for	  a	  helix	  turn	  is	  identified	  for	  this	  short	  fragment.	  Finally,	  the	  inspection	  of	  the	  data	  for	  CR4	  also	  enables	  us	  to	  identify	  a	  very	   brief	   fragment	   characterized	   by	   a	  mild	   alpha	   helical	   secondary	   structural	  propensity	  for	  residues	  (268-­‐270).	  	  	  
Conclusions	  In	  summary,	  the	  high	  resolution	  information	  on	  the	  more	  flexible	  and	  disordered	  parts	   of	   E1A	   achieved	   here	   provides	   the	   basis	   for	   the	   high	   resolution	  characterization	   of	   all	   the	   interactions	   in	   which	   this	   protein	   is	   known	   to	   be	  involved.	  Thanks	  to	  vast	  amount	  of	  data	  available	  on	  the	  functional	  properties	  of	  this	  protein,	  of	  its	  interactions	  with	  many	  partners	  involved	  in	  key	  processes	  in	  the	  cell	  as	  well	  as	  to	  the	  lack,	  as	  of	  today,	  of	  high	  resolution	  information	  on	  the	  structural	  and	  dynamic	  properties	  of	   the	  protein,	  we	  hope	   to	   contribute	   to	   the	  understanding	   of	   how	   this	   protein	   interacts	   with	   many	   partners	   and	  more	   in	  general	  to	  unraveling	  new	  ways	  of	  protein-­‐protein	  interactions	  enabling	  them	  to	  function	  as	  molecular	  hubs	  and	  of	  interfering	  with	  so	  many	  processes.	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  parameters	  of	  the	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  experiments;	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  of	  2D	  HN	  and	  CON	  maps;	  bioinformatics	  prediction	  on	  the	  extent	  of	  disorder.	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Figures	  
	  
Figure	  1.	  Schematic	  representation	  of	  HAdV	  2/5	  E1A	  protein	  amino	  acid	  sequence,	  
and	  division	  into	  4	  conserved	  region	  (CR)	  with	  short	  linear	  motifs	  (SLiMs)	  indicated	  in	  
black.[19]	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Figure	  2.	  The	  2D	  1H-­‐15N	  BEST-­‐TROSY	  spectra	  recorded	  for	  HAdV	  2/5	  E1A.	  Experiment	  
was	  recorded	  at	  21.1	  T	  and	  278	  K	  for	  a	  0.2	  mM	  E1A	  sample	  in	  10	  mM	  HEPES	  at	  pH	  
7.5,	  150	  mM	  KCl,	  10	  µM	  ZnCl2,	  and	  10	  mM	  DTT.	  The	  complete	  chemical	  shift	  table	  is	  
reported	  in	  Table	  S1.	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Figure	  3.	  A)	  The	  chemical	  shift	  differences	  between	  the	  assigned	  resonances	  of	  HAdV	  2/5	  E1A	  with	  respect	  to	  random	  coil	  values	  corrected	  for	  the	  sequence,	  pH	  and	   temperature[38]	   for	   NH,	   C’,	   Cα	   and	   Cβ	   nuclei.	   B)	   The	   Secondary	   structure	  propensity	   (SSP)	   score[32]	   obtained	  by	   combining	  Cα	   and	  Cβ	   chemical	   shifts	   for	  the	  resonances	  of	  HAdV	  2/5	  E1A.	  	  A) 
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Figure	  4.	  Relaxation	  data	  for	  backbone	  amide	  15N	  nuclei	  of	  HAdV	  2/5	  E1A	  as	  function	  
of	   the	   residue	   number.	   From	   top	   	   to	   bottom:	   1H-­‐15N	   NOE	   values	   (HETNOE),	   15N	  
transverse	   relaxation	   rates	   (R2),	   and	   15N	   longitudinal	   relaxation	   rates	   (R1).	  
Experiments	  were	  recorded	  at	  16.44	  T	  and	  278	  K	  for	  a	  0.1	  mM	  E1A	  sample	  in	  10	  mM	  
HEPES	  at	  pH	  7.5,	  150	  mM	  KCl,	  10	  µM	  ZnCl2,	  and	  100	  mM	  DTT.	  
	  
	  
	  
	  
	  
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   CHAPTER	  4	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   RESULTS	  
	  
	   111	  
	  
	  
	  
	  
Supplementary	  Material	  
	  
 
 
The highly flexible and heterogeneous nature of HAdV 
E1A characterized at atomic resolution through NMR 
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Acquisition	  Parameters	  
	  The	   NMR	   experiments	   and	   acquisition	   parameters	   used	   for	   sequence	   specific	  assignment	   of	   HN,	   N,	   C',	   Cα,	   Cß	   resonances	   and	   for	   further	   dynamic	  characterization	  of	  HAdV	  2/5	  E1A	  at	  278	  K.	  The	   following	   parameters	   were	   used	   in	   all	   experiments.	   The	   1H	   carrier	   was	  placed	  at	  4.7	  ppm,	  the	  15N	  carrier	  at	  118.5	  ppm.	  Band	  selective	  13C	  pulses	  were	  given	  at	  173	  and	  39	  ppm	  to	  excite	  or	   invert	  C'	  and	  Cα/ß	  spins	  respectively.	  The	  following	  band-­‐selective	  pulses	  were	  used:	  274	  µs	  with	  G4	  and	  time	  reversed	  G4	  shapes	   for	   C'	   and	   Cali	   excitation,	   190	   µs	   Q3	   shape	   for	   C'/Cali	   inversion.	   The	  experiments	   for	   sequence	   specific	   assignment	   were	   acquired	   with	   a	   Bruker	  AVANCE	   900	   spectrometer	   equipped	   with	   an	   inverse	   triple-­‐resonance	  cryogenically	  cooled	  probehead	  (1H-­‐15N	  BEST-­‐TROSY[1;2],	  BEST-­‐TROSY	  HNCO[3;4],	  BEST-­‐TROSY	   HNCACO[3;4],	   BEST-­‐TROSY	   HNCOCACB[3;4],	   BEST-­‐TROSY	  HNCACB[3;4],	  BEST-­‐TROSY	  HN(CA)NNH[3;5;6]	  and	  TROSY	  HN(COCA)NNH[7;8]).	  The	  other	  experiments	  (15N	  R1,	  15N	  R2	  and	  1H-­‐15N	  NOEs)	  were	  acquired	  with	  a	  Bruker	  AVANCE	   700	   spectrometer	   equipped	   with	   an	   inverse	   triple-­‐resonance	  cryogenically	  cooled	  probehead.	  	  
Experiments	  
	  
Dimension	  of	  
acquired	  data	  
Spectral	  width	  
(ppm)	   n
a	   db	  
t1	  	   t2	   t3	   F1	   F2	   F3	   	   	  	  	   	   	   	   	   	   	   	   	  
13C	  detected	   	   	   	   	   	   	   	   	  CON-­‐IPAPc	   	  512*	  (15N)	  1024	  (13C)	   	   38	   30	   	   48	   2.2	  HCBCACON-­‐IPAPc	   128*	  (13C)	   64	  (15N)	   1024	  (13C)	   60	   30	   49	   32	   1	  	   	   	   	   	   	   	   	   	  
1H	  detected	   	   	   	   	   	   	   	   	  1H-­‐15N	  HSQC	   256	  (15N)	   1024	  (1H)	   	   23	   12	   	   4	   1	  1H-­‐15N	  BEST-­‐TROSY	   512	  (15N)	   2048	  (1H)	   	   30	   12	   	   8	   0.2	  BEST-­‐TROSY	  HNCO	   96	  (13C)	   196	  (15N)	   2048	  (1H)	   8	   24	   15	   8	   0.2	  BEST-­‐TROSY	  HN(CA)CO	   164	  (13C)	   196	  (15N)	   2048	  (1H)	   8	   24	   15	   16	   0.2	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BEST-­‐TROSY	  HN(CO)CACB	   164	  (13C)	   196	  (15N)	   2048	  (1H)	   70	   24	   15	   16	   0.2	  BEST-­‐TROSY	  HNCACB	   164	  (13C)	   196	  (15N)	   2048	  (1H)	   70	   24	   15	   16	   0.2	  BEST-­‐TROSY	  HN(CA)NNH	   156	  (15N)	   156	  (15N)	   2048	  (1H)	   26	   26	   15	   24	   0.25	  TROSY	  HN(COCA)NNH	   96	  (15N)	   150	  (15N)	   2048	  (1H)	   26	   26	   15	   16	   1	  	   	   	   	   	   	   	   	   	  
Structure	  and	  dynamics	  15N	  T1d	   512	  (15N)	   2048	  (1H)	   	   24	   16.1	   	   8	   3.0	  15N	  T2d	   512	  (15N)	   2048	  (1H)	   	   24	   16.1	   	   8	   3.0	  Steady-­‐state	   heteronuclear	  1H	  -­‐15N-­‐NOEsd	   1024	  (15N)	   2048	  (1H)	   	   24	   16.1	   	   32	   3.0	  
a	  number	  of	  acquired	  scans.	  	  b	  Relaxation	  delay	  in	  seconds.	  c	   For	   experiments	   acquired	   in	   the	   IPAP	   mode,	   the	   dimension	   in	   which	   the	   two	  experiments	  are	  stored	  is	  indicated	  with	  an	  asterisk.	  d	   In	   15N	  R1,	   15N	  R2	   and	   heteronuclear	   1H-­‐15N-­‐NOEs	   experiments	   the	  water	   signal	  was	  suppressed	  with	  ‘water	  flip-­‐back’	  scheme.	  	  For	  the	  determination	  of	  R1,	  10	  experiments	  were	   acquired	   changing	   the	   variable	   delay	   from	   20	   ms	   to	   850	   ms.	   For	   the	  determination	  of	  R2	  ,	  9	  experiments	  were	  acquired	  changing	  the	  variable	  delay	  from	  18	  ms	  to	  250	  ms.	  All	   3D	   and	   2D	   spectra	  were	   processed	   using	   the	   standard	   Bruker	   software	   (TopSpin	  2.0)	  and	  analyzed	  through	  the	  ccpNMR	  (Collaborative	  Computing	  Project	  for	  NMR)[9]	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Figure	   S1.	   1H-­‐15N	   HSQC	   and	   13C-­‐15N	   CON-­‐IPAP	   spectra	   recorded	   for	   HAdV	   2/5	  E1A.	  Experiments	  were	  recorded	  at	  16.4	  T	  and	  278	  K	  for	  a	  0.2	  mM	  E1A	  sample	  in	  10	  mM	  HEPES	  buffer	  at	  pH	  7.5,	  150	  mM	  KCl,	  10	  µM	  ZnCl2,	  and	  10	  mM	  DTT.	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Figure	  S2.	  A)	  The	  prediction	  was	  done	  with	  the	  IUPred[10]	  and	  combined	  with	  the	  prediction	  of	  binding	  regions	  of	  E1A	  by	  ANCHOR[11].	  B)	   The	   prediction	  was	   done	  with	   the	  metapredictor	   PONDR-­‐FIT[12]	   comparing	  both	   sequences	   of	   the	   HAdV	   12S	   and	   13S	   protein	   sequences.	   The	   12S	   E1A	  sequence	   doesn’t	   contain	   the	   CR3	   region,	  which	   is	   predicted	   to	   be	   folded.	   The	  alignment	   between	   both	   constructs	   was	   done	   taking	   in	   consideration	   the	   46	  residues	   of	   the	   CR3	   region	   between	   residues	   144	   and	   191	   of	   the	   13S	   E1A	  containing	  289	  residues.	  
	  A)	  
	  	  B)	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5. General conclusions and Perspectives 	  
In this research project two key proteins from two different viral systems have 
been investigated. The Human Papilloma Virus E7 and the Human 
Adenovirus E1A proteins have been studied for the first time by NMR 
spectroscopy. These studies have been complemented by the results of other 
biophysical techniques. New insights for both proteins have been obtained, 
laying the basis for future investigations, in particular towards the 
understanding of the mode of interaction of these proteins with their targets.  
 
5.1. Human Papilloma Virus E7 protein 
 
The HPV 16 E7 protein has been studied for more than 30 years. Many 
attempts where done in the past to obtain high quality samples for NMR 
investigation of E7 from this particularly malignant phenotype without 
success. In this work the sample preparation was a crucial step. Many aspects 
were taken into consideration for getting high quality samples with various 
enrichment schemes of the full construct as well as for obtaining the folded E7 
CR3 region, providing a body of data helpful to better understand the 
biophysics of this systems. 
The full length HPV 16 E7 protein was analyzed by NMR spectroscopy for the 
first time. The dynamic properties of the entire protein were analyzed, 
revealing heterogeneous structural and dynamic properties well beyond the 
accepted schematic view of CR1 and CR2 being fully disordered and CR3 
well structured. In addition, the NMR characterization provided an important 
platform for the study of the post-translational modifications and interactions 
of E7 from HPV 16 with the many partners known to interact with the 
different parts of the protein.  
These data were completed by SAXS experiments using the full construct of 
E7 protein, which enabled to formulate an hypothesis on the mode the protein 
assembles in solution, eventually giving oligomeric forms, possibly 
explaining the different behavior of this protein with respect to the variants 
isolated from other viral types. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   CHAPTER	  5	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   CONCLUSIONS	  
	  
	   118	  
The current study opens the way to the atomic resolution characterization of 
the many interactions in which E7 is involved that may provide important 
information to understand the features that promote progression of cells to 
malignant and possibly , contribute to the design of new drugs. 
 
5.2. Human Adenovirus E1A protein 	  
The adenovirus E1A protein has been one of the most used models to study 
viral infections which promote cancer development. The lack of high-
resolution information on the protein together with its relevance as a crucial 
modulator of host transcription upon infection prompted the study of this 
protein by NMR. E1A shares some important structural and dynamical 
similarities with E7, as revealed by NMR spectroscopy. The high resolution 
information obtained confirmed the presence of flexible and disordered parts, 
rich in short linear motives able to interact with the many targets of 
interaction. These comprise the CR1, CR2 and CR4 regions, while the CR3 
region is expected to be characterized by an ordered structure.  
As an immediate perspective of this work, we started the expression and the 
characterization of pRB and CBP/p300 proteins, which were shown to 
interact both with E7 and E1A. Preliminary data to initiate the expression of 
pRB have been obtained while for CBP the preparation of the protein has 
been already initiated. As the latter is 2442 amino acid residues, we choose 
one of the five intrinsically disordered regions, present among the structural 
domains that compose the architecture of CBP, the CBP-ID4. This domain is 
located right after a structured domain that was shown to interact with a 
short construct of E1A.  
Concluding, the high resolution characterization of viral IDPs involved in 
oncogenic processes has been started with this research work. Thanks to vast 
amount of data available on the functional properties of the two key proteins 
selected, the high resolution information on their structural and dynamic 
properties achieved in this work contributes to the understanding of how 
they interact with many partners and more in general to unraveling new 
ways of protein-protein interactions, enabling them to function as molecular 
hubs and of interfering with many cellular processes. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   119	  
6. References 	  
 
Ablack, J.N.G., Pelka, P., Yousef, A.F., Turnell, A.S., Grand, R.J.A., and Mymryk, J.S. (2010). 
Comparison of E1A CR3-dependent transcriptional activation across six different human 
adenovirus subgroups. J. Virol. 84, 12771–12781. 
Alzari, P.M., Berglund, H., Berrow, N.S., Blagova, E., Busso, D., Cambillau, C., Campanacci, 
V., Christodoulou, E., Eiler, S., Fogg, M.J., et al. (2006). Implementation of semi-automated 
cloning and prokaryotic expression screening: the impact of SPINE. Acta Crystallogr. D Biol. 
Crystallogr. 62, 1103–1113. 
Arnau, J., Arnau, J., Lauritzen, C., Lauritzen, C., Petersen, G.E., Petersen, G.E., Pedersen, J., 
and Pedersen, J. (2006). Current strategies for the use of affinity tags and tag removal for the 
purification of recombinant proteins. Protein Expr. Purif. 48, 1–13. 
Babich, H., and Stotzky, G. (1978). Toxicity of zinc to fungi, bacteria, and coliphages: 
influence of chloride ions. Appl. Environ. Microbiol. 36, 906–914. 
Bandara, L.R., and La Thangue, N.B. (1991). Adenovirus E1a prevents the retinoblastoma 
gene product from complexing with a cellular transcription factor. Nature 351, 494–497. 
Banks, L., Pim, D., and Thomas, M. (2012). Human tumour viruses and the deregulation of 
cell polarity in cancer. Nat. Rev. Cancer 12, 877–886. 
Barbosa, M.S., Lowy, D.R., and Schiller, J.T. (1989). Papillomavirus polypeptides E6 and E7 
are zinc-binding proteins. J. Virol. 63, 1404–1407. 
Berezutskaya, E., Yu, B., Morozov, A., Raychaudhuri, P., and Bagchi, S. (1997). Differential 
regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 
oncoprotein. Cell Growth Differ. 8, 1277–1286. 
Berk, A.J., Lee, F., Harrison, T., Williams, J., and Sharp, P.A. (1979). Pre-early adenovirus 5 
gene product regulates synthesis of early viral messenger RNAs. Cell 17, 935–944. 
Bermel, W., Bertini, I., Csizmok, V., Felli, I.C., Pierattelli, R., and Tompa, P. (2009). H-start for 
exclusively heteronuclear NMR spectroscopy: the case of intrinsically disordered proteins. J. 
Magn. Reson. 198, 275–281. 
Bermel, W., Bertini, I., Felli, I.C., Gonnelli, L., Koźmiński, W., Piai, A., Pierattelli, R., and 
Stanek, J. (2012). Speeding up sequence specific assignment of IDPs. J. Biomol. NMR 53, 293–
301. 
Bermel, W., Bertini, I., Felli, I.C., Kümmerle, R., and Pierattelli, R. (2006a). Novel 13C direct 
detection experiments, including extension to the third dimension, to perform the complete 
assignment of proteins. J. Magn. Reson. 178, 56–64. 
Bermel, W., Bertini, I., Felli, I.C., Lee, Y.-M., Luchinat, C., and Pierattelli, R. (2006b). 
Protonless NMR experiments for sequence-specific assignment of backbone nuclei in 
unfolded proteins. J. Am. Chem. Soc. 128, 3918–3919. 
Bernadó, P., and Svergun, D.I. (2012a). Structural analysis of intrinsically disordered proteins 
by small-angle X-ray scattering. Mol. BioSyst. 8, 151–167. 
Bernadó, P., and Svergun, D.I. (2012b). Analysis of intrinsically disordered proteins by small-
angle X-ray scattering. Methods Mol. Biol. 896, 107–122. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   120	  
Bernadó, P., Mylonas, E., Petoukhov, M.V., Blackledge, M., and Svergun, D.I. (2007a). 
Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. 
Chem. Soc. 129, 5656–5664. 
Bernadó, P., Mylonas, E., Petoukhov, M.V., Blackledge, M., and Svergun, D.I. (2007b). 
Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. 
Chem. Soc. 129, 5656–5664. 
Bernard, H.-U., Burk, R.D., Chen, Z., van Doorslaer, K., Hausen, H.Z., and de Villiers, E.-M. 
(2010). Classification of papillomaviruses (PVs) based on 189 PV types and proposal of 
taxonomic amendments. Virology 401, 70–79. 
Bernat, A., Avvakumov, N., Mymryk, J.S., and Banks, L. (2003). Interaction between the HPV 
E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22, 7871–7881. 
Bertini, I., McGreevy, K.S., and Parigi, G. (2012). NMR of Biomolecules (John Wiley & Sons). 
Block, H., Maertens, B., Spriestersbach, A., Brinker, N., Kubicek, J., Fabis, R., Labahn, J., and 
Schäfer, F. (2009). Immobilized-metal affinity chromatography (IMAC): a review. Meth. 
Enzymol. 463, 439–473. 
Boulet, G., Horvath, C., Broeck, D.V., and Sahebali, S. (2007). Human papillomavirus: E6 and 
E7 oncogenes. Int. J. Biochem. Cell Biol. 39, 2006–2011. 
Braun, D., Wider, G., and Wuethrich, K. (1994). Sequence-Corrected 15N “Random Coil” 
Chemical Shifts. J. Am. Chem. Soc. 116, 8466–8469. 
Brito, R.M.M., and Vaz, W.L.C. (1986). Determination of the Critical Micelle Concentration of 
Surfactants Using the Fluorescent-Probe N-Phenyl-1-Naphthylamine. Anal. Biochem. 152, 
250–255. 
Bruton, R.K., Pelka, P., Mapp, K.L., Fonseca, G.J., Torchia, J., Turnell, A.S., Mymryk, J.S., and 
Grand, R.J.A. (2008). Identification of a second CtBP binding site in adenovirus type 5 E1A 
conserved region 3. J. Virol. 82, 8476–8486. 
Buchan, D.W.A., Minneci, F., Nugent, T.C.O., Bryson, K., and Jones, D.T. (2013). Scalable web 
services for the PSIPRED Protein Analysis Workbench. Nucleic Acids Research 41, gkt381–
W357. 
Burgess, R., Richard, R., and Murray, P. (2009). Refolding Solubilized Inclusion Body 
Proteins. Methods Enzymol 259–282. 
Calçada, E.O., Felli, I.C., Hošek, T., and Pierattelli, R. (2013). The heterogeneous structural 
behavior of E7 from HPV16 revealed by NMR spectroscopy. ChemBioChem 14, 1876–1882. 
Chemes, L.B., Glavina, J., Faivovich, J., de Prat-Gay, G., and Sánchez, I.E. (2012). Evolution of 
Linear Motifs within the Papillomavirus E7 Oncoprotein. J. Mol. Biol. 422, 336–346. 
Chemes, L.B., Sánchez, I.E., Smal, C., and de Prat-Gay, G. (2010). Targeting mechanism of the 
retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, 
intrinsic disorder and phosphorylation of human papillomavirus E7. Febs J. 277, 973–988. 
Cheng, J., Saigo, H., and Baldi, P. (2006). Large‐scale prediction of disulphide bridges using 
kernel methods, two‐dimensional recursive neural networks, and weighted graph matching. 
Proteins: Structure, Function, and Bioinformatics 62, 617–629. 
Chinami, M., Sasaki, S., and Hachiya, N. (1994). Functional oligomerization of purified 
human papillomavirus types 16 and 6b E7 proteins expressed in Escherichia coli. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   121	  
Chinnadurai, G. (2002). CtBP, an Unconventional Transcriptional Corepressor in 
Development and Oncogenesis. Mol. Cell 9, 213–224. 
Chinnadurai, G. (2011). Opposing oncogenic activities of small DNA tumor virus 
transforming proteins. Trends Microbiol. 19, 174–183. 
Clements, A., Johnston, K., Mazzarelli, J.M., Ricciardi, R.P., and Marmorstein, R. (2000). 
Oligomerization Properties of the Viral Oncoproteins Adenovirus E1A and Human 
Papillomavirus E7 and Their Complexes with the Retinoblastoma Protein. Biochemistry 39, 
16033–16045. 
Cohen, M.J., Yousef, A.F., Massimi, P., Fonseca, G.J., Todorovic, B., Pelka, P., Turnell, A.S., 
Banks, L., and Mymryk, J.S. (2013). Dissection of the C-terminal region of E1A redefines the 
roles of CtBP and other cellular targets in oncogenic transformation. J. Virol. 87, 10348–10355. 
Conte, Lo, M., and Carroll, K.S. (2013). The redox biochemistry of protein sulfenylation and 
sulfinylation. Journal of Biological Chemistry 288, 26480–26488. 
Coutard, B., Danchin, E.G.J., Oubelaid, R., Canard, B., and Bignon, C. (2012). Single pH buffer 
refolding screen for protein from inclusion bodies. Protein Expr. Purif. 82, 352–359. 
Cowieson, N.P., Wensley, B., Listwan, P., Hume, D.A., Kobe, B., and Martin, J.L. (2006). An 
automatable screen for the rapid identification of proteins amenable to refolding. Proteomics 
6, 1750–1757. 
Culp, J.S., and Webster, L.C. (1988). The 289-amino acid E1A protein of adenovirus binds zinc 
in a region that is important for trans-activation. Proc. Natl. Acad. Sci. U.S.a. 85, 6450–6454. 
Das, U., Hariprasad, G., Ethayathulla, A.S., Manral, P., Das, T.K., Pasha, S., Mann, A., 
Ganguli, M., Verma, A.K., Bhat, R., et al. (2007). Inhibition of Protein Aggregation: 
Supramolecular Assemblies of Arginine Hold the Key. PLoS ONE 2. 
Davey, N.E., Haslam, N.J., Shields, D.C., and Edwards, R.J. (2010). SLiMFinder: a web server 
to find novel, significantly over-represented, short protein motifs. Nucleic Acids Research 38, 
W534–W539. 
Davey, N.E., Travé, G., and Gibson, T.J. (2011). How viruses hijack cell regulation. Trends 
Biochem. Sci. 36, 159–169. 
Davies, R., Hicks, R., Crook, T., Morris, J., and Vousden, K. (1993). Human papillomavirus 
type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary 
for transformation. The Journal of Virology 67, 2521–2528. 
Di Marco, V.B., and Bombi, G.G. (2006). Electrospray mass spectrometry (ESI‐MS) in the 
study of metal–ligand solution equilibria. Mass Spectrometry Reviews 25, 347–379. 
Diaz, A.A., Tomba, E., Lennarson, R., Richard, R., Bagajewicz, M.J., and Harrison, R.G. (2010). 
Prediction of protein solubility in Escherichia coli using logistic regression. Biotechnology 
and Bioengineering 105, 374–383. 
Diella, F., Haslam, N., Chica, C., Budd, A., Michael, S., Brown, N.P., Trave, G., and Gibson, 
T.J. (2008). Understanding eukaryotic linear motifs and their role in cell signaling and 
regulation. Front Biosci 13, 6580–6603. 
Dimmock, N., Easton, A., and Leppard, K. (2007). Introduction to Modern Virology (Wiley-
Blackwell). 
Dinkel, H., Chica, C., Via, A., Gould, C.M., Jensen, L.J., Gibson, T.J., and Diella, F. (2011). 
Phospho.ELM: a database of phosphorylation sites—update 2011. Nucleic Acids Research 39, 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   122	  
D261–D267. 
Dosztányi, Z., and Tompa, P. (2008). Prediction of Protein Disorder. Structural Proteomics 
426, 103–115. 
Dosztányi, Z., Csizmok, V., Tompa, P., and Simon, I. (2005). IUPred: web server for the 
prediction of intrinsically unstructured regions of proteins based on estimated energy 
content. Bioinformatics 21, 3433–3434. 
Dunker, A.K., and Obradovic, Z. (2001). The protein trinity - linking function and disorder. 
Nat. Biotechnol. 19, 805–806. 
Dunker, A.K., Lawson, J.D., Brown, C.J., Williams, R.M., Romero, P., Oh, J.S., Oldfield, C.J., 
Campen, A.M., Ratliff, C.M., Hipps, K.W., et al. (2001). Intrinsically disordered protein. J. Mol. 
Graph. Model. 19, 26–59. 
Dunker, A.K., Babu, M.M., Barbar, E., Blackledge, M., Bondos, S.E., Dosztányi, Z., Dyson, 
H.J., Forman-Kay, J.D., Fuxreiter, M., Gsponer, J., et al. (2013). What’s in a name? Why these 
proteins are intrinsically disordered. Intrinsically Disordered Proteins 1, e24157. 
Dunker, A.K., Oldfield, C.J., Meng, J., Romero, P., Yang, J.Y., Chen, J.W., Vacic, V., Obradovic, 
Z., and Uversky, V.N. (2008a). The unfoldomics decade: an update on intrinsically disordered 
proteins. BMC Genomics 9 Suppl 2, S1. 
Dunker, A.K., Silman, I., Uversky, V.N., and Sussman, J.L. (2008b). Function and structure of 
inherently disordered proteins. Curr. Opin. Struct. Biol. 18, 756–764. 
Dyson, H.J., and Wright, P.E. (2001). Nuclear magnetic resonance methods for elucidation of 
structure and dynamics in disordered states. Meth. Enzymol. 339, 258–270. 
Dyson, H.J., and Wright, P.E. (2005). Intrinsically unstructured proteins and their functions. 
Nat. Rev. Mol. Cell Biol. 6, 197–208. 
Dyson, N., Guida, P., McCall, C., and Harlow, E. (1992a). Adenovirus-E1a Makes 2 Distinct 
Contacts with the Retinoblastoma Protein. The Journal of Virology 66, 4606–4611. 
Dyson, N., Guida, P., Münger, K., and Harlow, E. (1992b). Homologous Sequences in 
Adenovirus E1a and Human Papillomavirus E7 Proteins Mediate Interaction with the Same 
Set of Cellular Proteins. The Journal of Virology 66, 6893–6902. 
Dyson, N., Howley, P.M., Münger, K., and Harlow, E. (1989). The human papilloma virus-16 
E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934–937. 
El-Aneed, A., Cohen, A., and Banoub, J. (2009). Mass spectrometry, review of the basics: 
Electrospray, MALDI, and commonly used mass analyzers. Applied Spectroscopy Reviews. 
Emanuelsson, O., Brunak, S.O.R., Heijne, von, G., and Nielsen, H. (2007). Locating proteins in 
the cell using TargetP, SignalP and related tools. Nat Protoc 2, 953–971. 
Esposito, D., and Chatterjee, D.K. (2006). Enhancement of soluble protein expression through 
the use of fusion tags. Current Opinion in Biotechnology 17, 353–358. 
Eswar, N., Webb, B., Marti-Renom, M.A., Madhusudhan, M.S., Eramian, D., Shen, M.-Y., 
Pieper, U., and Šali, A. (2006). Comparative protein structure modeling using Modeller. Curr 
Protoc Bioinformatics UNIT 5.6, Unit5.6. 
Felli, I.C., and Pierattelli, R. (2012). Recent progress in NMR spectroscopy: Toward the study 
of intrinsically disordered proteins of increasing size and complexity. Iubmb Life 64, 473–481. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   123	  
Fera, D., and Marmorstein, R. (2012). Different Regions of the HPV-E7 and Ad-E1A Viral 
Oncoproteins Bind Competitively but through Distinct Mechanisms to the CH1 
Transactivation Domain of p300. Biochemistry 51, 9524–9534. 
Ferguson, B., Krippl, B., Andrisani, O., Jones, N., Westphal, H., and Rosenberg, M. (1985). 
E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized 
transcription activators but do not directly bind DNA. Mol. Cell. Biol. 5, 2653–2661. 
Ferreon, A.C.M., Ferreon, J.C., Wright, P.E., and Deniz, A.A. (2013). Modulation of allostery 
by protein intrinsic disorder. Nature 498, 390–394. 
Ferreon, J.C., Martinez-Yamout, M.A., Dyson, H.J., and Wright, P.E. (2009). Structural basis 
for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc. Natl. 
Acad. Sci. U.S.a. 106, 13260–13265. 
Ferrè, F., and Clote, P. (2006). DiANNA 1.1: an extension of the DiANNA web server for 
ternary cysteine classification. Nucleic Acids Research 34, W182–W185. 
Ferron, F., Longhi, S., Canard, B., and Karlin, D. (2006). A practical overview of protein 
disorder prediction methods. Proteins 65, 1–14. 
Franke, D., and Svergun, D.I. (2009). DAMMIF, a program for rapid ab-initio shape 
determination in small-angle scattering. J. Appl. Crystallogr. 42, 342–346. 
Frisch, S.M., and Mymryk, J.S. (2002). Adenovirus-5 E1A: paradox and paradigm. Nat. Rev. 
Mol. Cell Biol. 3, 441–452. 
Fuchs, M., Gerber, J., Drapkin, R., Sif, S., Ikura, T., Ogryzko, V., Lane, W.S., Nakatani, Y., and 
Livingston, D.M. (2001). The p400 Complex Is an Essential E1A Transformation Target. Cell 
106, 297–307. 
Fuxreiter, M., Tompa, P., and Simon, I. (2007). Local structural disorder imparts plasticity on 
linear motifs. Bioinformatics 23, 950–956. 
Fuxreiter, M., Tompa, P., Simon, I.A.N., Uversky, V.N., Hansen, J.C., and Asturias, F.J. (2008). 
Malleable machines take shape in eukaryotic transcriptional regulation. Nat. Chem. Biol. 4, 
728–737. 
Gallimore, P.H. (1972). Tumour Production in Immunosuppressed Rats with Cells 
Transformed in vitro by Adenovirus Type 2. Journal of General Virology 16, 99–102. 
Garcia-Alai, M.M., Alonso, L.G., and de Prat-Gay, G. (2007). The N-terminal module of 
HPV16 E7 is an intrinsically disordered domain that confers conformational and recognition 
plasticity to the oncoprotein. Biochemistry 46, 10405–10412. 
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M.R., Appel, R.D., and Bairoch, 
A. (2005). Protein Identification and Analysis Tools on the ExPASy Server (Totowa, NJ: 
Humana Press). 
Getz, E.B., Xiao, M., Chakrabarty, T., Cooke, R., Cooke, R., Selvin, P.R., and Selvin, P.R. 
(1999). A Comparison between the Sulfhydryl Reductants Tris(2-carboxyethyl)phosphine and 
Dithiothreitol for Use in Protein Biochemistry. Anal. Biochem. 273, 73–80. 
Grzesiek, S., and Bax, A. (1993). Measurement of amide proton exchange rates and NOEs 
with water in 13C/15N-enriched calcineurin B. J. Biomol. NMR 3, 627–638. 
Guinier, A. (1939). La diffraction des rayons X aux tres petits angles: applications a l'etude de 
phenomenes ultramicroscopiques. Annales De Physique, EDP Sciences. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   124	  
Gupta, B.B. (1983). Determination of native and denatured milk proteins by high-
performance size exclusion chromatography. Journal of Chromatography A 282, 463–475. 
Halldén, G. (2012). Adenoviral Gene Expression and Replication in Human Tumor Explant 
Models. Oncolytic Viruses 797, 65–78. 
Harpaz, Y., Gerstein, M., and Chothia, C. (1994). Volume changes on protein folding. 
Structure 2, 641–649. 
Hateboer, G., Gennissen, A., Ramos, Y., Kerkhoven, R.M., Sonntagbuck, V., Stunnenberg, 
H.G., and Bernards, R. (1995). Bs69, a Novel Adenovirus E1a-Associated Protein That Inhibits 
E1a Transactivation. Embo J. 14, 3159–3169. 
Hausen, zur, H. (2002). Papillomaviruses and cancer: from basic studies to clinical 
application. Nat. Rev. Cancer 2, 342–350. 
Haynes, C., Oldfield, C.J., Ji, F., Klitgord, N., Cusick, M.E., Radivojac, P., Uversky, V.N., 
Vidal, M., and Iakoucheva, L.M. (2006). Intrinsic Disorder Is a Common Feature of Hub 
Proteins from Four Eukaryotic Interactomes. PLoS Comput. Biol. 2, e100. 
He, B., Wang, K., Liu, Y., Xue, B., Uversky, V.N., and Dunker, A.K. (2009). Predicting intrinsic 
disorder in proteins: an overview. Cell Res. 19, 929–949. 
Hearing, P., and Shenk, T. (1983). The adenovirus type 5 E1A transcriptional control region 
contains a duplicated enhancer element. Cell 33, 695–703. 
Huh, K., Zhou, X., Hayakawa, H., Cho, J.-Y., Libermann, T.A., Jin, J., Harper, J.W., and 
Münger, K. (2007). Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 
ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor 
suppressor. The Journal of Virology 81, 9737–9747. 
Hulo, C., de Castro, E., Masson, P., Bougueleret, L., Bairoch, A., Xenarios, I., and Le Mercier, 
P. (2011). ViralZone: a knowledge resource to understand virus diversity. Nucleic Acids 
Research 39, D576–D582. 
Hunt, I. (2005). From gene to protein: a review of new and enabling technologies for multi-
parallel protein expression. Protein Expr. Purif. 40, 1–22. 
Iakoucheva, L.M., Radivojac, P., Brown, C.J., O’Connor, T.R., Sikes, J.G., Obradovic, Z., and 
Dunker, A.K. (2004). The importance of intrinsic disorder for protein phosphorylation. 
Nucleic Acids Research 32, 1037–1049. 
Ignatova, Z., and Gierasch, L.M. (2006). Inhibition of protein aggregation in vitro and in vivo 
by a natural osmoprotectant. Proceedings of the National Academy of Sciences 103, 13357–
13361. 
Ishida, T., and Kinoshita, K. (2008). Prediction of disordered regions in proteins based on the 
meta approach. Bioinformatics 24, 1344–1348. 
Jacques, D.A., Guss, J.M., Svergun, D.I., and Trewhella, J. (2012). Publication guidelines for 
structural modelling of small-angle scattering data from biomolecules in solution. Acta 
Crystallogr. D Biol. Crystallogr. 68, 620–626. 
Jana, S., and Deb, J.K. (2005). Strategies for efficient production of heterologous proteins in 
Escherichia coli. Appl Microbiol Biotechnol 67, 289–298. 
Jones, N., and Shenk, T. (1979a). An adenovirus type 5 early gene function regulates 
expression of other early viral genes. Proc. Natl. Acad. Sci. U.S.a. 76, 3665–3669. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   125	  
Jones, N., and Shenk, T. (1979b). Isolation of adenovirus type 5 host range deletion mutants 
defective for transformation of rat embryo cells. Cell 17, 683–689. 
Jumpertz, T., Tschapek, B., Infed, N., Smits, S.H.J., Ernst, R., and Schmitt, L. (2011). High-
throughput evaluation of the critical micelle concentration of detergents. Anal. Biochem. 408, 
64–70. 
Katzen, F. (2007). Gateway ®recombinational cloning: a biological operating system. Expert 
Opin. Drug Discov. 2, 571–589. 
Kay, L.E., Torchia, D.A., and Bax, A. (1989). Backbone dynamics of proteins as studied by 15N 
inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. 
Biochemistry 28, 8972–8979. 
Kelly, S.M., Jess, T.J., and Price, N.C. (2005). How to study proteins by circular dichroism. 
Biochimica Et Biophysica Acta (BBA) - Proteins and Proteomics 1751, 119–139. 
Kimelman, D., Miller, J.S., Porter, D., and Roberts, B.E. (1985). E1a regions of the human 
adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related. The 
Journal of Virology 53, 399–409. 
Kindermann, B., Döring, F., Fuchs, D., Pfaffl, M.W., and Daniel, H. (2005). Effects of increased 
cellular zinc levels on gene and protein expression in HT-29 cells. Biometals 18, 243–253. 
Konarev, P.V., Petoukhov, M.V., Volkov, V.V., and Svergun, D.I. (2006). ATSAS 2.1, a 
program package for small-angle scattering data analysis. J. Appl. Crystallogr. 39, 277–286. 
Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M.H.J., and Svergun, D.I. (2003). PRIMUS: 
a Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 36, 
1277–1282. 
Krezel, A., Latajka, R., Bujacz, G.D., and Bal, W. (2003). Coordination properties of tris(2-
carboxyethyl)phosphine, a newly introduced thiol reductant, and its oxide. Inorg Chem 42, 
1994–2003. 
Krogh, A., Larsson, B., Heijne, von, G., and Sonnhammer, E.L.L. (2001). Predicting 
transmembrane protein topology with a hidden markov model: application to complete 
genomes. J. Mol. Biol. 305, 567–580. 
Lee, J.O., Russo, A.A., and Pavletich, N.P. (1998). Structure of the retinoblastoma tumour-
suppressor pocket domain bound to a peptide from HPV E7. Nature 391, 859–865. 
Lesley, S.A. (2009). Parallel Methods for Expression and Purification. In Methods in 
Enzymology, (Elsevier), pp. 767–785. 
Lian, L.Y. (1998). NMR structural studies of glutathione S-transferase. Cell. Mol. Life Sci. 54, 
359–362. 
Lieutaud, P., Canard, B., and Longhi, S. (2008). MeDor: a metaserver for predicting protein 
disorder. BMC Genomics 9 Suppl 2, S25. 
Lillie, J.W., and Green, M.R. (1989). Transcription activation by the adenovirus E1a protein. 
Nature 338, 39–44. 
Linding, R., Jensen, L.J., Diella, F., Bork, P., Gibson, T.J., and Russell, R.B. (2003a). Protein 
Disorder Prediction. Structure 11, 1453–1459. 
Linding, R., Russell, R.B., Neduva, V., and Gibson, T.J. (2003b). GlobPlot: exploring protein 
sequences for globularity and disorder. Nucleic Acids Research 31, 3701–3708. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   126	  
Linn, S. (2009). Strategies and Considerations for Protein Purifications. In Methods in 
Enzymology, (Elsevier), pp. 9–19. 
Liu, A., Riek, R., Wider, G., Schroetter, von, C., Zahn, R., and Wüthrich, K. (2000). NMR 
experiments for resonance assignments of 13C, 15N doubly-labeled flexible polypeptides: 
application to the human prion protein hPrP(23-230). J. Biomol. NMR 16, 127–138. 
Liu, F., and Green, M.R. (1994). Promoter targeting by adenovirus E1a through interaction 
with different cellular DNA-binding domains. Nature 368, 520–525. 
Liu, X., Clements, A., Zhao, K., and Marmorstein, R. (2006). Structure of the Human 
Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma 
Tumor Suppressor. Journal of Biological Chemistry 281, 578–586. 
Louis-Jeune, C., Andrade-Navarro, M.A., and Perez-Iratxeta, C. (2012). Prediction of protein 
secondary structure from circular dichroism using theoretically derived spectra. Proteins 80, 
374–381. 
Magnan, C.N., Randall, A., and Baldi, P. (2009). SOLpro: accurate sequence-based prediction 
of protein solubility. Bioinformatics 25, 2200–2207. 
Malhotra, A. (2009). Tagging for Protein Expression. In Methods in Enzymology, (Elsevier), 
pp. 239–258. 
Malloy, A.H., and Carson, E.C. (2008). Oncogene Proteins: New Research (Nova Science 
Publishers). 
Marsh, J.A., Singh, V.K., Jia, Z., and Forman-Kay, J.D. (2006). Sensitivity of secondary 
structure propensities to sequence differences between α‐ and γ‐synuclein: Implications for 
fibrillation. Protein Sci. 15, 2795–2804. 
McLaughlin-Drubin, M.E., and Münger, K. (2009). The human papillomavirus E7 
oncoprotein. Virology 384, 335–344. 
McLaughlin-Drubin, M.E., Meyers, J., and Munger, K. (2012). Cancer associated human 
papillomaviruses. Curr Opin Virol 2, 459–466. 
Mertens, H.D.T., and Svergun, D.I. (2010). Structural characterization of proteins and 
complexes using small-angle X-ray solution scattering. Journal of Structural Biology 172, 128–
141. 
Miller, M.S., Pelka, P., Fonseca, G.J., Cohen, M.J., Kelly, J.N., Barr, S.D., Grand, R.J.A., Turnell, 
A.S., Whyte, P., and Mymryk, J.S. (2012). Characterization of the 55-residue protein encoded 
by the 9S E1A mRNA of species C adenovirus. J. Virol. 86, 4222–4233. 
Mirecka, E.A., Rudolph, R., and Hey, T. (2006). Expression and purification of His-tagged 
HPV16 E7 protein active in pRb binding. Protein Expr. Purif. 48, 281–291. 
Mittag, T., and Forman-Kay, J.D. (2007). Atomic-level characterization of disordered protein 
ensembles. Curr. Opin. Struct. Biol. 17, 3–14. 
Mittermaier, A., and Kay, L.E. (2006). Review - New tools provide new insights in NMR 
studies of protein dynamics. Science 312, 224–228. 
Monastyrskyy, B., Fidelis, K., Moult, J., Tramontano, A., and Kryshtafovych, A. (2011). 
Evaluation of disorder predictions in CASP9. Proteins: Structure, Function, and 
Bioinformatics 79, 107–118. 
Moody, C.A., and Laimins, L.A. (2010a). Human papillomavirus oncoproteins: pathways to 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   127	  
transformation. Nat. Rev. Cancer 10, 550–560. 
Moody, C.A., and Laimins, L.A. (2010b). Human papillomavirus oncoproteins: pathways to 
transformation. Nat. Rev. Cancer 10, 550–560. 
Munger, K., Howley, P., and DiMaio, D. (2007). Human Papillomavirus E6 and E7 
Oncogenes. The Papillomaviruses 197–252. 
Münger, K., Phelps, W.C., Bubb, V., Howley, P.M., and Schlegel, R. (1989). The E6 and E7 
genes of the human papillomavirus type 16 together are necessary and sufficient for 
transformation of primary human keratinocytes. J. Virol. 63, 4417–4421. 
Münger, K., Baldwin, A., Edwards, K.M., Hayakawa, H., Nguyen, C.L., Owens, M., Grace, 
M., and Huh, K. (2004). Mechanisms of human papillomavirus-induced oncogenesis. The 
Journal of Virology 78, 11451–11460. 
Narisawa Saito, M., and Kiyono, T. (2007). Basic mechanisms of high‐risk human 
papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Science 98, 1505–
1511. 
Nevins, J.R., Ginsberg, H.S., Blanchard, J.M., Wilson, M.C., and Darnell, J.E. (1979). 
Regulation of the primary expression of the early adenovirus transcription units. The Journal 
of Virology 32, 727–733. 
Oates, M.E., Romero, P., Ishida, T., Ghalwash, M., Mizianty, M.J., Xue, B., Dosztányi, Z., 
Uversky, V.N., Obradovic, Z., Kurgan, L., et al. (2013). D²P²: database of disordered protein 
predictions. Nucleic Acids Research 41, D508–D516. 
Ohlenschläger, O., Seiboth, T., Zengerling, H., Briese, L., Marchanka, A., Ramachandran, R., 
Baum, M., Korbas, M., Meyer-Klaucke, W., Dürst, M., et al. (2006). Solution structure of the 
partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene 25, 5953–5959. 
Outten, C.E., and O'Halloran, A.T.V. (2001). Femtomolar Sensitivity of Metalloregulatory 
Proteins Controlling Zinc Homeostasis. Science 292, 2488–2492. 
Passerini, A., Lippi, M., and Frasconi, P. (2011). MetalDetector v2.0: predicting the geometry 
of metal binding sites from protein sequence. Nucleic Acids Research 39, W288–W292. 
Pelka, P., Ablack, J.N.G., Fonseca, G.J., Yousef, A.F., and Mymryk, J.S. (2008). Intrinsic 
structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse 
processes. J. Virol. 82, 7252–7263. 
Pelka, P., Ablack, J.N.G., Torchia, J., Turnell, A.S., Grand, R.J.A., and Mymryk, J.S. (2009). 
Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP. Nucleic Acids 
Research 37, 1095–1106. 
Pelka, P., Miller, M.S., Cecchini, M., Yousef, A.F., Bowdish, D.M., Dick, F., Whyte, P., and 
Mymryk, J.S. (2011). Adenovirus E1A directly targets the E2F/DP-1 complex. J. Virol. 85, 
8841–8851. 
Peng, J.W., and Wagner, G. (1994). Investigation of protein motions via relaxation 
measurements. Meth. Enzymol. 239, 563–596. 
Perricaudet, M., rvi, G.O.R.A.A., Virtanen, A., and Pettersson, U. (1979). Structure of two 
spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature 
281, 694–696. 
Petoukhov, M.V., Franke, D., Shkumatov, A.V., Tria, G., Kikhney, A.G., Gajda, M., Gorba, C., 
Mertens, H.D.T., Konarev, P.V., and Svergun, D.I. (2012). New developments in the ATSAS 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   128	  
program package for small-angle scattering data analysis. J. Appl. Crystallogr. 45, 342–350. 
Petoukhov, M.V., and Svergun, D.I. (2013). Applications of small-angle X-ray scattering to 
biomacromolecular solutions. Int. J. Biochem. Cell Biol. 45, 429–437. 
Phelps, W.C., Münger, K., Yee, C.L., Barnes, J.A., and Howley, P.M. (1992). Structure-function 
analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66, 2418–2427. 
Phelps, W.C., Yee, C.L., Munger, K., and Howley, P.M. (1988). The human papillomavirus 
type 16 E7 gene encodes transactivation and transformation functions similar to those of 
adenovirus E1A. Cell 53, 539–547. 
Prilusky, J., Felder, C.E., Zeev-Ben-Mordehai, T., Rydberg, E.H., Man, O., Beckmann, J.S., 
Silman, I., and Sussman, J.L. (2005). FoldIndex©: a simple tool to predict whether a given 
protein sequence is intrinsically unfolded. Bioinformatics 21, 3435–3438. 
Qoronfleh, M.W., Hesterberg, L.K., and Seefeldt, M.B. (2007). Confronting high-throughput 
protein refolding using high pressure and solution screens. Protein Expr. Purif. 55, 209–224. 
Radivojac, P., Iakoucheva, L.M., Oldfield, C.J., Obradovic, Z., Uversky, V.N., and Dunker, 
A.K. (2007). Intrinsic disorder and functional proteomics. Biophys. J. 92, 1439–1456. 
Ratnayake, S., Dias, I.H.K., Lattman, E., and Griffiths, H.R. (2013). Stabilising cysteinyl thiol 
oxidation and nitrosation for proteomic analysis. J Proteomics 92, 160–170. 
Rehder, D.S., and Borges, C.R. (2010). Cysteine sulfenic acid as an intermediate in disulfide 
bond formation and nonenzymatic protein folding. Biochemistry 49, 7748–7755. 
Rezaei Ghaleh, N., Blackledge, M., and Zweckstetter, M. (2012). Intrinsically Disordered 
Proteins: From Sequence and Conformational Properties toward Drug Discovery. 
ChemBioChem 13, 930–950. 
Roessle, M.W., Klaering, R., Ristau, U., Robrahn, B., Jahn, D., Gehrmann, T., Konarev, P., 
Round, A., Fiedler, S., Hermes, C., et al. (2007). Upgrade of the small-angle X-ray scattering 
beamline X33 at the European Molecular Biology Laboratory, Hamburg. J. Appl. Crystallogr. 
190–194. 
Roman, A., and Munger, K. (2013). The papillomavirus E7 proteins. Virology 445, 138–168. 
Romero, P., Obradovic, Z., Kissinger, C., Villafranca, J.E., and Dunker, A.K. (1997). 
Identifying disordered regions in proteins from amino acid sequence. (IEEE), pp. 90–95. 
Round, A.R., Franke, D., Moritz, S., Huchler, R., Fritsche, M., Malthan, D., Klaering, R., 
Svergun, D.I., and Roessle, M. (2008). Automated sample-changing robot for solution 
scattering experiments at the EMBL Hamburg SAXS station X33. J. Appl. Crystallogr. 41, 913–
917. 
Schenk, P.M., Baumann, S., Mattes, R., and Steinbiss, H. (1995). Improved high-level 
expression system for eukaryotic genes in Escherichia coli using T7 RNA polymerase and 
rare ArgtRNAs. Biotechniques 19, 196–200. 
Schiffman, M., Castle, P., Jeronimo, J., and Rodriguez, A. (2007). Human papillomavirus and 
cervical cancer. The Lancet 370, 890–907. 
Schlessinger, A., Punta, M., Yachdav, G., Kajan, L., and Rost, B. (2009). Improved Disorder 
Prediction by Combination of Orthogonal Approaches. PLoS ONE 4, e4433. 
Schwarzinger, S., Kroon, G.J., Foss, T.R., Chung, J., Wright, P.E., and Dyson, H.J. (2001). 
Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123, 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   129	  
2970–2978. 
Shatzman, A.R. (1995). Expression systems. 
Shetty, V., Spellman, D.S., and Neubert, T.A. (2007). Characterization by tandem mass 
spectrometry of stable cysteine sulfenic acid in a cysteine switch peptide of matrix 
metalloproteinases. J Am Soc Mass Spectrom 18, 1544–1551. 
Sickmeier, M., Hamilton, J.A., LeGall, T., Vacic, V., Cortese, M.S., Tantos, A., Szabo, B., 
Tompa, P., Chen, J., Uversky, V.N., et al. (2007). DisProt: the Database of Disordered Proteins. 
Nucleic Acids Research 35, D786–D793. 
Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam, H., 
Remmert, M., Soeding, J., et al. (2011). Fast, scalable generation of high-quality protein 
multiple sequence alignments using Clustal Omega. Molecular Systems Biology 539. 
Singh, S.M., Singh, S.M., Panda, A.K., and Panda, A.K. (2005). Solubilization and refolding of 
bacterial inclusion body proteins. Journal of Bioscience and Bioengineering 99, 303–310. 
Smialowski, P., Martin-Galiano, A.J., Mikolajka, A., Girschick, T., Holak, T.A., and Frishman, 
D. (2007). Protein solubility: sequence based prediction and experimental verification. 
Bioinformatics 23, 2536–2542. 
Spera, S., and Bax, A. (1991). Empirical correlation between protein backbone conformation 
and C.alpha. and C.beta. 13C nuclear magnetic resonance chemical shifts. J. Am. Chem. Soc. 
113, 5490–5492. 
Stephens, C., and Harlow, E. (1987). Differential splicing yields novel adenovirus 5 E1A 
mRNAs that encode 30 kd and 35 kd proteins. Embo J. 6, 2027–2035. 
Stewart, P.L., Burnett, R.M., Cyrklaff, M., and Fuller, S.D. (1991). Image reconstruction reveals 
the complex molecular organization of adenovirus. Cell 67, 145–154. 
Subramanian, T., Zhao, L., and Chinnadurai, G. (2013). Interaction of CtBP with adenovirus 
E1A suppresses immortalization of primary epithelial cells and enhances virus replication 
during productive infection. Virology 313–320. 
Svergun, D.I. (1992). Determination of the regularization parameter in indirect-transform 
methods using perceptual criteria. J. Appl. Crystallogr. 25, 495–503. 
Šali, A., and Blundell, T.L. (1993). Comparative Protein Modelling by Satisfaction of Spatial 
Restraints. J. Mol. Biol. 234, 779–815. 
Testa, L., Brocca, S., Santambrogio, C., DUrzo, A., Habchi, J., Longhi, S., Uversky, V.N., and 
Grandori, R. (2013). Extracting structural information from charge-state distributions of 
intrinsically disordered proteins by non-denaturing electrospray-ionization mass 
spectrometry. Intrinsically Disordered Proteins 1, e25068. 
Theillet, F.-X., Kalmar, L., Tompa, P., Han, K.-H., Selenko, P., Dunker, A.K., Daughdrill, G.W., 
and Uversky, V.N. (2013). The alphabet of intrinsic disorder I. Act like a Pro: On the 
abundance and roles of proline residues in intrinsically disordered proteins. Intrinsically 
Disordered Proteins 1, 0–12. 
Todorovic, B., Hung, K., Massimi, P., Avvakumov, N., Dick, F.A., Shaw, G.S., Banks, L., and 
Mymryk, J.S. (2012). Conserved region 3 of human papillomavirus 16 E7 contributes to 
deregulation of the retinoblastoma tumor suppressor. J. Virol. 86, 13313–13323. 
Tompa, P. (2012). On the supertertiary structure of proteins. Nat. Chem. Biol. 8, 597–600. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   130	  
Tompa, P., and Fersht, A. (2009). Structure and Function of Intrinsically Disordered Proteins 
(Chapman and Hall/CRC). 
Tompa, P., and Fuxreiter, M. (2008). Fuzzy complexes: polymorphism and structural disorder 
in protein–protein interactions. Trends Biochem. Sci. 33, 2–8. 
Tong, K.I., Yamamoto, M., and Tanaka, T. (2008). A simple method for amino acid selective 
isotope labeling of recombinant proteins in E. coli. J. Biomol. NMR 42, 59–67. 
Uversky, V.N., and Longhi, S. (2011). Flexible Viruses: Structural Disorder in Viral Proteins. 
Uversky, V.N. (2011). Intrinsically disordered proteins from A to Z. Int. J. Biochem. Cell Biol. 
43, 1090–1103. 
Uversky, V.N. (2013a). A decade and a half of protein intrinsic disorder: biology still waits for 
physics. Protein Sci. 22, 693–724. 
Uversky, V.N. (2013b). Unusual biophysics of intrinsically disordered proteins. Biochimica Et 
Biophysica Acta (BBA) - Proteins and Proteomics 1834, 932–951. 
Uversky, V.N., and Dunker, A.K. (2010). Understanding protein non-folding. Biochim. 
Biophys. Acta 1804, 1231–1264. 
Uversky, V.N., Oldfield, C.J., and Dunker, A.K. (2005). Showing your ID: intrinsic disorder as 
an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 18, 343–384. 
Uversky, V.N., Oldfield, C.J., and Dunker, A.K. (2008). Intrinsically disordered proteins in 
human diseases: introducing the D2 concept. Annu Rev Biophys 37, 215–246. 
Uversky, V.N., Roman, A., Oldfield, C.J., and Dunker, A.K. (2006). Protein intrinsic disorder 
and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from 
high risk HPVs. J. Proteome Res. 5, 1829–1842. 
Varadi, M., Kosol, S., Lebrun, P., Valentini, E., Blackledge, M., Dunker, A.K., Felli, I.C., 
Forman-Kay, J.D., Kriwacki, R.W., Pierattelli, R., et al. (2013). pE-DB: a database of structural 
ensembles of intrinsically disordered and of unfolded proteins. Nucleic Acids Research. 
Vincentelli, R., Canaan, S., Campanacci, V., Valencia, C., Maurin, D., Frassinetti, F., 
Scappucini-Calvo, L., Bourne, Y., Cambillau, C., and Bignon, C. (2004). High-throughput 
automated refolding screening of inclusion bodies. Protein Science 13, 2782–2792. 
Wagner, G. (1993). NMR relaxation and protein mobility. Curr. Opin. Struct. Biol. 3, 748–754. 
Wang, F., Marshall, C.B., and Ikura, M. (2013). Transcriptional/epigenetic regulator 
CBP/p300 in tumorigenesis: structural and functional versatility in target recognition. Cell. 
Mol. Life Sci. 1–20. 
Ward, J.J., Sodhi, J.S., McGuffin, L.J., Buxton, B.F., and Jones, D.T. (2004a). Prediction and 
Functional Analysis of Native Disorder in Proteins from the Three Kingdoms of Life. J. Mol. 
Biol. 337, 635–645. 
Ward, J.J., McGuffin, L.J., Bryson, K., Buxton, B.F., and Jones, D.T. (2004b). The DISOPRED 
server for the prediction of protein disorder. Bioinformatics 20, 2138–2139. 
Wong, H.K., and Ziff, E.B. (1994). Complementary functions of E1a conserved region 1 
cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters. The 
Journal of Virology 68, 4910–4920. 
Wright, P.E., and Dyson, H.J. (1999). Intrinsically unstructured proteins: re-assessing the 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   REFERENCES	  
	  
	   131	  
protein structure-function paradigm. J. Mol. Biol. 293, 321–331. 
Xue, B., Dunbrack, R.L., Williams, R.W., Dunker, A.K., and Uversky, V.N. (2010). PONDR-
FIT: a meta-predictor of intrinsically disordered amino acids. Biochim. Biophys. Acta 1804, 
996–1010. 
Xue, B., Ganti, K., Rabionet, A., Banks, L., and Uversky, V.N. (2013). Disordered Interactome 
of Human Papillomavirus. Curr. Pharm. Des. 1–19. 
Zamanian, M., and La Thangue, N.B. (1992). Adenovirus E1a prevents the retinoblastoma 
gene product from repressing the activity of a cellular transcription factor. Embo J. 11, 2603–
2610. 
Zerler, B., Roberts, R.J., Mathews, M.B., and Moran, E. (1987). Different Functional Domains 
of the Adenovirus E1a Gene Are Involved in Regulation of Host-Cell Cycle Products. Mol. 
Cell. Biol. 7, 821–829. 
Zhang, O., Forman-Kay, J.D., Shortle, D., and Kay, L.E. (1997). Triple-resonance NOESY-
based experiments with improved spectral resolution: applications to structural 
characterization of unfolded, partially folded and folded proteins. J. Biomol. NMR 9, 181–200. 
INTRINSICALLY	  DISORDERED	  PROTEINS	  	   	  FROM	  SAMPLE	  PREPARATION	  TO	  MOLECULAR	  BASIS	  OF	  FUNCTION	   SUPPLEMENTARY	  DATA	  
	  
	   132	  
7. Supplementary data 
 
Table 6.1. Summary of proteins studied in this work. Legend: MM, molecular mass in Daltons; pI, 
isoelectric point; ε, extinction coefficient factor. 
 
HPV16  
E7 
HPV16  
E7 CR3 
HAdV 2/5 
E1A13S 
HAdV 2 
E1A12S CBP-ID4 
MM (Da) 12087 6401 33176 26500 22539 
pI 4.7 6.0 4.9 4.4 12.1 ε	  (M-­‐1	  cm-­‐1)	   5960 1490 7450 1490 6990 
Nºresidues 106 58 299 243 211 
 
Ala (A) 3 (3%) 2 (3%) 13 (4%) 13 (5%) 19 (9%) 
Arg (R) 3 (3%) 3 (5%) 18 (6%) 14 (6%) 13 (6%) 
Asn (N) 2 (2%) 1 (2%) 7 (2%) 6 (2%) 7 (3%) 
Asp (D) 10 (9%) 4 (7%) 17 (6%) 14 (6%) 1 (1%) 
Cys (C) 7 (7%) 6 (10%) 12 (4%) 7 (3%) 0 (0%) 
Gln (Q) 5 (5%) 2 (3%) 8 (3%) 8 (3%) 34 (16%) 
Glu (E) 10 (9%) 2 (3%) 33 (11%) 30 (12%) 3 (1%) 
Gly (G) 5 (5%) 3 (5%) 16 (5%) 11 (5%) 11 (5%) 
His (H) 10 (9%) 2 (3%) 19 (6%) 7 (3%) 3 (1%) 
Ile (I) 5 (5%) 4 (7%) 12 (4%) 11 (5%) 4 (2%) 
Leu (L) 12 (11%) 6 (10%) 24 (8%) 21 (9%) 7 (3%) 
Lys (K) 2 (2%) 2 (3%) 3 (1%) 3 (1%) 1 (1%) 
Met (M) 3 (3%) 1 (2%) 7 (2%) 4 (2%) 12 (6%) 
Phe (F) 1 (1%) 2 (3%) 7 (2%) 5 (2%) 2 (1%) 
Pro (P) 6 (6%) 3 (5%) 46 (16%) 43 (18%) 46 (22%) 
Ser (S) 5 (5%) 4 (7%) 20 (7%) 18 (7%) 17 (8%) 
Thr (T) 9 (9%) 6 (10%) 11 (4%) 9 (4%) 15 (7%) 
Trp (W) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 
Tyr (Y) 4 (4%) 1 (2%) 5 (2%) 1 (0%) 1 (1%) 
Val (V) 4 (4%) 4 (7%) 21 (7%) 18 (7%) 14 (7%) 
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Sequence alignment of E1A 13S proteins between HAdV2 and HAdV5 	  
HAdV2   E1A  MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEE 
HAdV2/5 E1A  MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEE 
HAdV5   E1A  MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEE 
             ************************************************************ 
 
HAdV2   E1A  AVSQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVI 
HAdV2/5 E1A  AVSQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVI 
HAdV5   E1A  AVSQIFPDSVMLAVQEGIDLLTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVI 
             *******:************:*************************************** 
 
HAdV2   E1A  DLTCHEAGFPPSDDEDEEGEEFVLDYVEHPGHGCRSCHYHRRNTGDPDIMCSLCYMRTCG 
HAdV2/5 E1A  DLTCHEAGFPPSDDEDEEGEEFVLDYVGHPGHGCRSCHYHRRNTGDPDIMCSLCYMRTCG 
HAdV5   E1A  DLTCHEAGFPPSDDEDEEGEEFVLDYVEHPGHGCRSCHYHRRNTGDPDIMCSLCYMRTCG 
             *************************** ******************************** 
 
HAdV2   E1A  MFVYSPVSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSPVSRECNSSTDSCDSGPSNTP 
HAdV2/5 E1A  MFVYSPVSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSPVSRECNSSTDSCDSGPSNTP 
HAdV5   E1A  MFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAILRRPTSPVSRECNSSTDSCDSGPSNTP 
             ****************************:.****************************** 
 
HAdV2   E1A  PEIHPVVPLCPIKPVAVRVGGRRQAVECIEDLLNESGQPLDLSCKRPRP 
HAdV2/5 E1A  PEIHPVVPLCPIKPVAVRVGGRRQAVECIEDLLNEPGQPLDLSCKRPRP 
HAdV5   E1A  PEIHPVVPLCPIKPVAVRVGGRRQAVECIEDLLNEPGQPLDLSCKRPRP 
             *********************************** ************* 
 
 
The sequence alignment shows the differences between the E1A 13S proteins 
from the HAdV2, the HAdV5 and HAdV 2/5 hybrid that we studied in the 
present work (summarized on table 6.2). The hybrid between both constructs 
is essentially the sequence of HAdV2 13S E1A protein with exception for the 
residue number 276 which is a proline originated from the HAdV5 13S E1A 
protein sequence. There is also a glycine residue on position 148 instead of the 
expected glutamic acid typical from both HAdV 2 and 5 types. 	  
	   	  
Table 6.2. Comparison of amino acid differences between E1A protein sequences from 
HAdV2, HAdV5 and the resulting HAdV2/5 hybrid 
HAdV 13S E1A 
residue number HAdV2 E1A HAdV5 E1A HAdV2/5 E1A hybrid 
  68 E D E 
  81 F L F 
148 E E G 
209 L M L 
210 V A V 
276 S P P 
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Sequence alignment of HAdV2 E1A 12S and 13S proteins 	  
HAdV2 13S    MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEE 
HAdV2 12S    MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEE 
             ************************************************************ 
 
HAdV2 13S    AVSQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVI 
HAdV2 12S    AVSQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVI 
             ************************************************************ 
 
HAdV2 13S    DLTCHEAGFPPSDDEDEEGEEFVLDYVGHPGHGCRSCHYHRRNTGDPDIMCSLCYMRTCG 
HAdV2 12S    DLTCHEAGFPPSDDEDEEG----------------------------------------- 
             *******************                                          
 
HAdV2 13S    MFVYSPVSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSPVSRECNSSTDSCDSGPSNTP 
HAdV2 12S    -----PVSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSPVSRECNSSTDSCDSGPSNTP 
                  ******************************************************* 
 
HAdV2 13S    PEIHPVVPLCPIKPVAVRVGGRRQAVECIEDLLNESGQPLDLSCKRPRP 
HAdV2 12S    PEIHPVVPLCPIKPVAVRVGGRRQAVECIEDLLNESGQPLDLSCKRPRP 
             *************************************************	  
 
The sequence alignment difference between the HAdV2 12S and 13S E1A 
proteins is essentially the 46 residues corresponding to the CR3 domain, 
which is predicted to be folded. The CR3 domain is only present on the 13S 
E1A protein, between the residues 144 and 191. 
 
Sequence alignment of HAdV 2/5 13S E1A proteins with HPV16 E7 protein  
 
E1A      MRHIICHGGVITEEMAASLLDQLIEEVLADNLPPPSHFEPPTLHELYDLDVTAPEDPNEE 
E7       -----------------------------------MHGDTPTLH---------------- 
                                             * : ****                 
 
E1A      AVSQIFPESVMLAVQEGIDLFTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNLVPEVI 
E7       -------------------------------------------------EYMLDLQPETT 
                                                            * :* **.  
 
E1A      DLTCHEAGFPPSDDEDEEGEE-----------FVLDYVGHPGHGCRSCH---------YH 
E7       DLYCYEQLNDSSEEEDEIDGPAGQAEPDRAHYNIVTFCCKCDSTLRLCVQSTHVDIRTLE 
         ** *:*     *::***                :: :  :     * *           . 
 
E1A      RRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKLVPAILRRPTSP 
E7       DLLMGTLGIVCPICSQKP------------------------------------------ 
             *   *:* :*  :                                            
 
E1A      VSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGGRRQAVECIEDLLNEPGQPL 
E7       ------------------------------------------------------------ 
                                                                      
 
E1A      DLSCKRPRP 
E7       --------- 	  
The alignment between the HAdV2/5 hybrid and the HPV 16 E7 protein 
showed an identity matrix of 29.5 %. The observed similarity is essentially 
between the CR1 and CR2 regions from both proteins. 
 
